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Abstract 
Macroautophagy (hereafter referred to as autophagy) is a highly conserved eukaryotic 
cellular response to starvation, resulting in the formation of double-membrane vesicles 
known as autophagosomes. These sequester cytoplasmic contents to the lysosome, where 
they are degraded to generate amino acids which can be used for protein synthesis during 
periods of nutrient deprivation. Membrane targeting of LC3, the major structural protein of 
the autophagosome, is essential for autophagy. LC3 is processed from its cytosolic form 
(LC3-I) to its lipidated form (LC3-II) in a series of ubiquitin-like conjugation events. Of 
particular importance is Atg16-like-1 (Atg16L1), which through its interactions with Atg5-
Atg12, specifies the site of LC3 incorporation into the expanding autophagosomal 
membrane. 
 
In this study tools have been generated for the study and characterisation of Atg16L1 
domains in cell culture. Atg16L1 -/- MEFs have also been generated and used for 
reconstitution experiments, which confirm that the coiled-coil domain of Atg16L1 is 
sufficient to restore autophagy in response to starvation and to a surrogate pathogen.  
A novel interaction between Atg16L1 and the serine/threonine kinase MEKK4 has been 
characterised in this study. Existing research has established an interaction between the 
pathogen recognition receptors NOD1/2 and Atg16L1. The NOD receptors are activated by 
bacterial peptidoglycan (PG), which has been shown to drive autophagy. Interestingly, 
MEKK4 inhibits NOD2 signalling by binding the downstream adaptor protein RIP2, leading 
to the hypothesis that MEKK4 may play a role in autophagy. The interaction was verified by 
co-immunoprecipitation, with domain analysis indicating that MEKK4 binds to the linker 
region of Atg16L1. The kinase activity of MEKK4 was also required for the interaction. The 
complex between Atg16L1 and MEKK4 persisted during starvation induced autophagy. 
Lipidation of LC3 in response to starvation required expression of MEKK4, with a 
redistribution of LC3 to large perinuclear aggregrates that co-localised with p62 and 
ubiquitin in siRNA silenced cells and CRISPR/Cas MEKK4 knockout cells. The aggregates 
were also able to recruit LC3 I, indicating a role of aggresome-like induced structures 
(ALIS). 
This thesis documents an interaction between Atg16L1 and MEKK4 that is vital for LC3 
processing. The potential role for MEKK4 in regulating autophagy through Atg16L1 is 
discussed and experiments proposed to further explore this interaction in the context of 
autophagy.
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1: Introduction 
1.1 Overview of Autophagy   
Autophagy was originally discovered more than forty years ago as a cellular response to 
starvation, where cells digest portions of the cytosol to generate amino acids.  This catabolic 
process involves the trafficking of proteins and organelles to the lysosome for degradation, 
with subsequent amino acids recycled back to the cytosol. Autophagy is highly conserved 
from simple eukaryotes such as yeast to complex higher eukaryotes such as humans (Yang 
and Klionsky., 2009). 
Three distinct forms of autophagy have been described in eukaryotic cells – 
macroautophagy, microautophagy and chaperone mediated autophagy. Microautophagy 
involves the direct engulfment of cytoplasm at the lysosome surface by invagination, 
protrusion and septation of the lysosomal membrane (Yang and Klionsky., 2009). In 
contrast, chaperone mediated autophagy does not involve this type of membrane 
rearrangement. Instead, chaperone proteins interact with targeting sequences on cargo 
proteins, resulting in translocation of unfolded, soluble proteins directly across the limiting 
membrane of the lysosome (Bandyopadhyay et al., 2008).  
Macroautophagy, the subject of this report and herein referred to as autophagy, involves 
formation of new membranes that engulf and sequester cytoplasmic components into 
double membrane vesicles, known as autophagosomes. These fuse with lysosomes, forming 
autolysosomes, where the contents are degraded in the lumen by lysosomal enzymes, with 
the resulting amino acids recycled to the cytosol through membrane permeases (Figure 
1.1). Autophagy occurs at basal levels within the majority of cells, performing 
‘housekeeping’ functions including the turnover of proteins and organelles and as such, acts 
as a quality control system. However, it is dramatically upregulated during cellular stress 
e.g. nutrient starvation or growth factor withdrawal (Yang and Klionsky., 2009). Autophagy 
also provides a detoxification pathway that removes toxic cytosolic components, protein 
aggregates, damaged organelles and intracellular pathogens for degradation and recycling 
(Shintani and Klionsky., 2004). It can play a role during developmental processes, allowing 
cells to meet amino acid-poor growth conditions (Levine and Klionksy., 2004). Autophagy 
has an essential role in cell survival, development and homeostasis, and is implicated in the 
pathogenesis of human diseases, such as cancer, neurodegenerative disorders including 
Alzheimer’s and Parkinson’s disease, infection and inflammatory disorders (Huang and 
Klionksy., 2007; Mizushima et al., 2008; Levine and Kroemer., 2008). Importantly, 
autophagy is also an effector of innate and adaptive immunity providing a defence against 
intracellular pathogens, and influencing MHC II presentation of antigens (Paludan et al., 
2005; English et al., 2009). 
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1.1.1 The core molecular machinery in mammalian autophagy 
The molecular regulators of autophagy have been studied in detail, with many essential 
ATGs (autophagy-related genes) first identified in yeast and their orthologs found in other 
organisms; confirming the conservation of autophagic machinery across eukaryotes (Huang 
and Klionsky., 2007). To date more than 30 ATGs have been identified (Yang and Klionksy., 
2009). Among these proteins, one subset is essential for autophagosome formation, and is 
referred to as the core molecular machinery; this drives the initiation, expansion and closure 
of the autophagosome (Xie and Klionksy., 2007; Mehrpour et al., 2010b). The core ATG 
proteins can be grouped into four subgroups; the ATG1/unc-51-like-kinase (ULK) complex; 
the class III phosphatidylinositol 3-kinase (PI3K)/Vps34 complex I; the transmembrane 
protein mATG9, and lastly the two ubiquitin-like protein (ATG12-ATG5:ATG16L and 
ATG8/LC3) conjugation systems. These core ATG proteins are recruited to the site of 
autophagosome formation; the phagophore assembly site (PAS) (Yang and Klionksy., 2010; 
Proikas-Cezanne et al., 2004). 
 
This report focuses on mammalian autophagy, which differs in some part to the yeast 
autophagy pathway. 
The mammalian target of rapamycin complex 1 (mTORC1) plays a key role in the control 
of autophagy. mTORC1 is a highly conserved serine/threonine protein kinase that acts as a 
central sensor of growth factors, nutrient signals and the energy status of the cell (Yang 
and Klionsky., 2010). When the cell has a ready supply of nutrients, mTORC1 inhibits the 
induction of autophagy. However during starvation or in the presence of the drug 
rapamycin, mTORC1 is inhibited and consequently autophagy is upregulated (Yang and 
Klionsky., 2009). 
 
Under nutrient rich conditions, mTORC1 inhibits autophagy by binding the ULK complex, 
which contains ULK1/2, ATG13 and FIP200. mTOR inactivates ULK1/2 by phosphorylation 
(Chan et al., 2009; Ragusa et al., 2012; Mehrpour et al., 2010a).  
Inactivation of mTORC1 by starvation or rapamycin leads to the dissociation of the ULK 
complex from mTORC1, and activation of ULK1/2 kinase activity, resulting in the 
phosphorylation of Atg13 and FIP200 (Chan et al., 2009; Ragusa et al., 2012; Mehrpour et 
al., 2010a). 
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Figure 1.1: A schematic representation of the autophagy pathway 
Autophagy involves the formation of double membrane vesicles known as autophagosomes, 
which sequester cytoplasmic components and protein aggregates. Their initiation, 
elongation and closure are regulated by the core machinery of the autophagy pathway. In 
yeast, following maturation, the autophagosome will fuse with a lysosome, generating an 
autolysosome; the contents of which are degraded and recycled back to the cytosol through 
membrane permeases. In mammalian autophagy, the autophagosome is thought to fuse 
with components of the endocytic pathway forming an amphisome, prior to lysosomal 
fusion.  
Image from Yang and Klionsky, 2010
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The endoplasmic reticulum (ER) is a well characterised site of autophagosome formation, 
with early autophagosomes (phagophores) arising from ER-derived omegasomes (Axe et 
al., 2008). Other subcellular compartments have also been shown to contribute to the 
membrane of the autophagosome e.g. plasma membrane and Golgi (Ravikumar et al., 
2010; Ge et al., 2014). The nucleation and assembly of the early autophagosome depends 
upon the PI3K complex. This consists of hVps34, its regulatory protein kinase hVps15, 
Beclin1 and ATG14L/Barkor (Itakura et al., 2008; Sun et al., 2008). The class III Vps34 lipid 
kinase is activated (Wirth et al, 2013), translocates to the ER along with the ULK complex, 
and produces an autophagosome specific pool of phosphatidylinositol 3-phosphate 
(PtdIns(3)P or PI3P) (Russell et al., 2013). The activity of this complex is tightly regulated; 
positive regulators include vacuole membrane protein 1 (VMP1) and myeloid differentiation 
factor 88 (MyD88) (Cecconi and Levine., 2008; Mehrpour et al., 2010a).  
 
During autophagosome formation, the increased levels of PI3P at the membrane of the 
elongating phagophore leads to the recruitment of autophagy specific PI3P effectors, such 
as DCFP1 (double FYVE-containing protein 1) and the WIPI (WD-repeat PI3P-effector 
protein) family of proteins (Karanasios et al., 2013; Koyama-Honda et al., 2013; Polson et 
al., 2010). The WIPI proteins are phospholipid-binding effectors, which can act as a PI3P 
scaffold in the early stages of autophagy (Proikas-Cexanne et al., 2004).  
 
The only known transmembrane autophagy protein is mATG9 or ATG9L1. During nutrient 
rich conditions, mATG9 traffics between the trans-Golgi network and late endosomes 
(Young et al., 2006). In response to autophagy activation, mATG9 translocates to a 
peripheral pool where it co-localises with the autophagosome markers LC3 and Rab7. The 
trafficking of mAtg9 is dependent upon the p38α mitogen-activated protein kinase and its 
binding protein p38IP (Webber and Tooze., 2010). The putative role(s) of mAtg9 in 
autophagy is to serve as a platform for recruiting effectors to the developing 
autophagosome and/or act as a lipid carrier (Longatti and Tooze., 2009). 
To enable expansion of the forming autophagosome, two vital protein complexes are 
required; the multimeric ATG12–ATG5-ATG16L complex and the lipidated form of LC3 and 
its family members GATE16 and GABARAP (GABA receptor-associated protein) 
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(Kabeya et al., 2000; Mizushima et al., 2003). Both utilise evolutionarily conserved ubiquitin-
like conjugation systems which allow association with the autophagosome and eventual 
incorporation of LC3 into the membrane. ATG12 is activated by ATG7 in a process 
homologous to the E1 ubiquitin-activating enzyme. The activated ATG12 is then conjugated 
to ATG5 via an internal lysine residue by ATG10 in a reaction similar to the E2 ubiquitin-
conjugating enzyme (Figure 1.2). The ATG12–ATG5 conjugate is then able to interact with 
ATG16L in a non-covalent manner, which subsequently oligomerises to form a large 
multimeric complex referred to as the ATG16L complex (Mizushima et al., 2003; Mehrpour 
et al., 2010b). This complex is thought to generate curvature in the autophagosome 
membrane. The interaction between ATG16L1 and WIPI2 drives recruitment of the 
ATG16L1 complex to the membrane of the developing autophagosome, which is dependent 
on PI3P formation (Figure 1.2) (Dooley et al., 2014; Itakura and Mizushima et al., 2010). 
Interactions between ATG16L1, FIP200 and ubiquitin have also been shown to play a role 
in the recruitment of ATG16L1 to the autophagosome membrane (Gammoh et al., 2013; 
Nishimura et al., 2013; Fujita et al., 2013). In a separate reaction ATG8/LC3 is cleaved by 
ATG4 at its C-terminus, exposing a glycine residue. At this point LC3 is referred to as LC3 
I. In the absence of autophagy this form of LC3 remains cytosolic and diffuse. During 
autophagy the E1-like activating enzyme ATG7 activates LC3, and ATG3 binds to and is 
activated by ATG12, allowing ATG3 (E2-like) to transfer PE (phosphatidylethanolamine) to 
the C-terminus of ATG8/LC3 (Ichimura et al., 2000; Sakoh-Nakatogawa et al., 2013). This 
generates LC3 II, its lipidated form. The ATG16L complex actively recruits LC3 I to the 
expanding phagophore membrane, defining the site where it is conjugated to PE (Saitoh et 
al., 2008). The lipidated form of LC3 associates with both the inner and outer membranes 
of the developing phagophore/autophagosome. Membrane expansion leads to the 
sequestration of cytosol and closure of the autophagosomal membrane. When the 
autophagosome is fully formed, the ATG16L complex and other Atg associated proteins 
dissociate from the membrane, with LC3 remaining attached (Mizushima et al, 2003; 
Mizushima et al, 2001). LC3 present on the outer/cytosolic membrane is cleaved from the 
PE by the protease ATG4, and recycled back to the cytosol (Mehrpour et al., 2010b). At this 
point only LC3 remains associated with the inner autophagosomal membrane. The LC3 
family members assist the expansion and closure of the autophagosome (Fujita and 
Hayashi-Nishino et al., 2008; Weidberg et al.,2011), and as such are a useful marker for 
the identification of autophagosomes. The next stage of the autophagy pathway involves 
the maturation of the autophagosome. This consists of the docking and fusion of the 
autophagosome with lysosomal compartments, which then becomes the autolysosome. The 
autolysosome is a functional degradative compartment, acquiring lipases and proteases 
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from the lysosome (Simonsen and Tooze., 2009). Though there is plenty of data to support 
this model in yeast, there is a lack of evidence in mammalian cells. It has been suggested 
that the autophagosome matures following input from the endocytic pathway, prior to 
fusion with the lysosome. The autophagosome can merge with endocytic compartments, 
such as the early and late endosomes, and MVBs (multivesicular bodies) (Liou et al., 2997; 
Razi et al., 2009), resulting in the formation of amphisomes. The lumen of the amphisome 
is more acidic than that of the autophagosome, gaining hydrolytic enzymes from the 
endocytic vesicle. This stage of autophagy depends on the acidification of autophagic 
compartments, and the proteins that regulate the fusion of autophagosomes with 
components of the endocytic pathway (Mehrpour et al., 2010b). The final stage of the 
pathway is vesicular breakdown and degradation of the lumenal contents of the 
autophagosome/amphisome, carried out by lysosomal cathepsins, among other enzymes. 
The inner membrane of the autophagosome is also degraded along with associated LC3 II, 
which is released into the lumen of the autolysosome. The digested lipids and amino acids 
are subsequently exported back into the cytoplasm to be recycled (Xie and Klionsky., 2007; 
Yang and Klionsky., 2009). 
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Figure 1.2: Two ubiquitin like systems involved in autophagosome formation 
The two ubiquitin-like conjugation systems are utilised during autophagosome formation. 
(A) Atg12 is activated in an E1-like manner by Atg7. Atg12 can then be conjugated to Atg5 
through an E2-like reaction with Atg7. This complex can then associate with Atg16L, which 
can actively recruit LC3 to the developing autophagosome.  
(B) Atg8/LC3 is processed using another ubiquitin-like conjugation system utilising Atg7 
(E1-like), Atg3 (E2-like) and the ATG16L complex (E3-like) (Geng and Klionsky., 2008). 
(C) The Atg16L1-complex is recruited to the phagophore in early autophagy by WIPI2. The 
Atg16L complex specifies the site of LC3 lipidation and incorporation of LC3 into the 
autophagosomal membrane. For the sake of simplicity, “Atg” has been omitted from this 
section of the diagram. 
Images modified from Geng and Klionsky, 2008; Dooley et al., 2014.  
A 
B 
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1.1.2 Autophagy in health and disease 
In recent years, it has become clear that autophagy has a role to play in various aspects of 
human health. Autophagy promotes health by performing ‘housekeeping’ functions in the 
cells, eliminating defective or long-lived proteins and organelles, preventing abnormal 
protein aggregate accumulation and removing intracellular pathogens (Figure 1.3). This 
enables autophagy mediated protection against ageing, neurodegenerative diseases and 
pathogen infection (Levine and Kroemer., 2008). Conversely, defective or dysregulated 
autophagy has also been linked with the pathogenesis of disease, including 
neurodegeneration, cancer and inflammatory disease. 
The role of autophagy in immunity and inflammation has become a great area of interest. 
The innate and adaptive immune response in mammals aims to provide defence 
mechanisms against invading pathogens which threaten the host, including bacteria, fungi 
and viruses (Medzhitov., 2007). Autophagy has been implicated in the homeostasis of T 
and B cells, the positive and negative selection of CD4 T cells, thymic selection enabling the 
regulation of self-tolerance and the delivery of antigenic peptides to MCH II processing 
compartments (Mehrpour et al., 2010a; Deretic and Levine., 2009; Schmid et al., 2007).  
As part of the innate immune response, autophagy aids the targeted removal of 
microorganisms that invade the cell; this is termed xenophagy (Figure 1.3). Many medically 
important microorganisms are eliminated from the cell by this process including the bacteria 
Staphylococcus aureus and Mycobacterium tuberculosis, and the parasite Toxoplasma 
gondii (Deretic and Levine., 2009). During xenophagy invading microbes and their 
intermediates are captured and delivered to various cellular compartments, where they 
subsequently activate pathogen recognition receptors (PRRs), resulting in proinflammatory 
signalling. Interestingly, autophagy can also downregulate the proinflammatory response, 
including interleukin (IL) -1β, IL-18 and type I interferon production (Deretic and Levine., 
2009). It appears that the immune system and autophagy are intricately linked, supporting 
its importance in health and disease.  
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Figure 1.3: Autophagy in innate and adaptive immunity 
In xenophagy, invading pathogens are engulfed by autophagosomes and degraded in the 
autolysosome. Autophagy can also activate innate immunity by delivering viral nucleic acids 
to compartments contain the PRR Toll-like receptor 7. When activated, this receptor can 
signal the induction of a type 1 interferon response. Autophagy is also involved in the 
delivery of antigenic pathogens to MHC-II processing compartments. Antigenic peptides 
can then be presented on the surface of APCs, where they are recognised by CD4+ T cells, 
which activates the adaptive immune response  
Image from Levine and Kroemer (2008).  
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1.2 A mutation in the autophagy gene ATG16L1 is associated with 
Crohn’s disease 
Increasing evidence suggests a strong link between mutations in autophagy and 
autophagy-related genes and inflammatory bowel disease (IBD); two main subsets of which 
are ulcerative colitis (UC) and Crohn’s disease (CD). Epidemiological data strongly supports 
a genetic contribution in the pathogenesis of Crohn’s disease. Fifteen percent of patients 
with CD have a family member affected by IBD; the relative risk to siblings is approximately 
17x population risk with around 50% concordance in identical twins, compared to less than 
10% in non-identical twins (Stappenbeck et al., 2011; Breslin et al., 1997).  
Genome-wide association studies (GWAS) have found that a point mutation in the 
autophagy gene ATG16L1 is implicated in CD (Barrett et al., 2008; Hampe et al., 2007; 
Rioux et al., 2007; Consortium., 2007; Cheng et al., 2010). The mutation in question 
encodes a base pair substitution from an adenine to a guanine, which results in a single 
amino acid exchange from a polar threonine to a non-polar alanine at position 300 amino 
acid of ATG16L1 (T300A). This single nucleotide polymorphism (SNP) appears to carry 
nearly all the disease risk exerted by ATG16L1 (Hampe et al., 2007). Studies have shown 
that the ATG16L1 protein is expressed in the colon, small intestine, intestinal epithelial cells, 
leukocytes and spleen (Fujita et al, 2008). Additionally, the T300A mutation has been 
associated with the onset of a specific subtype of CD; ileal CD (Sventoraityte et al., 2010). 
Crohn’s disease and ulcerative colitis are both chronic and debilitating inflammatory 
disorders affecting the gastrointestinal tract. CD differs from ulcerative colitis in that CD 
inflammation mostly involves the ileum and colon, though it can affect any region of the 
gut. The inflammation associated with the disease is transmural, typically discontinuous and 
associated with granulomas. Ulcerative colitis, on the other hand, is usually limited to the 
colon and rectum, with continuous inflammation that is confined to the superficial mucosal 
and submucosal layers of the intestinal wall (Cho, 2008, Stappenbeck et al., 2011). It is 
apparent that the barrier function of the gut epithelium, commensal bacteria and 
appropriate intestinal immune response are important to the maintenance of a healthy gut. 
In CD, these factors no longer appear to function correctly, leading to prolonged activation 
of the immune response and chronic inflammation. Impaired immune defence mechanisms 
against bacteria may be due to genetic susceptibility; this link is apparent in GWA studies. 
Research is beginning to point towards how the T300A polymorphism contributes towards 
the pathogenesis of CD, but to greater understand the significance of this mutation, the 
structure of ATG16L1 and its known functions will be outlined below. 
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Table 1.1. A comparison between mouse and human Atg16L1 on the genetic 
and protein level 
 
Gene Organism Accession 
no. 
cDNA 
length 
(bp) 
Nucleotide 
homology 
Number 
of 
residues 
(aa) 
Protein 
homology 
ATG16L1 
γ 
Homo 
sapiens 
NM_030803.6 1875  
89 % 
624  
94% 
Atg16L1 
γ 
Mus 
musculus 
NT_078297.6 1872 623 
 
 
1.2.1 Structure and function of ATG16L1 
The ubiquitin-like conjugation systems, utilising the ATG8 system and the ATG16L1 
complex, are evolutionarily conserved across eukaryotes. The protein ATG16L1 shares 
many similarities with its yeast counterpart ATG16. Both comprise of an N-terminal ATG5-
binding domain, followed by a coiled-coil domain (CCD). In higher complex eukaryotes there 
is an additional linker region and a WD40 repeat domain at the C-terminus (Figure 1.4 a). 
The T300A polymorphism falls towards the end of this linker region, before the start of the 
WD40 repeat. Alignment of the amino acid sequence from Saccharomyces cerevisiae 
(yeast) and from Mus musculus (mouse) shows homology in the CCD. The homology, 
though weak, is significant and lies between amino acids 28-145 with around 22% identity 
and 43% similarity (Mizushima et al., 2003) . Mus musculus and Homo sapiens (human) 
ATG16L1 share high nucleic acid identity (89%) and amino acid similarity (94%) (Table 
1.1). Both contain a linker region and seven WD40 repeats at the C-terminal end, something 
which yeast ATG16 completely lacks (Mizushima et al., 2003). The WD40 motif was 
originally identified in the β subunits of G proteins, and forms blades which can assemble 
into a β-propeller structure. This symmetrical structure acts as a stable platform, allowing 
interactions with various proteins (Smith et al., 1999). The WD repeat itself is a 40-60 amino 
acid sequence that typically contains a GH dipeptide 11-24 residues from its N-terminus 
and the WD dipeptide at its C-terminus. The WD40 repeat domain in ATG16L1 is not 
required for autophagy, but is conserved across higher eukaryotes. 
The crystal structure of yeast ATG16 has shown it forms a parallel coiled-coil dimer, in 
solution. Sequence alignment of ATG16 homologues suggests that this model is a conserved 
feature (Fujioka et al., 2010). However, more structural analysis is needed to confirm 
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whether the structure of ATG16L1 conforms to this model. Residues 22-46 of yeast ATG16 
form an alpha helix that binds ATG5. Both the ATG5 binding region and the CCD are widely 
conserved. A model of the yeast ATG12–ATG5-ATG16 complex has been proposed (Figure 
1.4 b), though it has yet to be experimentally determined. As the crystal structure of the 
full length mammalian ATG16L1 has not been determined, it is not clear whether the WD40 
domain assembles into 7 or 8 blades. The number of predicted WD40 repeats has been 
disputed (Mizushima et al., 2003; Hampe et al., 2008), with the potential eighth WD40 
repeat containing the T300A polymorphism. Until this structure is crystallised, the position 
of the T300A mutation will remain unknown. 
A homologue of Atg16L1 was identified which is not required for autophagy; Atg16L2 
(Ishibashi et al., 2011). Whilst the N-terminus (including the majority of the CCD) and the 
C-terminal WD40 domains are conserved (32.1% and 43% amino acid identity, 
respectively), the end of the CCD and linker region are relatively poorly conserved (20.7% 
amino acid identity). Characterisation of Atg16L2 determined that it was unable to localise 
to the autophagosome, and that this was likely due to the poor conservation in this region 
(Ishibashi et al., 2011). 
To greater understand the role of ATG16L1 and the function of the T300A mutation in CD, 
various mouse models have been developed, which are discussed below. 
 
1.2.2 Development of Atg16L1 mouse models 
To further understand the role of Atg16L1 in autophagy and the significance of the T300A 
mutation, a number of mouse models have been generated. Attempts to create a complete 
knockout mouse of Atg16L1 have resulted in a post-natal phenotype, with mice dying within 
1 day of delivery (Saitoh et al., 2008). This phenotype has occurred previously in Atg5- and 
Atg7- knockout mice, demonstrating the requirement of these autophagy proteins during 
the neonatal starvation period (Kuma et al., 2004; Komatsu et al., 2005).  
The first Atg16L1 deficient mouse model was generated by deletion of the coiled-coil 
domain of Atg16L1, with the resulting mice expressing a truncated Atg16L1 protein (ΔCCD) 
(Saitoh et al., 2008). However, this was not a knockout of Atg16L1. As the linker and WD40 
domains remain, this mouse model can be considered a functional knockout. Nonetheless, 
this mutation led to post-natal mortality, indicating how vital Atg16L1 is for survival. Mouse-
embryonic fibroblasts (MEFs) harvested from these mice were deficient in autophagy 
following starvation. Additionally, Atg16L1 was required for conjugation of LC3 to PE, with 
an overall decrease in the bulk degradation of long lived proteins (Saitoh et al., 2008). 
Studies arising from the creation of these mice confirmed the vital importance of the CCD 
domain in the function of autophagy. Whilst this study highlights the importance of the CCD 
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in autophagy, it does not address the consequences of the T300A mutation, or the function 
of the WD40 repeat domain.  
The issue of lethality in Atg16L1 functional knockout mice has been overcome in part by 
the development of a mouse hypomorphic for Atg16L1 protein expression by Cadwell et al 
2008. The levels of Atg16L1 expression were confirmed to be 23-37% of expected levels. 
Whilst not a true knockout (recruitment of LC3 to the autophagosome was not completely 
ablated), this mouse can give an indication of the impact low levels of functional Atg16L1 
may have on autophagy and the gut. Markers of autophagy were altered in Atg16L1HM ileal 
lysates in a similar fashion to mice with diminished Atg5 expression demonstrating a 
consistent role for Atg16L1 and Atg5 in ileal autophagy (Cadwell et al., 2008). Infection of 
these mice with the bacteria Listeria monocytogenes found no increase in susceptibility to 
systemic infection when compared to controls, indicating that in this mouse model, Atg16L1 
is not important for microbial processing. What was most striking however, was the Paneth 
cell abnormalities seen in Atg16L1HM mice. Paneth cells are part of the intestinal epithelium 
and are located at the base of the intestinal crypt. They play an essential role in the control 
of intestinal microbiota by secretion of antimicrobial peptides and lysozyme packaged within 
granules (Porter et al., 2002). The Paneth cell abnormalities seen in the Atg16L1HM mice 
affected the packaging of the lysozyme, granule number and organisation, which 
phenocopied abnormalities seen in CD patients carrying the ATG16L1 risk allele (Cadwell et 
al., 2008).  
The abnormalities seen in ATG16L1HM mice were later found to be dependent upon 
persistent infection with murine norovirus (MNV) (Cadwell et al., 2010). ATG16L1HM mice 
were rederived by embryo-transfer into an enhanced barrier facility, where more steps are 
taken to lower the risk of infection e.g. all cages, bedding and chow are autoclaved prior to 
use and sentinel mice are used and routinely screened for common mouse pathogens. 
When raised in the enhanced barrier facility the ATG16L1HM mice gut morphology was 
comparable to wild type mice. The Paneth cell abnormalities could be reconstituted 
following infection with MNV (Cadwell et al., 2010; Simmons., 2010).  
Tissue specific knockouts of Atg16L1 have been generated by Conway et al., 2013, who 
have studied the effects of Atg16L1 deficiency in the intestinal epithelium (IEC) and 
dendritic cells. The expression of Atg16L1 was conditionally knocked out using either the 
Villin-cre promoter for intestinal epithelial cre expression, or the CD11c-Cre promoter for 
dendritic mononuclear cell cre expression. Knockout of Atg16L1 was confirmed by Western 
blotting, with impaired LC3 conversion and accumulation of p62 (Conway et al., 2013). 
These mice were then infected with Salmonella typhimurium SL1344, a strain able to 
traverse the epithelium and disseminate systemically. These studies found an intestinal 
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specific requirement for autophagy in the clearance of bacteria and prevention of systemic 
infection, however this was not the case for the dendritic cells. Atg16L1 expression was 
essential for co-localisation of S.typhi with LC3, and furthermore, the Paneth cells in IEC 
specific Atg16L1 knockouts displayed abnormalities in lysosome granules, antimicrobial 
peptide expression, and a decrease in the overall number of Paneth cells per crypt 
compared to a control mouse. Whilst the Paneth cell abnormalities are similar between the 
IEC specific knockout and the Atg16L1HM mouse model, there is a difference in requirement 
of Atg16L1 in the prevention of systemic infection. The residual expression of Atg16L1 in 
the hypomorph may account for the lack of significant results in infection studies. 
Alternatively, the use of different types of bacteria (Salmonella and Listeria) could also have 
affected the outcomes of the studies, as the manner in which these bacteria interact with 
the host cell and autophagy machinery may not be comparable. 
These mouse models show how genetic susceptibility, virus infection, injury to the gut 
mucosa, commensal and pathogenic bacteria all interact to initiate an inflammatory 
response, similar to that seen in CD in humans. CD pathogenesis is a very complex process, 
it is still unclear precisely what causes the disease, and as yet there is no known cure. 
Reproducing some, but not all, pathologies seen in CD patients raises the possibility that 
virus infection can interact with gene susceptibility to trigger chronic inflammation. 
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Figure 1.4: Conservation of Atg16L1 domains and proposed model of the yeast 
ATG12–ATG5-ATG16 complex 
(A) Schematic representation of yeast Apg16 and murine Atg16L1 γ. The coiled-coil domain 
in yeast Apg16 is conserved in mouse Atg16L1, with the addition of a linker and WD40 repeat 
domain. Modified from Mizushima et al., 2003. 
(B) Two ATG16 molecules are able to form a parallel coiled-coil dimer (shown in green and 
yellow), though more structural analysis is required to confirm whether this structure 
applies to ATG16L1. However, sequence alignment of ATG16 homologues suggests that 
this model is a conserved feature, and would explain how ATG16 oligomerises to form the 
tetrameric ATG12–ATG5-ATG16 complex. ATG5 and ATG12 are coloured cyan and red, 
respectively.  
Image from Fujioka et al (2010).
A 
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1.2.3 Cell culture and mouse models of the CD associated mutation 
in Atg16L1  
The consequences of the ATG16L1 T300A mutation are slowly being unravelled, aided early 
on by the development of the first Atg16L1 mouse models. A study by Fujita et al 2009, 
utilised MEFs from the Atg16L1 functional knockout mouse model developed by Saitoh et 
al, 2008. By expressing constructs containing the CCD of ATG16L1, or full length ATG16L1 
T300A polymorphism they were able to reconstitute starvation induced autophagy (Fujita 
et al., 2009). This indicates that the T300A mutation and WD40 repeat domain are not 
required for starvation induced autophagy (Fujita et al., 2009). MEFs reconstituted with the 
CCD construct and the full length T300A construct were infected with Salmonella 
typhimurium. This resulted in no apparent difference in autophagosome formation around 
S.typhimurium which would suggest that the WD40 repeat domain and T300A mutation 
have no influence over xenophagy. However, an important point to note is that MEFs do 
not represent the highly specialised cells in the gut epithelium and mucosal immune system, 
as they lack important pathogen recognition receptors (PRRs) such as NOD2.  
The findings of the Fujita et al, 2009 study conflicts with findings in cell culture studies. To 
elucidate the role of the ATG16L1 T300A polymorphism in CD, a study was carried out by 
Kuballa et al, 2008, using HeLa, Human embryo kidney 293 (HEK293) and the colonic Caco2 
cell lines. Expression of the T300A polymorphism in ATG16L1 silenced cells did not affect 
basal autophagy, nor did it affect the ability of ATG16L1 to bind ATG5 (Kuballa et al., 2008). 
However, expression of the T300A variant diminished the cell’s ability to handle intracellular 
pathogens when infected with Salmonella typhimurium. This decrease in the efficiency of 
xenophagy could have consequences for the gut mucosal immune system, as cells may not 
respond appropriately to pathogen invasion. This study suggests that the effect of the 
T300A mutation may be confined to a selective form of autophagy.  
These previous papers utilise an overexpression method to study the Atg16L1 T300A 
variant. A cell culture based knock-in model was developed by Messer et al., 2013 using 
the colorectal cell line HCT116. Cells that expressed the CD associated T300A variant were 
protected against invasion by Salmonella, however those T300A expressing cells that were 
invaded by the bacteria showed an increase in intracellular bacterial growth due to reduced 
clearance of microbes by autophagy. The conflicting results in these cell culture based 
studies highlight the importance of cell type when monitoring xenophagy. Whilst all these 
studies have used the same bacteria (Salmonella), the cell lines have been the variable. It 
has also been shown that Salmonella invasion of fibroblasts occurs though distinct 
mechanisms compared to epithelial cells (Aistui et al., 2010), so the manner in which 
bacteria invade different cell types could impact the requirements for autophagy. 
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Additionally, genotyping of gastrointestinal cell lines has identified that the Caco2 cell line 
carried SNPs associated with IBD for ATG16L1 and NOD2 (Huebner et al., 2010). Therefore, 
results of studies using this particular cell line should be treated with caution, as it is difficult 
to decouple the results from the expression of the SNP. The study of the T300A mutation 
in vivo offers the best opportunity to resolve the effects of the ATG16L1 T300A mutation 
on autophagy and xenophagy. 
Two independent groups developed a T300A knock-in mouse model in 2014, with both 
discovering and characterising a putative caspase cleavage motif that lies adjacent to the 
T300 residue (Murthy et al., 2014; Lassen et al., 2014). The cleavage of this motif is 
mediated by caspase 3 (Murthy et al., 2014) and possibly by caspase 7 (Lassen et al., 
2014). Importantly, a functional consequence of the T300A mutation was identified using 
a combination of cells derived from the knock-in mouse model and human cells donated 
from carriers of the T300A mutation. The caspase mediated cleavage of Atg16L1 is 
enhanced in the T300A variant, which was shown to have a subsequent effect on autophagy 
(Murthy et al., 2014). Defects in Paneth cells were also observed, similar to those seen in 
the Atg16L1HM, IEC specific knockout mouse models and CD patients. Infection of MEFs 
isolated from the T300A knock-in mice with Shigella confirmed a reduction in xenophagy 
(Lassen et al., 2014). Precisely how the caspase cleavage mechanism contributes to CD is 
unclear, though it paves the way for further studies focusing on activation and regulation 
of caspase pathways in the context of microbial infection, with the knock-in mice a valuable 
tool in achieving this. 
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1.2.4 Crohn’s disease susceptibility gene interactions – NOD2 and 
ATG16L1 
A vital arm of the innate immune system are the PRRs, which sense conserved pathogen 
associated molecular patterns (PAMPs); this includes viruses and their nucleic acid. PRR 
signalling is thought to affect autophagy, cytokine secretion and antigen presentation to 
effector immune cells (Simmons., 2010). 
Polymorphisms in NOD2 were one of the first susceptibility risk factors identified in Crohn’s 
disease (Cho., 2008). Two studies by Cooney et al, 2010 and Travassos et al, 2010 have 
demonstrated cross-talk between the NOD and autophagy pathways and a direct interaction 
between ATG16L1 and NOD2. 
NOD2 belongs to the NOD-like receptor (NLR) family of PRRs, which play a key role in 
defence against pathogens and inflammation. NOD2 consists of two N-terminal CARD 
domains, a centrally located nucleotide-binding and oligomerisation domain and C-terminal 
leucine rich repeats (Figure 1.5) (Billmann-Born et al., 2011; Kumar et al., 2009). NOD2 
receptors are specifically activated by a peptidoglycan-derived motif muramyl dipeptide 
(MDP), which is a component of Gram positive bacteria (Shaw et al., 2008). Following MDP 
recognition by the LRRs of NOD2, the receptor undergoes a conformational change and self 
oligomerisation via the NOD domain. Subsequently, they recruit a cytosolic serine/threonine 
kinase known as RIP2 through homotypic CARD/CARD interactions (Ogura et al., 2001). 
RIP2 then autophosphorylates on Y474, which is required for optimal NF-κB activation 
(Tigno-Aranjuez et al., 2010). RIP2 is also modified with K63-linked polyubiquitin, which is 
thought to be mediated by a number of E3 ubiquitin ligases including ITCH and IAP proteins 
(Figure 1.6) (Tao et al., 2009; Bertrand et al., 2009; Krieg et al., 2009). Following this 
polyubiquitination of RIP2, the IKK scaffolding protein IKKγ (NEMO) becomes poly-
ubiquitinated via Lys63 linkages on Lys285 of NEMO. These ubiquitin chains are thought to 
provide a scaffold for the recruitment of TAK1 (TNF receptor-associated kinase 1), through 
its ubiquitin binding partners TAB2 and TAB3 (Figure 1.6) (Abbott et al., 2004; Abbott et 
al., 2007; Kanayama et al., 2004) enabling it to phosphorylate the activation loop of IKKβ 
(Figure 1.6). This eventually leads to the activation of nuclear factor-kappa B (NF-κB) 
transcription factors, the production of pro-inflammatory cytokines such as IL-1β, activation 
of mitogen activated protein kinases (MAPKs) ERK1/2, Jun-N-terminal kinase and p38. 
The NOD2 receptor is constitutively expressed in immune cells such as monocytes, 
macrophages and dendritic cells. In relation to the gut, intestinal epithelial cells 
constitutively express NOD1, a member of the NLR family (Hisamatsu et al., 2003), with 
Paneth cells and intestinal stem cells expressing NOD2 (Ogura et al., 2003; Nigro et al., 
2014), however the expression of NOD2 by intestinal epithelial cells is disputed (Billman-
  Chapter 1 
 
34 
 
Born et al., 2011; Hisamatsu et al., 2003). NOD2 induced signalling is involved in both 
systemic inflammatory responses and mediation of antimicrobial defence mechanisms 
through the secretion of α- and β-defensins along with other bactericidal proteins (Ogura 
et al., 2001). Therefore, it makes sense that mutations in NOD2 would lead to defective 
inflammation and defence against pathogenic bacteria. Three polymorphisms have been 
discovered in the NOD2 gene which contribute towards the development of CD. All three 
occur within the LRR region and result in a loss of function; L1007fsinsC is a one-base 
insertion, causing a frameshift mutation that results in a truncated LRR, whilst R702W and 
G908R are SNPs that result in single amino acid substitutions. (Figure 1.5) (Billmann-Born 
et al., 2011). It has been suggested this may cause epithelial barrier dysfunction due to 
facilitated bacterial entry into the base of the crypt-villus, as there is a failure to regulate 
the expression and secretion of defensins. Overall this would amount to a defective gut 
immune response to invasive pathogens.  
The link between autophagy and NOD2 signalling was first demonstrated by Cooney et al. 
2010. Initially they found that the NOD2 ligand, MDP, was able to induce autophagosome 
formation. This was dependent on NOD2 and required input from ATG5, ATG12, ATG16L1 
and PI3K; all essential components of the core autophagy machinery (Cooney et al., 2010). 
Furthermore, MHC-II trafficking and antigen presentation in DCs was found to be influenced 
by NOD2 induced autophagy. Dendritic cells from CD patients carrying NOD2 or ATG16L1 
polymorphisms were defective in MDP induced autophagy, were defective in MHC-II 
processing and failed to generate antigenic responses (Cooney et al., 2010). This may well 
lead to dysfunctional immune responses, resulting in the chronic tissue inflammation seen 
in CD. 
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Figure 1.5: The domain structure of NOD2 and location of the CD associated 
polymorphisms 
The NOD2 receptor consists of a trimodular structure, with two N-terminal CARD domains 
(red), a centrally located NOD domain (blue) and a series of C-terminal leucine rich repeats 
(yellow). The 3 CD associated polymorphisms in NOD2 occur in the leucine rich repeat 
region. In brackets are binding partners for the various domains. The interaction of NOD2 
with RIP2 has been described by Tao et al., 2009, the interaction with ATG16L1 by 
Travassos et al., 2010 and Boada-Romero et al., 2013., the interaction with IGRM by 
Chauhan et al., 2015, and the interaction with TRAF4 by Marinis et al. 2011. 
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Figure 1.6 Activation of NOD2 signalling 
Following MDP recognition by NOD2, the receptor undergoes a conformational change and 
can self oligomerise via its NOD domain. RIP2/RICK, a serine/threonine kinase is recruited 
to NOD2 via homotypic CARD/CARD interactions. This leads to the activation of the IκB-
kinase/ NF-κB pathway and subsequent production of pro-inflammatory cytokines. 
Assembled using data from Tigno-Aranjuez et al., 2010, Tao et al., 2009; Bertrand et al., 
2009; Krieg et al., 2009, Abbott et al., 2004; Abbott et al., 2007; Kanayama et al., 2004.  
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A study published simultaneously by Travassos et al, 2010 confirmed a direct interaction 
between NOD2 and ATG16L1 (Figure 1.7). A series of in vitro and in vivo experiments 
confirmed that agonists of NOD1 and NOD2 receptors e.g. MDP, lead to the induction of 
autophagy. ATG16L1 was found to co-localise at the plasma membrane with NOD2, and 
when both constructs were co-expressed an ATG16L1-NOD2 complex could be precipitated, 
confirming that these two proteins can interact with each other. Furthermore, when cells 
were infected with the bacterium Shigella flexneri, NOD2 and ATG16L1 translocated to the 
site bacterial entry, forming LC3 positive autophagosomes around invading bacteria 
(Travassos et al., 2010). This mechanistic link between NOD2 and ATG16L1 provides great 
scope for research into a potential pathway involving these two CD risk alleles. The 
biological consequences of this pathway, and from mutations within it, would shed light on 
the development of CD, and may even provide future therapeutic targets. 
This signalling axis has been explored in vivo with the use of the Atg16L1HM and Nod2 -/- 
mouse models. The bacterial pathogen Citrobacter rodentium, which models infective colitis 
(Bhinder et al., 2013), was used to infect both these mouse stains, and revealed that the 
Atg16L1HMconferred protection to infection whereas the Nod2 -/- mice displayed poor 
survival rates. This resistance in the Atg16L1HM mice was due to a hyperimmune 
transcriptional response which was present before infection (Marchiando et al., 2013). This 
protective effect was lost when the Atg16L1HM mice were crossed with Nod2 -/- mice, 
demonstrating that this effect is dependent on the expression of this PRR, and may be 
related to this important signalling axis. 
The link between the two pathways was further investigated at the molecular level in cell 
cultures studies by Sorbara et al. 2013. Using Atg16L1 deficient MEFs that lack the CCD, 
they specifically show that Atg16L1 is able to regulate Nod driven cytokine production in 
response to infection. The mechanism behind this was Atg16L1 dependent interference with 
two important molecular events in Nod2 signalling; poly-ubiquitination of Rip2 and 
recruitment of Rip2 into large signalling complexes (Sorbara et al., 2013) (Figure 1.7). 
Interestingly the T300A variant of Atg16L1 had less of an effect on Rip2/Nod2. This study 
further illustrates the importance of the Nod2:Atg16L1 interaction in a physiologically 
relevant context.  
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Figure 1.7 Crosstalk between the NOD2 and autophagy pathways 
NOD2-activated autophagy involves a direct interaction between NOD2 and ATG16L1, and 
leads to the targeting of autophagosomes to intracellular bacteria. ATG16L1 negatively 
regulates NOD2 signalling by inhibiting the recruitment of RIP2 into large signalling 
complexes and preventing the polyubiquitination of RIP2. 
Figure assembled using data from Travassos et al., 2010; Sorbara et al., 2013.  
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1.3. The aims and objective of the thesis 
GWAS have identified mutations in ATG16L1 and NOD2 that are strongly associated with 
CD (Barrett et al., 2008; Hampe et al., 2007; Rioux et al., 2007; Consortium., 2007; Cheng 
et al., 2010). The main objective of this project was to gain further insight into the role of 
ATG16L1 by studying novel protein interactions which may impact on the NOD2:ATG16L1 
signalling axis. 
 
Aim 1. To determine the role played by different domains of ATG16L1 during autophagy 
and see if these roles are affected by the T300A mutation.  
While the function of the coiled-coil domain of ATG16L1 is known, the role of the linker and 
WD40 repeat domain remains unclear. Deletion constructs of ATG16L1 were generated and 
tagged with eGFP at the C-terminus, to allow the study of the role of the individual domains 
of ATG16L1. Site directed mutagenesis was used to generate the CD associated T300A 
mutation and remove a putative phosphorylation site to study the contribution of these 
residues to autophagy. This work was carried out in the first results chapter, and generated 
vital tools for studies carried out in the second results chapter. 
 
Aim 2. To validate a role for MEKK4 as a novel ATG16L1 interaction partner that may 
modulate NOD2 signalling. A yeast-two-hybrid screen had been carried out on behalf of the 
lab by Hybrigenics Global PBS®, using Mus musculus Atg16l1 as bait against a human colon 
cDNA library. The human colon cDNA library was chosen so as to identify interactions with 
proteins that are likely expressed in the gut. One of the interactions identified by this screen 
was the kinase MEKK4 (also referred to as MAP3K4 and MTK1). In order to validate this 
interaction, immunoprecipitation assays were carried out using the GFP-tagged Atg16L1 
constructs (generated in the first results chapter) and an HA-tagged MEKK4 construct, 
obtained. Literature searches of MEKK4 found that the protein plays a key role in the 
regulation of NOD2 signalling (Clark et al., 2008). Previous studies have identified that 
stimulation of NOD2 signalling results in the activation of autophagy, and that NOD2 binds 
ATG16L1 following stimulation of NOD2 signalling with MDP (Cooney et al., 2010; Travassos 
et al., 2010) though the mechanisms by which stimulation of NOD2 leads to the activation 
of autophagy are unknown. It was therefore hypothesised that MEKK4 may interact with 
ATG16L1 to modulate NOD2 activated autophagy. To confirm whether the ATG16L1:MEKK4 
interaction is involved in NOD activated autophagy, HA-tagged NOD2 constructs were used 
in complex immunoprecipitation assay. 
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Aim 3. To determine if interaction between ATG16L1 and MEKK4 controls autophagy. 
MEKK4 has been linked to the regulation of autophagy through p38 MAPK (Keil et al., 2012), 
and is required for NOD2 directed autophagy against intracellular bacteria (Homer et al., 
2012). To study the role of MEKK4 in autophagy, siRNAs were used to silence MEKK4 and 
the effect on autophagy monitored by the formation of autophagosomes and the conversion 
of LC3. Furthermore, the effects of MEKK4 silencing were replicated using a genome editing 
technique to generate MEKK4 knockout cell lines, for future studies. This work is described 
in the third and final results chapter. 
 
Overall, the findings of this thesis will contribute to a greater understanding of the 
ATG16L1:NOD2 axis through the characterisation and dissection of a novel interaction 
between ATG16L1 and MEKK4, a protein that also regulates NOD2 signalling.
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2. Materials and Methods 
 
2.1 Materials 
2.1.1 Chemicals, reagents and materials 
Chemicals were obtained from the companies Sigma-Aldrich (UK), Roche (UK) and Melford 
(UK). Restriction enzymes were from Roche (Germany). All media solutions and reagents 
were purchased from Invitrogen (Paisley, UK), and all chemical compounds purchased from 
Sigma (Dorset, UK), unless otherwise stated. 
 
 
2.1.2 Kits used for molecular biology 
Kits used in molecular cloning are detailed in table 2.1 
 
Table 2.1 Kits used for molecular cloning 
Kit Company 
Expand High Fidelity PCR system Roche 
VELOCITY DNA Polymerase BIOLINE 
Geneclean II DNA purification kit MP Biomedicals 
Ready-To-Go T4 DNA ligase Amersham/GE 
Lifesciences 
Fast DNA End repair kit Thermo Scientific 
GeneJET PCR Purification Kit Thermo Scientific 
QIAGEN Mini and MIDI plasmid prep kits QIAGEN 
Macherey-Nagel Nucleospin and Nucleobond plasmid prep 
kits 
Macherey-Nagel 
QuikChange Lightning Site-Directed Mutagenesis Kit Agilent Technologies 
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2.1.3 Frequently used buffers and solutions 
Buffers were prepared with ultrapure dH2O unless otherwise stated. The full list of buffers 
and solutions is detailed in table 2.2 
 
Table 2.2 List of buffers and solutions  
Buffer Formula  Buffer Formula 
50X TAE 
buffer 
40 mM Tris acetate, 2 mM 
EDTA 
(pH 8.5) 
 PBS (10x) 80g NaCl, 2g KCl, 26.8g 
Na2HPO4 and 2.4g 
KH2PO4, up to 1 litre 
H2O, pH 7.4 
TE buffer 10 mM Tris/HCl (pH 8.5), 1 
mM EDTA 
(pH 8.0) 
 TBS (10x) 500 mM Tris/HCl (pH 
7.4) and 1.5 M 
NaCl 
TFB I buffer 30 mM K acetate, 50 mM 
Mn2Cl, 100 
mM RbCl, 10 mM CaCl2, 15 % 
(v/v) 
Glycerine (pH 5.8), filter 
sterile 
 DNA loading 
buffer (5x) 
50% (v/v) Glycerol, 1X 
TAE, 0.5 % 
(w/v) Orange G 
TFB II buffer 10 mM MOPS/NaOH (pH 7.0), 
75 mM 
CaCl2, 10 mM RbCl, 15 % 
(v/v) 
Glycerine, filter sterile 
 TENS buffer 50 mM Tris/HCl (pH 
8.0), 20 mM 
EDTA (pH 8.0), 100 mM 
NaCl, 1.0 % 
(w/v) SDS 
SDS-PAGE 
Sample 
Buffer (5x) 
2.5ml Glycerin (25%), 
0.2423g Tris (200mM), 0.5g 
SDS (5%), 5mg bromophenol 
blue, pH 6.8 
 Ponceau-S 0.2% in 5% TCA 
SDS-PAGE 
Running 
Buffer (10x) 
25mM Tris base, 190 mM 
glycine, 
0.1 % SDS, pH 8.3 
 Transfer 
Buffer (10x) 
390 mM Glycine, 480 
mM Tris, 0.3% SDS, pH 
9.2 
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2.1.4 Tissue Culture media 
All media solutions for tissue culture were made as follows: 
 
 Dulbecco’s Modified Eagles Media (DMEM) with 1g/L GlutaMAX (Invitrogen) was 
supplemented with 10% (v/v) foetal calf serum (FCS) and 1% (100 units/μl) 
penicillin-streptomycin (P/S) for culture of HeLa, the immortalised MEF cell lines 
MEF, Atg5 -/-, p62 -/- and African green monkey epithelial cells or Vero cell lines.  
 
 DMEM with 1g/L GlutaMAX was supplemented with 10% FCS, 1% P/S, 1% (100 
units/μl) of Non-essential amino acids (NEAA) and 1% (100 units/μl) of sodium 
pyruvate (Sigma) for culture of Human embryo kidney 293 (HEK293) cell lines. 
 
  DMEM with 4g/L GlutaMAX was supplemented with 10% FCS and 1% P/S for culture 
of the primary MEF cell lines and Raw 264.7 cells.  
 
 DMEM with 1g/L GlutaMAX was supplemented with 10% FCS, 1% P/S, 1% NEAA, 
1% sodium pyruvate and 10 μg/ml of puromycin for the culture of HEK293 episomal 
cells containing the pCEP-Pu vector.  
 
 DMEM with 1g/L GlutaMAX was supplemented with 10% FCS, 1% P/S, 1% NEAA, 
1% sodium pyruvate and 200 μg/ml of hygromycin for the culture of HEK293 
episomal cells containing the pCEP4 vector.  
 
 Where both episomal vectors were maintained, both selective antibiotics were added 
to the media.  
 
 DMEM with 1g/L GlutaMAX was supplemented with 10% FCS, 1% P/S 1 μg/ml 
puromycin and 10 μg/ml blasticidin for the culture of Platinum-E cells.  
 
 DMEM with 4g/L GlutaMAX was supplemented with 10% FCS, 1% P/S and 2 μg/ml 
of puromycin for the culture of Raw 264.7 cells containing shRNA lentiviral vectors.  
 
FCS was purchased from Biosera (Sussex, UK). PBS for use in tissue culture was purchased 
from Invitrogen. Trypsin 0.05% EDTA (Invitrogen) was used for passaging of HeLa, Vero, 
Platinum-E, MEF and HEK293 cell lines. Cell scraping was used to passage Raw 264.7 cell 
lines. Hank’s Balance Salt Solution (HBSS) media with magnesium and calcium (Invitrogen) 
was used as a starvation media. 
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2.1.5 Additives and Transfection reagents 
Torin1, an ATP-competitive inhibitor that suppresses both mTORC1 and mTORC2, was 
provided by Drs. Gray and Sabatini (Harvard Medical School, Boston) as a 1mM solution in 
DMSO. To prepare for use in tissue culture, Torin1 was diluted 1:4 in DMSO then 1:1000 in 
cell culture media. The final concentration of Torin1 applied to cell culture was 250 nM.  
Muramyl dipeptide (MDP), a NOD2 agonist was obtained from Source Bioscience Life 
Sciences, (UK). Stock solutions were prepared in endotoxin free water to a concentration 
of 10mg/ml. To prepare for use in tissue culture, MDP was diluted 1:1000 in cell culture 
media to a final concentration of 10 μg/ml or 1:500 for a concentration of 20 μg/ml. 
 
Puromycin, hygromycin B and blasticidin were purchased from Invitrogen. Puromycin and 
blasticidin were provided at stock concentrations of 10 mg/ml. Hygromycin B was provided 
at a concentration of 50 mg/ml and diluted to a stock concentration of 10 mg/ml in sterile 
PBS. The antibiotics were diluted and added to media as required. 
 
Transfast (E2431) from Promega (UK), a cationic lipoplex carrier, was used as a surrogate 
pathogen associated molecular pattern, and prepared according to manufacturer’s 
instructions. 
 
Transfection of HeLa, HEK293 and Vero cells was carried out using the jetPRIMETM DNA and 
siRNA transfection reagent (Polyplus transfection, UK), according to the manufacturers 
protocol. The transfection protocol was optimised for HeLa and HEK293 cells as shown in 
table 2.3. The 1:2 ratio of DNA to jetPRIME is maintained whilst reducing the DNA and 
jetPRIME content to 0.5X of the original. 
 
Table 2.3 Optimisation of jetPRIME transfection protocol for HEK293 and HeLa 
cells 
Transfection 
protocol for 24 
well 
Volume of 
jetPRIME buffer 
Amount of DNA Volume of 
jetPRIME reagent 
Original 50 ul 0.5 μg 0.1 μl 
HeLa/HEK293 50 ul 0.25 μg 0.5 μl 
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For dual transfections, the jetPRIME protocol was optimised as shown in table 2.4. Both 
transfection mixes are prepared separately, incubated for 10 min according to 
manufacturer’s instructions, and then combined and the dual transfection mix added to cells 
 
Table 2.4 Optimisation of jetPRIME transfection protocol for dual transfection 
Transfection 
protocol for 
100mm dish 
Volume of 
jetPRIME 
buffer (x 2) 
Amount of 
DNA 
(x 2) 
Volume of 
jetPRIME 
added 
(x 2) 
Total 
combined 
transfection 
mix added to 
cells 
HEK293/HeLa 
cells 
250 μl 3.75 μg 7.5 μl 500 μl 
Other cell lines 375 μl 7.5 μg 15 μl 750 μl 
 
siRNA transfections were carried out according to manufacturer’s protocol at a 
concentration of 50nM per siRNA. 
 
2.1.6 Fixation solutions 
All coverslips were fixed with 100% ice cold methanol for 5 min (unless otherwise stated). 
For cells immunostained with mouse anti-HA, coverslips were fixed with 100% ice cold 
methanol for 10 min, followed by a 1' incubation with ice cold acetone for 1 min.  
 
2.1.7 Cell lines  
The HeLa (human cervix eptheloid carcinoma) cells (ECACC 93021013), HEK-293 (ECACC 
85120602), Raw 264.7 (ECACC 91062702), Vero (ECACC 84113001) cell lines were obtained 
from the European Collection of Cell cultures (ECACC) (Porton Down, UK). The Platinum-E 
cell line for retroviral packaging was purchased from Cell Biolabs Inc. The MEF wild-type 
and MEF Atg5 -/- cell lines were a kind gift from Professor Noboru Mizushima of Tokyo 
Medical and Dental University (Mizushima et al., 2001). The p62 -/- cell line and wild type 
counterpart were a kind gift from Professor Terje Johansen of The Department of Medical 
Biology, University of Norway (Komatsu et al., 2007; Kirkin et al., 2009). The HEK293 cell 
line stably expressing eGFP-LC3 was a kind gift from Dr Sharon Tooze of Cancer Research 
UK, London Research Institute (Köchl et al., 2006). Atg16L1 KO MEFs were generated as 
part of the work in this thesis and are described later in the methods section, all cells were 
grown in the stated media at 37oC and 5% CO2.  
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2.1.8 DNA plasmids 
The cDNA for mouse ATG16L1 γ isoform (Accession no NT_078297.6) was obtained from 
Geneservice (Source BioScience Life Sciences). Generation of the C-terminal tagged 
ATG16L1 and deletion constructs are outlined in the results section. The plasmid pEGFP-N1 
was obtained from Clontech (GenBank Accession #U55762).  
The MEKK4-HA plasmid was a kind gift from Dr Derek Abbott (Case Western Reserve 
University, Cleveland (Clark et al. 2008). The kinase dead MEKK4-HA plasmid was acquired 
from Addgene (plasmid 12188), deposited by Dr Gary L Johnson (University of Colorado 
Medical School) (Gerwins et al, 1997). The NOD1-HA and NOD2-HA plasmids were a kind 
gift from Professor Dana Philpott (University of Toronto, Canada) (Linderson et al., 2005). 
The pCEP4 plasmid was obtained from Invitrogen (Cat no. V044-50). The pCEP-Pu plasmid 
was a kind gift from Dr Eddie Kohfeldt (Max-Planck Institute of Biochemistry, Germany) 
(Kohfeldt et al., 1997). The pSpCas9-2A-GFP plasmid was acquired from Addgene (plasmid 
48138), deposited by Dr Feng Zhang (MIT), (Ran et al., 2013). The GFP-LC3-G120A plasmid 
was a kind gift from Professor Zvulun Elazar of the Weizmann Institute of Science, Israel 
(Fass et al., 2006). 
The RFP-Ub and GFP-Ub plasmids were obtained from Addgene (plasmid 11935 and 11928 
respectively), were deposited by Professor Nico Dantuma (Bergink et al., 2006; Dantuma 
et al., 2006). The mCherry-LC3 plasmid was obtained from Addgene (plasmid 40827), 
deposited by Professor David Rubinsztein (Jahreiss et al., 2008). The Mekk4 shRNA lentiviral 
vector (Cat no: RMM3981-9592704, Oligo ID: TRCN0000025296) was purchased from Open 
Biosystems (GE Dharmacon). 
 
  2.1.9 siRNA probes 
Predesigned siRNA probes were purchased from Ambion and are detailed in table 2.5 
 
Table 2.5 List of siRNA probes 
Catalogue number Sequence target 
4392420 Human MAP3K4 Silencer® Select siRNA 
8673 
Exon 3: nt 929 
4392421 Human MAP3K4 Silencer® Select siRNA 
8675 
Exon 2: nt 415 
AM4611 Silencer® Negative Control No. 1 siRNA 
Validated for human, mouse and rat cells. 
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2.1.10 Primary and secondary antibodies 
Primary antibodies used for immunofluoresence, Western blotting and immunoprecipitation 
are detailed in table 2.6. Alexa Fluor® secondary antibodies for immunofluorescence were 
donkey anti-rabbit 488, donkey anti-mouse 488, donkey anti-mouse 568, donkey anti-rabbit 
594, donkey anti-mouse 594, donkey anti-rabbit 647 and donkey anti-mouse 647 
(Invitrogen). All were used at 1:500 dilution. Cell nuclei were stained with 4',6-diamidino-
2-phenylindole (DAPI). All coverslips were mounted onto slides using with Gelvatol 
fluorescence mounting medium (made in house, described previously by Harlow et al., 
2006). 
 
IRDye® secondary antibodies for Western blotting were purchased from Li-Cor Biosciences. 
Donkey anti-mouse 680LT, donkey anti-rabbit 680LT, donkey anti-mouse 800CW and 
donkey anti-rabbit 800CW were all used at 1:10 000 dilution.  
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Table 2.6 Summary of antibodies used in immunofluorescence, immunoprecipitation and Western blotting 
Application Antibody name Clone Dilution Source Catalogue no. 
Immunofluorescence Rabbit anti-Atg16L - 1:300 MBL PM040 
Rabbit anti-LC3 - 1:1000 Sigma L7543 
Mouse anti-LC3 166AT1234 1:200 Abgent AM1800 
Mouse anti-WIPI2 2A2 1:1000 abcam ab101985 
Rabbit anti p62 - 1:1500 Sigma P0067 
Mouse anti-HA HA-7 1:1000 Sigma H9658 
Western blotting Mouse anti-Atg16L 1F12 1:1000 MBL M150-3 
Rabbit anti-Atg16L - 1:1000 MBL PM040 
Rabbit anti-p62 - 1:1000 abcam ab91526 
Rabbit anti-LC3 - 1:1000 Sigma L7543 
Mouse anti-β actin ACTN05 (C4) 1:10 000 abcam ab3280 
Mouse anti-HA HA-7 1:2500 Sigma H9658 
Rabbit anti-GFP - 1:1000 abcam ab290 
Mouse anti-MEKK4 MEKK4-338 1:1000 Sigma M7194 
Mouse anti-γ tubulin GTU-88 1:10 000 Sigma T6557 
Immunoprecipitation Mouse-anti-GFP GFP-20 - Sigma G6539 
Mouse anti-HA 16B12 - Biolegend (Covance) MMS-101P 
Rabbit anti-Atg16L - - MBL PM040 
Mouse anti-MEKK4 MEKK4-338 - Sigma M7194 
Normal mouse IgG - - Santa Cruz Biotechnology Sc-2025 
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2.1.11 Immunofluoresence Microscopy 
Fluorescence was visualised using a widefield fluorescence microscope (ApoTome Axio 
Imager M2, Carl Zeiss) using a Plan-APOCHROMAT 63x/1.4 Oil (Carl Zeiss) objective lens 
attached to a high definition camera (AxioCam HRm, Carl Zeiss). Filter sets are detailed in 
table 2.7 
 
Table 2.7 Excitation and emission wavelength ranges of filter sets 
Filter set (Zeiss) Excitation (nm) Emission (nm) 
DAPI 49 365 445/50 
GFP 38 470/40 525/50 
DS RED 43 545/25 605/70 
CY5 50 640/30 690/50 
 
Image processing was carried out using Axiovision Software v.4.7.1 (Carl Zeiss), with 
deconvolution applied to Z-stack images. Images were analysed using Imaris software 
v.7.6.3 (Bitplane).  
 
2.1.12 Reagents for Co-immunoprecipitation and Western 
Blotting 
Lysis buffer for all experiments was the mammalian protein extraction reagent (mPER) 
lysis buffer (Pierce, UK), with added protease inhibitors (cOmplete mini EDTA-Free) and 
phosphatase inhibitors (PhosSTOP), both from Roche. Immunoprecipitation assays were 
carried out using Dynabeads® protein G (Invitrogen), according to manufacturer’s 
protocol with the following amendments. The incubation for immunoprecipitating the 
target antigen was carried out overnight at 4oC. The dynabead-Ab-Ag complex was 
washed 5 times with wash buffer prior to elution. Elution was carried out using an in-
house reducing sample buffer at 95oC for 10 min. 
Where stated, crosslinking was carried out using Dithiobis[succinimidyl propionate] (DSP) 
(Pierce, UK). 
 
SDS-PAGE gels were prepared following recipes specified by Roche Lab FAQs (2011). Both 
30% acryl-bisacrylamide and TEMED was purchased from BioRad (Hemel Hemptead, UK). 
Gels were prepared at 6% or 8% to resolve immunoprecipitation experiments, unless stated 
otherwise, and 15% gels were prepared to resolve LC3 proteins. Precision Plus ProteinTM All 
blue standards molecular weight ladder was purchased from BioRad. Pierce Protein Free 
T20 (TBS) (Thermo scientific) was used as a blocking buffer.  
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2.2 Methods 
 
 2.2.2 Molecular cloning 
 
  2.2.2.1 Preparation of competent cells 
For preparation of competent cells DH5α were plated on antibiotic free LB-agar plates and 
grown at 37°C overnight for selection of single colonies. A single colony was picked with a 
sterile plastic tip and transferred to 2 ml LB media in 15 ml Polystyrene round bottom test 
tube and incubated in a shaker (200rpm) at 37°C overnight. The overnight culture was 
used to inoculate 100 ml of LB media (1:100 dilution) in a 1000ml beaker and left shaking 
at 37°C till at a wavelength of 600 nm an O.D. of approximately 0.3-0.55 was reached. 
The beaker was left on ice with gentle shaking from time to time to prevent precipitation 
of the bacteria. The cells were then transferred to pre-cooled centrifugation flasks and 
were centrifuged at 6000 rpm for 10 min at 4°C in a pre-cooled centrifuge. The pellet was 
then re-suspended carefully in 50 ml of TFB-I buffer taking care not to produce any air 
bubbles and was then centrifuged again same as above. The cells were then re-
suspended again this time in 4 ml TFB-II buffer and 100 μl aliquots were made using the 
fume cupboard in 1.5 ml Eppendorf tubes which were pre-cooled on a mixture of dry ice 
and acetone. The cells were then stored at -80°C and checked for competency at a later 
date.  
 
2.2.2.2 Molecular cloning and plasmid construction of GFP 
tagged domains of Atg16L1 
The primers designed for all five constructs are detailed in table 2.8. All primers, unless 
otherwise stated, were from Invitrogen (Paisley, UK). Primers for PCR reactions were 
diluted to a 10pmol concentration, and the PCR performed using the Expand High Fidelity 
PCR system (Roche). 
Sequences for Atg16L1 γ were obtained from Ensembl geneservice (www.ensembl.org), 
and the domains determined using online software available from www.expasy.org and 
data from ensemble SMART and ProSite profiles. 
All PCR samples were resolved by electrophoresis in 0.6% agarose gels. Gels were 
prepared using a 1 x TAE buffer from the 50 x stock solution, with agarose powder. 
Appropriate volumes of DNA loading buffer was added to samples. A 1 kb + ladder was 
used for comparison (Invitrogen). Gel extraction was performed using GeneClean DNA II 
purification kit (Anachem).   
  Chapter 2 
 
52 
 
A Klenow reaction was carried out on the extracted PCR products using a DNA polymerase 
Klenow fragment (Amersham Pharmacia Biotech) according to manufacturer’s 
instructions. This was incubated at 37oC for 30 min, followed by a phenol-chloroform 
extraction extract the DNA.  
DNA was isolated by sequential extractions by adding an equal volume of phenol-
chloroform and then chloroform.  The aqueous phase was separated by centrifugation 
and precipitated by adding 1/10th volume of NaAc 3M [pH 5.6] and 2.5 volumes of EtOH. 
This was incubated at – 20oC for 2 hrs to precipitate the DNA which was recovered by 
centrifugation (13k rpm, 30 min, 4oC). The pellet was washed three times with 70% 
EtOH, repelleted and dissolved in ddH2O.  
Ligations were carried out using a Ready to Go T4 DNA ligase kit (Amersham). The 
volumes of insert and vector were calculated to a 1:1 ratio. Where stated, a phosphatase 
alkaline reaction was performed on target vector DNA to remove the 5’ phosphoryl 
termini, prevent self-ligation and decrease vector background. DNA fragments requiring 
sequence verification were ligated into the sequencing vector pUC18/19. 
Ligation reactions were transformed into Subcloning Efficiency™ DH5α™ Chemically 
Competent E.coli cells using a 1:50 or a 1:20 ratio of DNA to cells, and plated on to LB + 
selective antibiotic agar plates. Successfully transformed colonies were selected for on the 
basis of antibiotic resistance, and grown in 2 ml of LB + selective antibiotic suspension. 
Plasmid DNA was extracted from the bacteria using a Mini-lyse DNA preparation protocol 
involving alkaline lysis and SDS extraction with TENS buffer. The plasmid DNA was then 
precipitated by adjusting the supernatant to 70% EtOH and cooling to – 20oC, washed 
once in 70% ethanol and dissolved in TE-RNAse (99:1 ratio). 
Test restriction digests were performed on extracted plasmid DNA to verify the insert was 
of the expected size. Plasmid DNA for sequencing was extracted from 20ml of bacterial LB 
suspension using a QIAGEN® Plasmid Mini kit (QIAgen) with the following alterations; in 
wash step 10 the QIAGEN-tip 20 was washed with 4 x 2ml Buffer QC; in step 14 the DNA 
pellet was redissolved in 50 µl of TE buffer. Plasmid DNA was sequenced by The Genome 
Analysis Centre (TGAC) at the John Innes Centre, using a 3730XL sequencer (Life 
Technologies). Sequences were verified and aligned using the online tool MultAlin (Corpet 
et al., 1988).  
 
Once verified, DNA for transfection was generated using a QIAGEN® Plasmid MIDI kit 
(QIAgen) with the following modifications; the volume of LB+antibiotic suspension was 
increased to 50 ml. After step 7 the supernatant was filtered through a damp tissue to 
  Chapter 2 
 
53 
 
remove any suspended material. For step 11 the QIAGEN tip was washed with 4 x 10 ml 
Buffer QC. After addition of isopropanol in step 13 the mixture was incubated for 2 hr at 
4oC.  
 
For the generation of the Atg16L1 point mutants, the QuikChange Lightning Site-Directed 
Mutagenesis Kit was used, and manufacturer’s instructions followed. The mutagenic 
primers were designed using the web-based QuikChange Primer Design Program 
www.agilent.com/genomics/qcpd and are detailed in table 2.8. Sequencing primers are 
shown in table 2.9. 
 
Table 2.8. List of primers used in the generation of ATG16L1 domain plasmids 
Primer Name Primer Sequence 5’ → 3’ File 
no 
3’ ATG16L1 For TGTTTGCAGGATCCAGCTGC 171 
3’ ATG16L1 Rev GATCGGATCCAAGCTTACTAGTGTAGGCTGTGCCCACAGCAC 172 
CCD For GATCGTCGACATGTCGTCGGGCCTGCGC 173 
CCD Rev GATCGGATCCAAGCTTACTAGTGTTTCCTTTGCTGCTTCTGCAA 174 
CCD+Linker Rev GATCGGATCCAAGCTTACTAGTGTGACTCTCACATCTTTACCAG 175 
Linker+WD40 
For 
GATCGTCGACACCATGCCTCTACCTGTTGAACAG 176 
WD40 Rev GCAGCTGGATCCTGCAAACA 177 
WD40 For GATCGTCGACACCATGCCAACTACTGCCTCGTAT 178 
For_ATG16L1-
S305A 
GGAGACGCTCTGTCGCTTCCATCCCAGTC 294 
Rev_ATG16L1-
S305A 
GACTGGGATGGAAGCGACAGAGCGTCTCC 295 
For_ATG16L1-
T300A 
CCAGGATATCATGGACGCTCATCCTGCTTCTGG 296 
Rev_ATG16L1-
T300A 
CCAGAAGCAGGATGAGCGTCCATGATATCCTGG 297 
 
 
Table 2.9 List of in-house sequencing primers  
Primer name Primer sequence 5’-3’ File No. 
pmCherryN1_438_Forseq CCATTGACGTCAATGGGAG 280 
pEGFPN1_807_Revseq GGTGCAGATGAACTTCAGGGTC 284 
WD40 Rev GCAGCTGGATCCTGCAAACA 177 
U6-Fwd GAGGGCCTATTTCCCATGATTCC 348 
Atg16L1 int.seq CTGAACAGTTAAGTTCCTAG 223 
Atg16L1 Kpn.int1.rev CCAAGAGACACTGACATAGG 226 
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2.2.2.3 Molecular cloning kits for episomal plasmid cloning 
Further molecular cloning was carried out to generate the episomal constructs used in this 
thesis. The following modifications were made to the cloning protocols: 
Any PCR reactions were carried out using the Velocity DNA polymerase system (Bioline). 
The Klenow reaction was carried out using the Fast DNA End Repair Kit (Thermo 
Scientific). The phenol/chloroform reaction was replaced with the GeneJET purification Kit 
(Thermo Scientific). Both kits were used according to manufacturer’s instructions. DNA for 
sequencing and transfection was generated by Macherey-Nagel Nucleospin and 
NucleoBond kits, respectively, and were used according to manufacturer’s protocol. 
Plasmid DNA was sequenced using the Source BioScience Sanger Sequencing Overnight 
service, using a 3730XL DNA Analyser (Applied Biosystems). 
 
   2.2.2.4. CRISPR/Cas9 Cloning 
The CRISPR Cas9 cloning was carried out according to the protocol specified by Ran et 
al., 2013. The sgRNA template was designed using online tools from www.e-crisp.org and 
later verified by the online software available at (http://tools.genome-engineering.org). 
sgRNA oligos were purchased from Invitrogen, and are detailed in table 2.10. The 
FastDigest BbsI restriction enzyme was purchased from Thermo Scientific. The T7 ligase 
was purchased from NewEngland Biolabs. Sequencing was carried out using the U6-Fwd 
primer detailed in table 2.9. 
 
Table 2.10 sgRNA template oligos used to construct MEKK4 targeted 
CRISPR/Cas9 vectors 
sgRNA ID Sequence 5’ – 3’ 
Hm MEKK4 gRNA FOR CACCGAGAGAAGCCGCTGCCGCGC 
Hm MEKK4 gRNA REV AAACGCGCGGCAGCGGCTTCTCTC 
Ms MEKK4 gRNA FOR CACCGTGTCGGCGAGGGCAGGAGG 
Ms MEKK4 gRNA REV AAACCCTCCTGCCCTCGCCGACAC 
 
 
 2.2.2.5 Mapping Atg16L1 binding motifs 
Atg16L1 binding motifs were mapped using the ProSite algorithm, available at the 
ScanProsite website (http://prosite.expasy.org/scanprosite/). (DeCastro et al., 2006) 
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2.2.3 Cell culture, Immunoprecipitation and Western blotting 
 
2.2.3.1 Transfection and cell culture 
For immunofluoresence studies cells were cultured on 13mm coverslips in 24 well plates. 
The coverslips were coated with 20 μg/ml collagen I prior to the seeding of cells. Cells were 
grown at 37oC 5% CO2. Cells were seeded at 1.5 x 104 per well in 500 µl supplemented 
media and allowed to grow for 24 hr prior to transfection. Cells were washed once in PBS 
and mixed with DNA transfection mix was used as shown in tables 2.3 and 2.4. After the 
transfection mix had incubated for 10 minutes at room temperature, 50 μl was added to 
media and then incubated with cells for 4 hrs. The media was then replaced with fresh pre-
warmed supplemented media, and the cells cultured for 48 hrs post plasmid transfection 
and 36 hrs post siRNA transfection prior to treatment and fixation. 
 
For western blotting cells were cultured in a 6 well plates, and for immunoprecipitation 
assays cells were cultured in a 10 cm plate (NUNC), pre-treated for tissue culture use. For 
immunoprecipitation assays 2-3 dishes per condition were used. The cells were grown at 
37oC, 5% CO2 in DMEM supplemented media 24 hours prior to transfection (48 hours for 
episomal cells). For 6 well plates, cells were seeded at 1-2 x 105 in 3 ml of media. Cells 
were seeded at 0.75-1.25 x 106 per dish in 10 ml of media (dependent on cell type) for 
immunoprecipitation assays. The transfection was performed as previously stated (tables 
2.3 and 2.4), and the cells cultures for 48 hours prior to treatment and/or lysis.  
 
   2.2.3.2 siRNA depletion 
For siRNA depletion studies, cells were cultured on 13mm coverslips in 24 well plates for 
immunofluorescence studies, and in 6 well plates for Western blot assays. Cells were seeded 
at 1 x 104 per well and allowed to grow 24h prior to the first round of siRNA depletion. Cells 
were transfected with a combination of 50nM siRNA from both probes (transfection mix 
shown in table 2.11). The transfection mixes were combined and added to each well as 
described in table 2.11, then incubated for 4 hours. The cells were allowed 24 hours 
recovery then the siRNA transfection repeated. After another 24 hours recovery, the assays 
were carried out. 
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Table 2.11 Transfection mix for siRNA depletion 
 Volume per 24 well 
50nM 
Volume per 6 well 
50nM 
jetPRIME buffer 50 µl 200 µl 
siRNA (50 µM stock) 0.55 µl 2.2 µl 
jetPRIME reagent 2 µl 4 µl 
Total volume added 
for dual siRNA 
75 µl 300 µl 
  
 
2.2.3.3 Induction of Autophagy 
To induce autophagy, cells were incubated with HBSS for 2-4 hrs or with 250nM Torin1 in 
supplemented media for 2 hrs. To induce NOD2 directed autophagy, cells were incubated 
with 10-20 μg MDP for 4-8 hrs as stated. 
 
2.2.3.4 Immunofluoresence 
Cells were washed with 1 x PBS and fixed with 100% ice cold methanol for 5 min unless 
otherwise stated. 1 x PBS was prepared from a 10 x stock solution, diluted with ultrapure 
H2O and autoclaved. Cells were subsequently washed three times with 1 x PBS before 
blocking for 20 min in 5% Normal Donkey Serum (NDS) in 1 x PBS, unless otherwise stated. 
Primary and secondary antibodies were diluted in 2 % NDS and incubated with cells for 
1hr. Primary antibody was removed by three washes with PBS + 0.1% Tween 20 (Sigma). 
After addition of secondary antibody coverslips were incubated for 40 min, then washed 
three times with 1 x PBST and stained with DAPI for 10 min. After a final wash with PBS, 
the coverslips were mounted onto glass slides using Gelvatol and left in the dark to dry. 
Immunofluorescence was visualised using a widefield fluorescence microscope (ApoTome 
Axio Imager M2, Carl Zeiss) using a Plan-APOCHROMAT 63x/1.4 Oil (Carl Zeiss) objective 
lens attached to a high definition camera (AxioCam HRm, Carl Zeiss).  
 
   2.2.3.5 Imaris Analysis and Statistical Analysis 
Images were analysed using Imaris software v.7.6.3 (Bitplane) to count puncta formation 
and colocalisation by user-defined spot definition parameters. Statistical analysis was 
performed using an unpaired two-tailed Student’s T-test assuming unequal variance, using 
GraphPad Prism 6 software (GraphPad), where stated. A diameter of 0.75 μm was assumed 
as the standard for autophagosome size (Mizushima., 2004), was used for analytical 
purposes. A diameter of 1.5 μm and above was assumed as an aggregate (Wileman., 2007). 
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All graphs were generated using GraphPad Prism 6. All statistical analysis was carried out 
within this programme. A Levene’s test was used to measure if the variance between the 
Atg16L1 domain puncta was equal. If a significant p value was returned, then there was a 
difference in the variances of the population. 
   
2.2.3.6 Cell Lysis and Protein concentration quantification 
For immunoprecipitation assays cells were washed with ice cold PBS 3 times, then lysed 
with 500 μl of supplemented MPER lysis buffer (Fisher) on ice. The lysis was done 
sequentially, so 2-3 dishes were combined with one lysate. The cells were scraped and 
transferred to a 1.5 ml Eppendorf then incubated on ice for 30 min with regular pipetting. 
For cells in 6 well plates, lysis was carried out with 30-80 μl of lysis buffer, depending on 
the confluency of cells. The lysate was clarified by centrifugation at 14 000 rpm at 4oC for 
10 min. The supernatant was either used fresh or kept at -20oC before use in 
immunoprecipitation or Western blotting. 
Protein concentrations were quantified by bicinchoninic acid (BCA) assay, which was 
purchased from Thermo Scientific and used according to manufacturer’s instructions. 
Samples were read on a colorimetric plate reader (Wallac Envision, Perkin Elmer) at 560nm. 
 
2.2.3.7 Co-immunoprecipitation assay 
Co-immunoprecipitations were carried out using Dynabeads® protein G (Invitrogen). In 
some experiments, protein interactions had been stabilised with a DSP crosslinker prior to 
cell lysis. The DSP crosslinking (where stated) was carried out according to manufacturer’s 
instructions with the following alterations. The crosslinker solution was used at a 
concentration of 1 mM and the reaction mixture was incubated at room temperature for 1 
hour. Equal concentrations of lysate were made up to 1ml with MPER in a 1.5 ml Eppendorf. 
25 μl of dynabeads were prepared with 3 μg of normal mouse IgG in 200 μl of PBST (0.02% 
Tween 20), according to manufacturers protocol. The lysate was precleared at room 
temperature for 10 min with rotation. To separate the lysate from the antibody-bead 
complex, the tube was placed on a magnet and the supernatant aspirated and reserved for 
the next step. The precipitating antibody was prepared as follows. 6-10 μg of precipitating 
antibody (dependent on binding affinity) was added to 200 μl of PBST. This was added to 
50 μl of Dynabeads and incubated at room temperature for 10 – 30 min with rotation. The 
supernatant was removed using the magnet to separate the beads, and the pre-cleared 
lysate added directly to the bead-precipitating antibody complex. This was incubated at 
4oC, overnight with rotation. Beads were washed 5 times in PBS with added protease and 
phosphatase inhibitors, and proteins eluted in sample buffer. A reducing agent, β-
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mercaptoethanol (β-ME) was added to samples to break down di-sulphide bonds in the 
precipitating antibody. Whole cell lysates and non-bound fractions were prepared for SDS-
PAGE by adding 2% of original immunoprecipitation lysate volume to sample buffer, β-ME 
and made up to 15 µl with ddH2O. Samples for use in SDS-PAGE were denatured by 
incubation at 95oC for 10 min. Eluted proteins from beads were removed by placing tubes 
on a magnet and aspirating the eluate into a fresh Eppendorf. 
 
2.2.3.8 SDS-PAGE and Western Blotting 
After quantification, equal concentrations of protein (20-40 μg) were prepared with sample 
buffer, β-ME and made up to 15 μl with ddH2O. The contents were mixed and denatured 
by incubation at 95oC for 10 min. Samples were run on SDS-PAGE gels at 150V for 60-90 
in dependent on the gel percentage. The protein was transferred by semi-dry transfer to 
PVDF membrane (Immobilon®-FL, Millipore Limited). Protein transfer was confirmed using 
Ponceau-S staining. All incubation steps are carried out with rocking. The membrane was 
blocked for 1 hour at room temperature using the Pierce protein free blocking buffer 
(Thermo Scientific). Primary and secondary antibodies were diluted in a 1:1 ratio of blocking 
buffer and TBST (0.1% Tween 20), with indicated dilutions of antibody. Primary antibodies 
were incubated overnight at 4oC then washed three times with TBST. Secondary antibodies 
were incubated at room temperature for 1 hour, then washed three times with TBST and 
once with TBS. Proteins detected by the labelled secondary antibodies were visualised using 
the Odyssey Infrared Imaging System, (LI-COR Biosciences)  
 
2.2.3.9 Generation of MEFs from embryos. 
The timed matings to obtain the embryos were set up by Devina Devikar and Ulrike Mayer. 
The uterus of 13.5 post-coitum females was removed, washed with 70% ethanol and 
transferred to a tissue culture fume hood. The embryos were removed and placed in PBS. 
The head and internal organs were removed, and the carcass placed into 1-2ml of 
trypsin/EDTA.  
The carcass was macerated using a sterile pair of dissection scissors, and incubated for 10 
min at 37oC. The tissue was broken down manually by pipetting with a 10 ml pipette, and 
the embryo was incubated for a further 10 min at 37oC. After neutralising the trypsin/EDTA 
with the addition of high glucose supplemented media, the tissue mass was broken up by 
pipetting with a 5ml pipette.  This was allowed to settle for 1 min, and the cells plated at 
the equivalent density of 2 embryos/10cm dish. 
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2.2.3.10 FACS sorting 
A BD FACS Aria II (Becton Dickinson) flow cytometer was used to perform single-cell sorting 
following the manufacturer’s aseptic sort protocol. FDG staining was carried out using a 
FluoReporter lacZ Flow Cytometry kit (Molecular Probes, Invitrogen), according to 
manufacturers protocol. Briefly, cells were trypsinised, the trypsin inactivated with FACS 
buffer (5% FCS in PBS) and pelleted at 1000 rpm for 5 min. The pellet was washed again 
with FACS buffer, repelleted and resuspended in 20 μl PBS and place on ice. A 2 mM working 
solution of FDG was prepared using ultrapure autoclaved H2O for tissue culture use. 20 μl 
of the working FDG solution was added to the resuspended cells and incubated for 45 sec 
at 37oC, then 500 μl of ice cold FACS buffer was added and the reaction incubated on ice 
for up to an hour. The cells were pelleted and washed as previously, then resuspended in 
an appropriate volume of FACS buffer prior to sorting. FDG staining and eGFP was detected 
using 488 nm laser excitation and 530/30 band pass-filter detection. Individual cells were 
sorted using the following gating criteria: debris discrimination using forward and 
orthogonal 488 nm laser scatter (cells selected), doublet discrimination using orthogonal 
pulse height and width (individual cells selected), and the above listed marker. 
 
2.2.3.11 Generation of lentiviral particles from Plat-E cell 
line 
The Plat-E cell line has been described previously (Morita et al., 2000). Cells were seeded 
in a T75 tissue culture flask at a density of 5-7 x 105 without selective antibiotics. After 24 
hours, the lentiviral plasmid was transfected into the cells following the jetPRIME protocol. 
Retroviral supernatant was harvested 48 hrs and 96 hrs post transfection. The viral particles 
were concentrated by centrifugation at 8000 rpm overnight at 4oC. The pellet was 
resuspended in Opti-MEM (Invitrogen) at 37oC for 15 min, then centrifuged at 1000 rpm for 
5 min to pellet cell debris. The supernatant containing the concentrated viral particles was 
aliquoted into 50 μl cryotubes, and stored at -80oC. 
 
   2.2.3.12 Yeast two hybrid screen 
The yeast two hybrid screen was carried out by Hybrigenics Global PBS®. The bait protein, 
Mus musculus ATG16L1γ was screened against a human colon cDNA library, to identify 
interactions likely to occur in the gut. The gamma isoform was chosen as it was the longest 
of the mouse Atg16L1 isoforms.  The interactions were analysed by Hybrigenics Global, 
with each interaction assigned a ranking, representing confidence in the interaction. This 
ranking is based on Hybrigenics Global algorithms, which take into account the likelihood 
of the interaction being a false positive, proven experimental artefact, or a prey protein 
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likely to missfold.  Upon receiving the results, a literature search was performed to ascertain 
how the high confidence hits may relate to autophagy. As well as MEKK4, one hit returned 
by the yeast two hybrid screen was FIP200, an interaction which has been described 
(Gammoh et al.,  2013).
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Chapter 3: The characterisation of the domains of Atg16L1 
 
3.1 Chapter Aims  
The aims of this chapter were to characterise the function of the domains of Atg16L1 in 
autophagy, by use of GFP-tagged deletion constructs. The cellular distribution, ability to 
form autophagosomes and localise with autophagic markers are characterised, so that these 
constructs can be used in future experiments. Atg16L1 KO MEFs are generated for use in 
reconstitution experiments. This allows the characterisation of the Atg16L1 deletion 
constructs on a WT and null Atg16L1 background. 
 
3.2 Introduction 
In mammalian autophagy, the ubiquitin-like conjugation systems that utilize LC3/Atg8 and 
the ATG16L1 complex, are evolutionarily conserved across eukaryotes. The mammalian 
Atg16L1 was originally identified in Mus musculus (mouse) in 2003 by Mizushima et al, 
based on its weak but significant homology to Saccharomyces cerevisiae (yeast) Apg16 
(Fig. 3.1). Three isoforms have been reported and experimentally verified; Atg16L1α, 
Atg16L1β and Atg16L1γ. Two further isoforms have been proposed, however experimental 
evidence to support a functional role in autophagy is lacking.  
The protein ATG16L1 shares many similarities with its yeast counterpart Apg16. Both 
comprise of an N-terminal ATG5-binding domain, followed by a coiled-coil domain (CCD). 
In higher complex eukaryotes there is an additional linker region and a WD40 repeat domain 
at the C-terminus. The Crohn’s disease associated T300A polymorphism falls towards the 
end of this linker region, before the start of the WD40 repeat (Figure 3.1). Alignment of the 
amino acid sequence from Saccharomyces cerevisiae (yeast) and from Mus musculus 
(mouse) shows homology in the CCD. The function of the linker and WD40 repeat domain 
in autophagy is poorly characterised. Whilst the yeast Apg16 lacks these domains, emerging 
research suggests that the linker and WD40 repeat domain govern interactions that are 
involved in selective forms of autophagy and the regulation of the innate immune response 
(Boada-Romero et al., 2013; Fujita et al., 2013). Additionally, phosphorylation sites have 
been identified within the linker region of Atg16L1, though their purpose has yet to be 
elucidated (Villén et al., 2007; Olsen et al., 2010).  
 
Therefore, the domains of Atg16L1 require further characterisation in the context of 
canonical and selective autophagy. This will be explored in the following chapter. 
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Figure 3.1 Schematic representation of the yeast Apg16 and Atg16L1 γ proteins. The 
coiled-coil domain in yeast Apg16 is conserved in mouse Atg16L1, with the addition of a linker and 
WD40 repeat domain. The CD associated mutation T300A, which has been mapped to the T316 
residue in mouse Atg16L1 lies within the linker region. Modified from Mizushima et al., 2003. 
 
. 
Figure 3.2 Summary of GFP-tagged Atg16L1 constructs 
This diagram summarises the regions of Atg16L1 γ that were tagged with eGFP in the generation of 
the deletion constructs. The coiled-coil domain is depicted in grey and the WD40 repeat domain 
represented by repeated black boxes. The numbering refers to the amino acid sequence in murine 
Atg16L1 γ. The point mutations are indicated with a red line. The spacer region between the C-
terminus of the Atg16L1 constructs and the N-terminus of eGFP is represented by a black line.  
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3.3 Results 
 
3.3.1 Generation of GFP tagged Atg16L1 constructs 
The Atg16L1 protein remains poorly characterised. To gain insight into the function of the 
domains of Atg16L1, deletion constructs of Atg16L1 were generated that are tagged at the 
C-terminus with eGFP. Three isoforms of Atg16L1 have been described, which arise from 
variation in exon splicing, and are referred to as Atg16L1 α, Atg16L1 β and Atg16L1 γ 
(Mizushima et al., 2003). The gamma isoform contains exons 1-19, the beta isoform does 
not contain exon 9, and the alpha isoform lacks exons 8 and 9 (Appendix 1). 
The CD associated mutation lies within exon 10. The Atg16L1 γ isoform was chosen as a 
template for the generation of the deletion constructs, as this is the longest isoform, 
containing 623 amino acids.  
 
The domains and features of Atg16L1 γ were mapped using SMART site profiling and data 
from Ensembl genome browser (table 3.1) to determine the regions that contain the coiled-
coil domain, the linker region and the WD40 repeats.  
 
Seven different constructs were generated using mouse Atg16L1 γ as a template. These 
are summarised in Figure 3.2 and are outlined below. The numbering of nucleotides/amino 
acids refers to the Atg16L1 γ isoform. 
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Table 3.1. The domains and features of mouse Atg16L1 γ determined from 
Ensembl data 
 
Domain/Features Amino acid 
residues 
Nucleotides in 
cDNA 
Spans exons 
Coiled-coil region 1 82-102 244-306 3 
Coiled-coil region 2 110-193 327-579 4 and 5 
Coiled-coil region 3 195-230 587-690 5 and 6 
Linker region 231-326 691-978 6, 7, 8, 9 and 10 
WD40 repeat 1 327-366 978-1098 10 and 11 
WD40 repeat 2 371-410 1111-1230 12 and 13 
WD40 repeat 3 413-452 1237-1356 13 and 14 
WD40 repeat 4 455-491 1363-1473 14 and 15 
WD40 repeat 5 494-532 1480-1596 16 
WD40 repeat 6 535-578 1603-1734 16, 17 and 18 
WD40 repeat 7 581-621 1741-1863 18 and 19 
 
 
3.3.1.1 Generation of Atg16L1-GFP 
The 5’-end of Atg16L1 was generated from pYX-Asc-Atg16L1 by restriction digestion with 
SalI and BamHI. This fragment was ligated into the multiple cloning site (MCS) of the 
mammalian expression vector pEGFP-N1, which was digested with SalI and BamHI to create 
compatible ends. Primers were designed to amplify the 3’-end of Atg16L1, using pYX-Asc 
as a template (primers 171 and 172, see table 2.8 for primer details). The 3’-Atg16L1 
forward primer simply targeted a region of Atg16L1 that contains a BamHI site in its 
nucleotide sequence. As the GFP tag is at the C-terminus, the stop codon of Atg16L1 had 
to be removed, and the reading frame with GFP maintained. To achieve this, the 3’ Atg16L1 
reverse primer was designed to remove the stop codon and insert two bases to maintain 
the reading frame. Three restriction sites, BamHI, HindIII and SpeI were also introduced 
by this primer.  
 
The resulting PCR fragment was verified by sequencing, digested with BamHI and ligated 
into the 5’Atg16L1-pEGFPN1 plasmid to obtain the full length C-terminal tagged fusion 
protein; Atg16L1-GFP.   
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3.3.1.2 Generation of the Coiled-coil domain and Coiled-coil 
domain & Linker GFP constructs 
Based on the SMART domain analysis, it was decided that the coiled-coil domain consisted 
of amino acids 1-230 of Atg16L1 γ, and that the coiled-coil domain and linker region 
consisted of amino acids 1-326 of Atg16L1 γ (Fig. 3.2 and table 3.1).  
 
Primers 173 and 174 (table 2.8) were designed to amplify the coiled-coil domain, primers 
173 and 175 (table 2.8) were designed to amplify the coiled-coil domain and linker region, 
both using pYX-Asc-Atg16L1 as a template. The CCD forward primer introduced a SalI site 
at the 5’ end of Atg16L1. To maintain the reading frame with GFP, the reverse primers 
introduced two additional bases. As with the generation of Atg16L1-GFP, the reverse 
primers also introduced three restriction sites; BamHI, HindIII and SpeI. The resulting PCR 
products were verified by sequencing, digested with SalI and BamHI and ligated into the 
pEGFP-N1 plasmid to obtain the coiled-coil domain and coiled-coil domain and linker regions 
of Atg16L1 tagged at the C-terminus with GFP; CCD-GFP and CCD+Linker-GFP. 
 
3.3.1.3 Linker and WD40 repeat domain and WD40 repeat 
domain 
Based on the SMART domain analysis, the linker-WD40 domain of Atg16L1 γ was 
determined to consist of amino acids 326-623, and the WD40 domain consisting of amino 
acids 327-623 (Fig. 3.2 and table 3.1). 
 
The 5’-region of the linker-WD40-GFP and WD40-GFP constructs was generated from pYX-
Asc Atg16L1 using primers 176 and 177, and 177 and 178, respectively (table 2.8). The 
forward primer introduced a Kozak ATG site to enable initiation of transcription. The PCR 
products were verified by sequencing and ligated into pEGFP-N1 using SalI and BamHI 
sites. The remaining 3’-fragment was digested with BamHI and ligated into the 5’-linker-
WD40-pEGFP-N1 and 5’-WD40-pEGFP-N1 plasmid to obtain the linker and WD40 repeat 
domain and WD40 repeat domain of Atg16L1 tagged at the C-terminus with eGFP; 
L+WD40-GFP and WD40-GFP. 
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3.3.1.4 Site directed mutagenesis: Atg16L1 point mutants – 
T316A and S305A 
The CD associated T300A mutation was mapped to residue T316 of Atg16L1 γ. A serine 
phosphorylation site of unknown function was mapped to residue S305 of Atg16L1 γ. Using 
the completed Atg16L1-GFP construct as a template, primers were designed to introduce 
point mutations. For T316A primer pair 296 and 297 were used, for S305A primer pair 294 
and 295 were used (table 2.8). Site directed mutagenesis was carried out using the 
QuikChange Lightning SDM kit (Agilent), and the mutations verified by sequencing. This 
resulted in the generation of the point mutants Atg16L1-T316A-GFP and Atg16L1-S305A-
GFP. 
 
All cloning strategies ensured an identical sequence between the 3’ end of Atg16L1 and the 
5’ of eGFP (Thr-Leu-Val-Ser-Leu-Asp-Pro-Pro-Val-Ala-Thr). This should allow a degree of 
flexibility and space in-between the fusion protein, as the coiled-coil and WD40 β-propeller 
structures could prevent correct protein folding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Chapter 3 
 
68 
 
3.3.2 Characterising endogenous expression of ATG16L1 and 
Atg16L1-GFP 
Before the full length and deletion constructs of Atg16L1 could be used, their stability, 
expression and ability to form autophagosomes had to be determined and compared to the 
function of endogenous Atg16L1.  Therefore HeLa cells were cultured in supplemented 
media or media containing the mTOR inhibitor Torin1 to induce autophagy (Thoreen et al., 
2009). Torin1 was used as a specific inducer of autophagy, to allow for fine control over 
early autophagosome formation and therefore puncta incorporating Atg16L1. The cells were 
fixed, stained for ATG16L1 and for the autophagosome markers LC3 and WIPI and 
visualised using widefield fluorescence microscopy. It should be noted that the antibody 
used to stain endogenous ATG16L1 was raised in rabbit, so LC3 was counterstained with 
an antibody raised in mouse. LC3 is a key marker of autophagosomes and is widely used 
to monitor autophagy (Klionsky et al., 2012; Mizushima, 2007). WIPI is recruited to the 
early autophagosome, and recruits Atg16L1 to the autophagosomal membrane, so will likely 
mark autophagosomes positive for Atg16L1 (Polson et al., 2010; Dooley et al., 2014). 
 
To compare with endogenous ATG16L1, the full length Atg16L1-GFP was transiently 
transfected in HeLa cells. With respect to the experiments performed in this chapter, all 
transfections are transient. The cells were treated as above, with the following exception. 
LC3 was immunostained with an antibody raised in rabbit. 
 
When there was a ready supply of nutrients both endogenous ATG16L1 and Atg16L1-GFP 
were evenly distributed in the cytoplasm, and not present in the nucleus (Fig. 3.3). When 
autophagy was induced with Torin1, the ATG16L1 and Atg16L1-GFP signals redistributed 
to punctate structures with LC3 and WIPI, indicating the formation of autophagosomes (Fig. 
3.4 and 3.5). This indicates that Atg16L1-GFP is able to form autophagosomes, and that 
this function has not been compromised by the addition of GFP at its C-terminal end.  
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Figure 3.3 Characterisation of ATG16L1 and the GFP tagged constructs in the absence of autophagy activation 
GFP-tagged Atg16L1 constructs were expressed in HeLa cells and compared to un-transfected cells. Atg16 was either visualised by anti-Atg16L immunostaining 
or GFP-tagged Atg16L1 construct expression. The nuclei were stained with DAPI. Regions of interest which show GFP positive puncta or filamentous structures 
are highlighted with dashed boxes and GFP puncta with indicated arrowheads. 
Scale bars are 10 μm. 
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3.3.3 Characterisation of the deletion constructs of Atg16L1 
The CCD of Atg16L1 is required for autophagy (Saitoh et al, 2008), however the function 
of the linker and WD40 repeat domain remains less characterised. To test and characterise 
the deletion constructs of Atg16L1, HeLa cells were transfected with CCD-GFP, CCD+L-GFP, 
L+WD40-GFP or WD40-GFP and counterstained for autophagy markers.  
 
In the absence of autophagy, CCD-GFP and CCD+L-GFP were expressed diffusedly in 
cytosol and were absent from the nucleus, similar to endogenous ATG16L1. However in 
some cells, both constructs were able to form a few GFP positive puncta indicating early 
autophagosomes (Fig. 3.3). Following autophagy induction by Torin1, CCD-GFP and 
CCD+L-GFP formed punctate structures which partially co-localised with LC3 and WIPI (Fig. 
3.4 and 3.5). These results indicate that CCD-GFP and CCD+L-GFP are capable of 
interacting with these autophagy proteins and have the ability to drive the formation of 
autophagosomes.  
 
In the absence of autophagy and following induction through Torin1, both L+WD40-GFP 
and WD40-GFP differ from the full length and other deletion constructs. These constructs 
localise evenly throughout the cytoplasm and nucleus (Fig. 3.4, 3.5 and 3.6). Furthermore, 
they fail to form puncta in response to the activation of autophagy and do not localise with 
autophagosomes, indicated by the lack of co-localisation with LC3 and WIPI. In some cells, 
L+WD40-GFP and WD40-GFP had a filamentous distribution, with a fraction localising to 
the plasma membrane (Fig. 3.3 and 3.5). These results show that the L+WD40 domains of 
Atg16L1 are not incorporated into puncta and therefore do not play a role in canonical 
autophagy. In later experiments these constructs are used as a control for their inability to 
form puncta. 
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Figure 3.4 The endogenous ATG16L1, Atg16L1-GFP, CCD-GFP and CCD+L-GFP form 
puncta that partially colocalise with LC3 after Torin1 treatment 
GFP-tagged Atg16L1 constructs were expressed in HeLa cells, and compared to endogenous Atg16 
and LC3 distribution. After autophagy induction by Torin1 ATG16L1 was either visualised by 
immunostaining or GFP expression immunostained for ATG16L1. LC3 was immunostained and nuclei 
were stained with DAPI. Regions of interest are highlighted in boxes and colocalised puncta with 
arrows. Scale bars,10 μm. 
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 Figure 3.5 The endogenous ATG16L1, Atg16L1-GFP, CCD-GFP and CCD+L-GFP form 
puncta that partially colocalise with WIPI after Torin1 treatment  
GFP-tagged Atg16L1 constructs were expressed in HeLa cells, and compared to endogenous Atg16 
and LC3 distribution. After autophagy induction by Torin1 ATG16L1 was either visualised by 
immunostaining or GFP expression immunostained for ATG16L1. WIPI was immunostained and 
nuclei were stained with DAPI. Regions of interest are highlighted in boxes and colocalised puncta 
with arrows. Scale bars,10 μm.
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Figure 3.6 Autophagosome formation is not impaired by S305A and T316A mutations 
Atg16L1-S305A-GFP or Atg16L1-T316A-GFP constructs were expressed in HeLa cells and compared to LC3 and WIPI distribution after the induction of autophagy 
by Torin1. LC3 (red) and WIPI (cyan) were immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes and colocalised puncta 
with arrows. Scale bars, 10 μm.
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3.3.4 Characterisation of the point mutants of Atg16L1 
Previous research has implicated the CD associated T316A variant of Atg16L1 with defective 
autophagy against invasive pathogens (Kuballa et al., 2008; Travassos et al., 2010). 
However, the role of this mutation during metabolic stress during canonical autophagy has 
been poorly explored. Furthermore, the linker region of Atg16L1 contains a serine 
phosphorylation site, the function of which is unknown (Villén et al., 2007). This serine, 
which has been mapped to position 305 of mouse Atg16L1 γ was mutated to alanine, to 
generate a putative phosphorylation defective mutant. Both point mutants were expressed 
in HeLa cells, to ascertain what role they play in autophagy. 
 
In the absence of autophagy, both mutants were diffuse in the cytosol, and formed a small 
number of puncta. When autophagy was induced by Torin1, the point mutants formed 
puncta which co-localise with WIPI and LC3 (Fig. 3.7), indicating that these mutants were 
able to drive the formation of autophagosomes and interact with these autophagosome 
markers. 
 
3.3.5 Quantification of Atg16L1 puncta 
The ability of the GFP tagged constructs to form puncta can be further quantified to further 
assess their ability to function during the activation of autophagy. This would enable subtle 
changes between the deletion constructs to be detected. The Atg16L1 puncta were 
quantified using Imaris software (Bitplane), to convert pixels to digital data sets to 
accurately measure the number of GFP puncta, their diameter and the degree of co-
localisation with the autophagosome markers WIPI and LC3. These parameters were 
normalised on a per cell basis (Klionsky et al., 2012). Highly overexpressing cells were 
excluded from the analysis, as they are likely undergoing ER stress and do not represent 
the physiological norm. 
 
In response to the induction of autophagy, the numbers of puncta containing endogenous 
Atg16L1 (8) were approximately half those seen following expression of Atg16L1 constructs 
fused to GFP (13-25) (Fig 3.7a). This increase in Atg16L1-GFP puncta when compared to 
endogenous Atg16L1 puncta is significant. However, the CCD-GFP and CCD+L deletion 
constructs and the T316A and S305A mutants did not significantly differ from Atg16L1-GFP 
in the number of puncta per cell induced by autophagy (Fig 3.7a).  
When the range of puncta/cell was plotted to ascertain the variable activity of each domain, 
the results indicated that endogenous Atg16L1, Atg16L1-GFP, S305A and T316A mutants 
were able to generate a consistent number of Atg16L1 containing puncta in response to 
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autophagy. The range of puncta/cell plotted for the CCD-GFP and CCD+L-GFP constructs 
were wider than endogenous ATG16L1, though the range was slightly smaller for the 
CCD+L-GFP compared to the CCD-GFP (Fig. 3.7b). A Levene’s test was applied to the data 
which showed that the variance for the CCD-GFP construct was close to statistical 
significance, with a p-value of 0.0821, when compared to the Atg16L1-GFP construct. The 
other constructs were not deemed statistically significant. Whilst the mean puncta/cell 
generated by the CCD domain are not significantly different from Atg16L1-GFP, it’s highly 
variable ability to form CCD containing puncta (as indicated by the Levene’s statistic) 
indicates an altered ability to induce and maintain autophagosomes. 
 
Next, the diameter of Atg16L1 puncta were measured to indicate the size of the developing 
autophagosome, to see whether the domains could efficiently generate autophagosomes 
above or below 0.75 μm diameter. This parameter was selected as autophagosomes are 
generally classified as 1 μm and above, though this varies by cell type (Mizushima, 2004). 
By focussing on Atg16L1 puncta above and below 0.75 μm diameter, it was intended to 
distinguish between early phagophore formation and the later stages of elongation and 
autophagosome formation, prior to the dissociation of Atg16L1. The number of puncta/cell 
below 0.75 μm containing endogenous Atg16L1 (7) were approximately half to a third of 
those seen following expression of the GFP tagged Atg16L1 constructs (12-27). This could 
correlate with an overall increase in the number of puncta in the cells expressing the 
Atg16L1-GFP constructs (Fig. 3.7a). The other constructs did not have a significantly 
different number of puncta below 0.75 μm when compared to Atg16L1-GFP. When the 
number of Atg16L1 puncta/cell above 0.75 μm was measured, the endogenous protein, 
Atg16L1-GFP, CCD-GFP, CCD+L-GFP and Atg16L1-S305A-GFP were shown to generate 
puncta above this threshold. However, the Atg16L1-T316A-GFP mutant was unable to form 
any puncta above 0.75 μm diameter (Fig 3.7d). This indicates that either the 
autophagosomes generated are of a smaller diameter, or that the mutant is out-recruited 
by endogenous Atg16L1 during the later stages autophagosome formation. 
 
Next the colocalisation between Atg16L1 puncta and WIPI was quantified. WIPI recruits 
Atg16L1 to the site of the autophagosomal membrane (Dooley et al., 2014), so the degree 
of co-localisation between Atg16L1 and WIPI is an indicator of whether this interaction has 
been altered by the addition of GFP to the C-terminus of the deletion constructs. 
Endogenous Atg16L1 and Atg16L1-GFP co-localised with WIPI to a similar degree at 88.5% 
and 81.8%, respectively. There was a decrease in the co-localisation of CCD-GFP with WIPI 
compared to endogenous protein and the GFP-tagged Atg16L1 and CCD+L constructs (Fig 
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3.8a). The point mutations (T316A and S305A) did not affect co-localisation with WIPI (Fig 
3.8a).  
 
Next colocalisation between Atg16L1 and LC3 was determined. The Atg16L1 complex is 
vital for LC3 incorporation into the developing autophagosomal membrane, and dissociates 
from the mature autophagosome, leaving LC3 associated with the membrane. Therefore, 
not all LC3 puncta will be Atg16L1 positive, as some represent mature autophagosomes. 
The endogenous Atg16L1 and Atg16L1-GFP puncta co-localised with LC3 to a similar extent 
(56% and 51%, respectively) (Fig 3.8b). The same was true for the deletion constructs 
(excluding the L+WD40 and WD40) and the point mutants. 
 
These results demonstrated that the full length GFP tagged Atg16L1 behaves in a similar 
manner to endogenous Atg16L1. Additionally, these results demonstrated that the CCD 
domain of Atg16L1 is less able to co-localise with WIPI than the full length Atg16L1 protein. 
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Figure 3.7 Quantification of Atg16L1 puncta/cell 
(A) Quantification of Atg16L1 puncta/cell showing mean and SEM. 10 cells analysed per condition. * 
p = 0.0185 
(B) Box plot of Atg16L1 puncta/cell, using data from (A). Levene’s test calculated with an alpha value 
of 0.05 
(C) Analysis of the data in (A) to show Atg16L1 puncta/cell less than or equal to 0.75 μm. * p = 
0.0279 
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 Figure 3.8 Quantification of colocalisation between Atg16L1 constructs and 
autophagosome markers WIPI2 and LC3 
(A) Analysis of experiments in figures 3.5 and 3.6. Atg16L1 puncta that were positive for WIPI were 
converted to a percentage of the total number of Atg16L1 puncta/cell. Bars show mean and SEM. p 
* = 0.0396 
(B) Analysis of experiments in figures 3.4 and 3.6. Atg16L1 puncta that were positive for LC3 were 
converted to a percentage of the total number of Atg16L1 puncta/cell. Bars show mean and SEM 
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3.3.6 Establishment of an Atg16L1 knockout MEF cell line 
 
3.3.6.1 Breeding scheme to obtain Atg16L1 fl/fl Rosa LacZ 
embryos  
To further characterise the role of the Atg16L1 domains and their ability to power 
autophagy, an Atg16L1 negative background was required. Therefore, a strategy to 
generate Atg16L1 KO MEFs using a conditional Atg16L1 knockout mouse model was utilised. 
The Atg16L1 flox/flox (fl/fl) mice were generated by Maryam Arasteh, and have been 
outlined in her thesis work. Briefly, exon 2 has been flanked by loxP sites, followed by a 
neomycin resistance cassette, flanked by Frt sites. The neomycin cassette has been 
removed by crossing heterozygous Atg16L1Fl/+ mice with mice carrying FlpO-recombinase, 
and is therefore not present in the mice used for the generation of the MEFs (Fig 3.9). The 
Atg16L1fl/fl mice were crossed with Rosa LacZ/LacZ mice (Fig 3.10) to obtain 
Atg16L1Fl/+//Rosa26LacZ/+ mice, which were then intercrossed to obtain 
Atg16L1fl/fl//Rosa26LacZ/+. E13.5 Atg16L1fl/fl // LacZ/+ embryos were obtained by time 
mating Atg16L1fl/fl with Atg16L1fl/fl //Rosa26LacZ/LacZ mice. This timed mating was set 
up by Devina Divekar and Ulrike Mayer. Since the disruption of Atg16L1fl/fl and the 
expression of the Rosa26-LacZ transgene are both controlled by the same Cre recombinase, 
LacZ expression/activity can serve as a useful marker of the cells with targeted gene 
disruption (Fig 3.10). 
 
3.3.6.2 Extraction, immortalisation and clonal selection of 
MEFs from embryos 
At E13 the pregnant mouse was humanely killed by a schedule 1 method. As the genotype 
of each embryo was identical, embryos were processed together. Immortalisation of MEFs 
can be achieved using serial passaging. In this method, immortalisation requires a 
stochastic genetic event, likely loss of p53 or less frequently loss of p19ARF (Kamijo et al., 
1997; Sharpless., 2006/Cellis). MEFs were split twice a week during the rapid growth phase 
of the culture, which was between the first 1-6 passages. As the cells entered senescence, 
the cells were split 1:2 or just replated, to maintain cells at near 100% confluency since 
seeding cells too sparsely at this stage decreases the immortalisation frequency (Sharpless., 
2005). Immortalised cells began to overgrow the cultures between passages 15-20, and 
were subsequently pooled for clonal selection to generate a homogenic population. Whilst 
the genotype of the immortalised MEFs were identical, other genetic variation between the 
pooled MEFs could not be accounted for e.g. immortalisation events and genetic variation 
between individual embryos.  
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Clones identified by clonal selection were expanded until enough cells were available for 
the adenoviral cre-recombinase expression, to knockout Atg16L1 expression. 
 
3.3.6.3 Generation and verification of Adeno-Cre specific 
Atg16L1 knockout MEFs 
The isolation of individual clones of immortalised Atg16L1 fl/fl LacZ +/- MEFs allowed for 
the generation of knockout Atg16L1 cells with Cre recombinase, while having a parental 
control genetically and morphologically identical to the Atg16L1-deficient cells. MEF Atg16L1 
fl/fl cells were incubated with the AdenoCre virus (AdCre) to express cre-recombinase in 
induced cells. The cells were then analysed by FACS. LacZ expression and therefore Atg16L1 
gene disruption can be determined using the fluorogenic β-galactosidase substrate 
fluorescein di β-D-galactopyranoside (FDG). The non-fluorescent FDG is sequentially 
hydrolysed by β-galactosidase, first to fluorescein monogalactoside (FMG) and then to 
highly fluorescent fluorescein (Guo and Wu., 2008). Parental fl/fl and AdCre treated cells 
were subjected to FDG stain, or left untreated as a control. The cells were then analysed 
and sorted by FACS. The parental fl/fl untreated, FDG treated and AdCre non FDG treated 
MEFs were negative for LacZ activity as determined by FACS (Fig 3.11). The AdCre FDG 
treated MEFs were positive for LacZ activity, and the population was sorted and collected 
for further analysis.  
 
To determine if the AdCre treatment and FDG LacZ sorting of cells had been successful in 
knocking out Atg16L1 expression, PCR was used to analyse genomic DNA from cell lysates 
with the forward primer targets Atg16L1 intron 1 (primer 223) and the reverse primer 
targets Atg16L1 intron 2 (primer 226, Table 2.9). PCR genotyping was carried out on two 
populations of clonal cells, before and after AdCre treatment and FACs sorting. Both 
populations of parental Atg16L1 fl/fl cells were homozygous for the Atg16L1 fl/fl allele, 
generating a band of 801 bp (Figs 3.19, 3.12). PCR genotyping of the AdCre treated clones 
confirmed excision of exon 2 and generation of a homozygous Atg16L1 KO cell, with a 
single band of 253 bp (Fig.3.12). A weak band for Atg16L1 fl/fl was seen in clone 2, and 
further analysis lead to this clone being discarded. 
 
Previous research has shown that Atg16L1 deficient MEFs are deficient in LC3 processing 
and accumulate long-lived proteins, such as p62 (Saitoh et al., 2008). To confirm that the 
MEFs were no longer expressing Atg16L1 at the protein level and were autophagy deficient, 
parental Atg16L1 fl/fl and AdCre FACS sorted Atg16L1 KO MEFs were subjected to an HBSS 
starvation time course, the protein lysates collected and analysed by Western blotting. HBSS 
  Chapter 3 
 
81 
 
starvation was used as it is a standardised protocol for inducing autophagy, and can be 
used for starving the cells over a longer timecourse than Torin1, without potential 
pharmacological side effects. The Atg16L1 fl/fl MEFs expressed the α and β isoforms of the 
protein, whereas there was no Atg16L1 protein present in Atg16L1 KO MEFs (Fig. 3.13a). 
Following the induction of autophagy by HBSS starvation, Atg16L1 fl/fl MEFs were able to 
process LC3-I to LC3-II, and degrade p62, while in Atg16L1 KO MEFs, LC3-I was not 
processed, and p62 accumulated throughout the starvation time course (Fig. 3.13a-b). 
Indeed, prior to the induction of autophagy, there was a three-fold increase in the level of 
p62 compared to Atg16L1 fl/fl cells (Fig. 3.13b), indicating that the Atg16L1 KO MEFs are 
autophagy defective.  
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Figure 3.9 PCR strategy for genotyping Atg16L1 transgenic mice. Primers used to determine 
WT, Atg16l1 floxed, removal of the neomycin cassette after Flp-mediated recombination and removal 
of exon 2 after Cre mediated recombination in mice. Courtesy of Maryam Arasteh  
 
 
Figure 3.10 Diagrammatic representation of the Rosa26 LacZ locus. A stop codon is flanked 
by two loxP sites, preventing transcription of the LacZ gene. Following cre-mediated recombination, 
the stop codon is removed, and the lacZ gene can be transcribed and translated. Modified from Le 
Lay and Kaestner., 2010. 
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Figure 3.11 Atg16L1 fl/fl RosaLacZ AdCre induced MEFs are positive for LacZ activity 
determined by FDG staining and FACS sorting. Cells were treated with FDG to determine LacZ 
activity. Untreated and parental cells served as a control. Cells were gated using forward and 
sideward scatter (P1). Fluorescence was detected using the 530/30 filter, with fluorescent cells gated 
as P2. In blue typeface are MEFs induced with AdenoCre which are positive for LacZ activity. 
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Figure 3.12 Adeno-cre specific knockout of Atg16L1 expression in FACS sorted MEFs as 
determined by PCR genotyping 
PCR Genotyping of Atg16L1 fl/fl and Atg16L1 AdCre treated MEFs post FACS sorting. Genomic DNA 
was extracted from clonal cells that had been sorted for LacZ activity by FDG staining to confirm 
excision of exon2 of Atg16L1 by the presence of a 253 bp band. M = marker, B = blank. 
 
 
Figure 3.13 Atg16L1 KO MEFS are autophagy deficient 
Autophagy deficiency in Atg16 KO MEFs. (A) Clonal Atg16L1 fl/fl or sorted Atg16L1 KO cells were 
cultured in nutrient rich medium or HBSS and lysates collected. The protein lysates were collected 
for analysis by Western blotting. (B) Quantification of the levels of p62 protein in (A) by densitometry.  
B 
A 
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Next, we tested whether Atg16L1 KO MEFs lacked the ability to form autophagosomes. 
Atg16L1 fl/fl and Atg16L1 KO MEFs were starved with HBSS for 2 h, fixed and 
immunostained for autophagosome markers. Atg16L1 fl/fl MEFs were able to form LC3 
puncta which co-localised with WIPI2 (Fig. 3.14). Formation of autophagosomes was not 
observed in Atg16L1 KO MEFs (Fig. 3.14). These results confirm the generation of an 
Atg16L1 KO MEF cell line that is autophagy deficient, resulting in accumulation of long lived 
proteins, such as p62. 
 
3.3.7 Reconstitution and quantification of Atg16L1 domains in 
Atg16L1 KO MEFs 
Earlier in this chapter, the properties of the individual domains of Atg16L1 in autophagy 
had been characterised. To explore the role of these domains without endogenous Atg16L1 
expression, full length, CCD, L+WD40 and CD associated Atg16L1-T316A mutant constructs 
were transfected in Atg16L1 KO MEFs, subjected to HBSS starvation to induce autophagy, 
and counterstained for the autophagosome marker LC3. In untransfected Atg16L1 KO 
MEFs, the distribution of LC3 remained diffuse during the activation of autophagy, with the 
exception of a few LC3 positive puncta (Fig. 3.15). In cells that were reconstituted with the 
full length Atg16L1-GFP, CCD-GFP and Atg16L1-T316A-GFP autophagosome formation was 
restored as indicated by the presence of GFP-positive puncta that co-localised with LC3 
puncta (Fig. 3.15). As expected, in cells that were reconstituted with the L+WD40 domain 
of Atg16L1 no GFP- or LC3-positive puncta were apparent (Fig. 3.15).  
 
Images from the reconstitution experiments were analysed to further quantify each 
domain’s ability to form puncta and restore autophagy. The number of Atg16L1-GFP and 
Atg16L1-T316A-GFP puncta per cell were comparable, while the number of puncta were 
highly variable when the CCD-GFP domain was expressed, which is in line with the earlier 
results in this chapter (3.3.3, 3.3.5, Fig. 3.16a,b). A Levene’s test showed that there was 
no significant difference in the variance between the CCD-GFP, T316A-GFP and the 
Atg16L1-GFP constructs, however the Levene’s statistic for the CCD-GFP was nearing the 
threshold for significance indicating a trend towards difference in variance. Quantification 
of LC3 puncta confirmed that the full-length Atg161L1-GFP had restored autophagy (Fig. 
3.16c). There was a small, non-significant decrease in cells expressing the CCD-GFP 
construct, highlighting the variability of this domain to effectively carry out autophagy. 
Interestingly, cells that expressed the Atg16L1-T316A-GFP construct showed a significant 
increase in the number of LC3 puncta generated (Fig. 3.16c).  
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The degree of co-localisation between Atg16L1 domains and LC3 was also analysed to 
determine how efficiently the domains could recruit LC3 to the site of the autophagosome. 
Atg16L1 puncta were classified as either LC3 positive or LC3 negative, with a larger 
proportion of Atg16L1/LC3 positive puncta indicating normal autophagosome maturation. 
Both the Atg16L1-GFP and Atg16L1-T316A-GFP constructs generated puncta that were 
predominantly LC3 positive during HBSS starvation (Fig. 3.16d). However, the CCD-GFP 
puncta were less likely to be associated with LC3, with fewer GFP/LC3 puncta compared to 
the other domains (Fig. 3.16d). Overall, this demonstrates that the CCD domain of Atg16L1 
is sufficient to drive autophagic activity of Atg16L1.  
 
3.3.8. The requirement of Atg16L1 domains in the formation of 
tubulovesicular autophagosomes 
So far in this chapter, the role of the Atg16L1 domains during starvation induced autophagy 
has been explored. To determine the involvement of Atg16L1 in the selective recognition 
and degradation of pathogens via autophagy, lipoplex transfection reagents were chosen, 
as they act like pathogen associated molecular patterns (PAMPs) to activate selective 
autophagy (Roberts et al., 2013; Fujita et al., 2013). Lipoplex transfection reagents (e.g. 
Transfast) can induce the formation of tubulovesicular autophagosome (TVAs) in a wide 
variety of cell types (Roberts et al., 2013). Furthermore, it has been shown that beads 
coated with transfection reagents are selectively targeted by LC3-positive autophagosomes 
(Fujita et al., 2013). To simulate pathogen invasion and induce TVA formation, Atg16L1 KO 
MEFs expressing the Atg16L1-GFP, CCD-GFP, L+WD40 or Atg16L1-T316A-GFP constructs 
were cultured in nutrient rich media, with the addition of lipoplex reagent. The Atg16L1-
GFP construct was able to restore the formation of large LC3 positive structures, which 
were clustered close to the nucleus. There was a degree of co-localisation between LC3 
and Atg16L1-GFP, with the LC3 signal confined to a complex of vesicles and tubules (Fig. 
3.18). Cells expressing CCD-GFP were also able to form TVAs. However, there were more 
CCD-GFP puncta observed which were LC3 negative (Fig. 3.18). The Atg16L1-T316A-GFP 
mutant was able to drive the formation of TVAs, which were both GFP and LC3 positive. 
Interestingly, there appeared to be an increase in the number of tubules and vesicles, 
though the tubules were shortened in length (Fig. 3.18). These results demonstrate that 
the CCD domain is sufficient to drive the autophagic response to surrogate PAMPS. 
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Figure 3.14 Atg16L1 KO MEFs do not form LC3 puncta 
Distribution of autophagosome markers in Atg16L1 fl/fl and Atg16L1 KO MEFs. 
Cells were incubated in HBSS for 2 h to induce autophagy. Cells were immunostained with LC3 and 
the nuclei were stained with DAPI. Scale bars, 10 μm. 
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Figure 3.15 Reconstitution of Atg16L1 KO MEFs with GFP-tagged Atg16L1 constructs 
demonstrates that the CCD restores autophagy. 
GFP-tagged Atg16L1 constructs were transfected in Atg16L1 KO MEFs and treated with HBSS for 2 
h to induced autophagy. Autophagosomes were immunostained with LC3. The nuclei were stained 
with DAPI. Regions of interest are highlighted in boxes and puncta of interest with arrows. Scale 
bars, 10 μm 
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Figure 3.16 Quantification of Atg16L1 and LC3 puncta in reconstitution experiments 
(A) Quantification of Atg16L1 puncta/cell from experiments in Figure 3.15.  
(B) Box plot of Atg16L1/puncta/cell using data from (A). Levene’s test calculated with an alpha value 
of 0.05 
(C) Analysis of LC3 puncta/cell from experiments in Figure 3.15. * p = 0.0413 
D) Analysis of Atg16L1 domain localisation with LC3 puncta from experiments in Figure 3.15.  
A B 
D 
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Figure 3.17 The CCD and the CD associated T316A mutant restore the autophagy 
response to surrogate pathogen in Atg16L1 KO MEFs 
Atg16L1 KO MEFs were reconstituted with GFP-tagged Atg16L1 domains. Cells were incubated with 
lipoplex transfection reagent for 4 h to induce TVAs. LC3 was immunostained and the nuclei stained 
with DAPI (blue) Regions of interest are highlighted in boxes. Scale bars, 10 μm 
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3.4 Chapter Discussion 
The main aims of this chapter were to determine the function of the Atg16L1 domains in 
autophagy. To study the function of the domains of Atg16L1, C-terminal GFP-tagged 
Atg16L1 constructs were generated. To ensure these constructs were stable when 
expressed, and to assess their contribution to autophagy, their localisation with autophagy 
markers was observed and quantified in cells with a background of ATG16L1 expression, 
and cells where Atg16L1 expression had been knocked out.  
 
The full length Atg16L1-GFP behaves as endogenous ATG16L1 and can still form 
autophagosomes, confirmed by the localisation with the autophagosome markers LC3 and 
WIPI. The ability of Atg16L1-GFP to associate with these autophagosome markers in 
response to autophagy induction indicates that the autophagic function of Atg16L1 has not 
been disrupted by the addition of a C-terminal GFP tag, confirming that Atg16L1-GFP is able 
to function in canonical autophagy. The deletion constructs CCD-GFP and CCD+L-GFP were 
capable of localising to the autophagosome with WIPI and LC3. When expressed in Atg16L1 
KO MEFs, the CCD-GFP construct was sufficient to restore LC3 puncta. However, a broad 
range of CCD-GFP puncta were detected (Fig. 3.18). This could indicate a potential loss of 
regulation or stability in the CCD, following deletion of the linker and WD40 domain. On the 
other hand, this could be caused by transfection efficiency varying between cells. The 
L+WD40-GFP and WD40-GFP deletion constructs did not form puncta and did not localise 
with LC3 and WIPI, and therefore do not play a role in driving the formation of 
autophagosomes. 
 
If the varied range of puncta number generated by CCD-GFP is caused by the loss of the 
linker and WD40 domain, this could allude to important interactions or posttranslational 
modifications within these domains. These interactions and modifications could therefore 
play a key role in regulating canonical autophagy. The coiled-coil domain of Atg16 is 
conserved from yeast to higher eukaryotes, and whilst sufficient to reconstitute autophagy 
in this and other studies (Fujita et al., 2009), it is possible that mechanisms may have 
evolved in higher eukaryotes to fine tune the autophagy pathway which involve the linker 
and WD40 domain, though this is highly speculative. Another explanation for the results is 
that the addition of eGFP to the C-terminus of the CCD may have altered the important 
interaction between Atg16L1 and WIPI2. This interaction is crucial for the recruitment of 
the Atg5-12-Atg16L1 complex to the early autophagosome and is dependent on two 
residues in Atg16L1 which lie at the end of the coiled-coil domain; E226 and E230 (Dooley 
et al., 2014). It is possible that the presence of an eGFP tag so close to these residues 
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results in steric hindrance of WIPI2, which would also explain why there is a slight trend 
for reduced colocalisation between CCD-GFP and WIPI2, when compared to full length 
Atg16L1-GFP. 
 
The putative phosphorylation mutant Atg16L1-S305A and the CD-associated mutant 
Atg16L1-T316A were also studied, to further understand the importance and function of 
these residues in autophagy. The S305A mutant was comparable to full length Atg16L1-
GFP construct, and was able to function in autophagy. If this serine phosphorylation of 
Atg16L1 plays a role in autophagy, it may be a subtle regulatory mechanism, and could be 
associated with autophagic flux. Similar mechanisms have been demonstrated in the 
autophagy proteins, such as the threonine phosphorylation of Atg5 by p38 (Keil et al., 
2013). The T316A mutant was able to incorporate into autophagosomes and was able to 
restore canonical autophagy, however, this construct was unable to form puncta above 
0.75 μm in diameter. This was unusual, as all other autophagy competent constructs tested 
were able to generate some puncta above this threshold, which represents a near-mature 
autophagosome. However, the number of large autophagosomes containing the GFP 
tagged Atg16L1 constructs typically did not exceed 2 per cell. The biological relevance of 
this is as yet unclear. This inability of the T316A mutant to generate large puncta, 
comparable to the full length wild type Atg16L1 could lead to the formation of smaller 
autophagosomes (Fig 3.18), due to the vital role Atg16L1 plays in the incorporation of LC3 
into the autophagosome, as less Atg16L1 is recruited to the phagophore (Fujita et al., 
2008). Indeed, this hypothesis was confirmed by Murthy et al., 2014, who demonstrated 
that the T316A mutant generated smaller autophagosomes in response to starvation. 
Previously, the CD-associated mutation had been linked to defective autophagy in response 
to pathogen invasion, resulting in a failure to capture pathogens within the autophagosome 
(Kuballa et al., 2008; Travassos et al., 2010). Therefore, the T316A mutation also has an 
impact on canonical autophagy. 
It has been established that the addition of transfection reagents such as lipoplex and 
polyplex can lead to the formation of tubulovesicular autophagosomes (TVAs) (Roberts et 
al., 2013). Previous studies have also shown that when latex beads coated with these 
transfection reagents are phagocytosed by cells, the autophagy machinery is activated and 
recruited to the bead in a response comparable to an invading microorganism (Fujita et al., 
2013). In this chapter, the CCD of Atg16L1 was able to contribute to the formation of TVAs 
in response to lipoplex reagents, whereas the L+WD40 was unable to. This is likely linked 
to the interaction between Atg16L1 and WIPI2, which directs Atg16L1 to the site of early 
autophagosome formation (Dooley et al., 2014). 
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Figure 3.18 Schematic representation of autophagosome formation by domains and 
mutants of Atg16L1. In response to nutrient deprivation, CCD of Atg16L1 is able to drive the 
formation of autophagosomes, though the number of autophagosomes is varied The CD associated 
T316A mutant of Atg16L1 is able to power autophagosome formation, however the T316A mutant 
is unable to incorporate into large puncta, which could lead to the formation of smaller 
autophagosomes compared to those generated by wild type Atg16L1. 
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This interaction also plays a vital role in the clearance of pathogens, so it was not surprising 
that the CCD, which contains the residues responsible for the interaction with WIPI2, would 
be able to contribute to TVA formation. The CCD is also sufficient for the clearance of 
Toxoplasma gondii in macrophages (Choi et al., 2014). However, the efficiency of TVA 
formation by the CCD was not investigated, so the comparison to the full length Atg16L1 
cannot be made. As the early results in this chapter have demonstrated, the loss of the 
L+WD40 domains affect the ability of the CCD to efficiently perform autophagy, and the 
same may be true of TVA formation. Whilst the CCD may be sufficient to recruit Atg16L1 
to the autophagosome in response to infection, other mechanisms within Atg16L1 have 
been characterised (Fig 3.19). The WD40 domain of Atg16L1 has also been shown to bind 
ubiquitin, which decorates ruptured endosomal membranes containing Salmonella or 
transfection coated beads. Deletion of the WD domain and further mutation of Atg16L1 in 
the FIP200 binding region and within the CCD domain reduces the formation of LC3 and 
Atg16L1 positive vesicles around Salmonella, demonstrating that FIP200 and an additional 
unknown protein interaction also contribute to Atg16L1 recruitment. The interactions 
between Atg16L1 and the pathogen recognition receptors (PRR) NOD1/2 and TLR2 are also 
thought to enable recruitment to the invading microorganism via the PRR (Travassos et al., 
2010; Boada-Romero et al., 2013). These separate regions and residues all appear to 
contribute towards different mechanisms in Atg16L1 recruitment in selective autophagy, 
indicating there are multiple ways in which Atg16L1 is recruited to the early autophagosome 
in response to many autophagic stimuli. 
 
A clearer picture is emerging of the function of the domains of Atg16L1 in canonical and 
selective forms of autophagy. Whilst the CCD is recruited to the site of the early 
autophagosome and is responsible for the autophagic activity of Atg16L1, there are 
additional functions of the linker and WD40 repeat domain, as indicated by the alteration 
in autophagosome behaviour in the deletion constructs and the CD-associated T316A 
mutant. As more interactions with Atg16L1 are characterised and published, the role of the 
linker and WD40 domain in canonical and selective autophagy will become more apparent. 
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Figure 3.19 Schematic outline of proteins able to recruit Atg16L1 to 
autophagosomal/endosomal membranes. An unknown mechanism has been shown to affect 
the recruitment of Atg16L1 to the autophagosome in canonical and selective autophagy (Fujita et 
al., 2013).  
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Chapter 4: Verification of a novel interaction between Atg16L1 and MEKK4 
 
 4.1 Chapter Aims 
The aims of this chapter were to verify and characterise the novel interaction between 
Atg16L1 and the serine/threonine kinase MEKK4, an interaction that was intitially identified 
in a yeast two hybrid screen. Cell lines that stably express epitope tagged Atg16L1 and 
NOD2 for use in interaction studies are described. The interactions were investigated by 
immunoprecipitation and the cellular distribution observed by immunofluorescence 
microscopy. The proteins of interest were Atg16L1, Mekk4 and Nod2. 
 
 4.2 Introduction 
To date, a number of proteins have been identified that interact with Atg16L1 (table 4.1). 
Those interactions that have been mapped to the N-terminus and the coiled-coil domain of 
Atg16L1 tend to be associated with canonical autophagy e.g. Atg5 and WIPI2 (Mizushima 
et al., 2003; Dooley et al., 2014). Interestingly, proteins which bind to the WD40 domain 
of Atg16L1 via the Atg16L1 interacting motif, identified by Boada-Romero et al in 2013 are 
involved in selective autophagy against intracellular pathogens e.g. Nod1/2 and TLR2. 
 
As discussed in the previous chapter, there are a number of proteins that are capable of 
recruiting Atg16L1 to the autophagosome or endosomal membrane, however no molecular 
switch for autophagic activity of Atg16L1 has been identified. Interestingly, several serine 
phosphorylation sites within the linker region of Atg16L1 have been discovered, though 
their function is not known (Villén et al., 2007; Olsen et al., 2010). 
 
Other components of the autophagy pathway have been shown to be tightly regulated by 
post-translational modifications. Under nutrient rich conditions, mTOR inhibits autophagy 
by phosphorylating the ULK complex, which contains ULK1/2, Atg13 and FIP200. 
(Hosokawa et al., 2009). Acetylation of Atg5, Atg7, Atg8 and Atg12 inhibits starvation 
induced autophagy (Lee and Finkel, 2009). Activity of Atg5 has been shown to be regulated 
by phosphorylation of a conserved threonine residue by p38 (Keil et al., 2012). Therefore, 
there is a possibility that Atg16L1 could be regulated by similar mechanisms during 
autophagy. 
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Table 4.1 A list of Atg16L1 interacting proteins determined from published data as of August 2014 
Interacting 
protein 
Region of Atg16L1 that 
binds to interacting 
protein 
Species of Atg16L1 
used in study 
Function in Autophagy Reference 
Atg16L1 1-276 (M.musculus) Atg16L1 homoligomerises via its coiled-coil domain (by similarity in 
yeast Apg16). 
Forms 800kDa complex with Atg5-12 conjugate. 
Mizushima et al., 
2003 
Atg5 1-79 (N-term) (M.musculus) Atg5 is required for membrane targeting of Atg16L1  Mizushima et al., 
2003 
Rab33b 1-79 (N-term) M.musculus May be involved in modulation of autophagosome formation, 
though not during starvation induced autophagy. 
Itoh et al., 2008. 
NOD1 WD40 domain* H.sapiens Binds to Atg16L1 interacting motif (AIM). Is directed to site of 
bacterial entry by NOD1 and drives anti-bacterial autophagy to 
engulf pathogen. 
Travassos et al., 
2010. 
*Refined by 
Boada-Romero et 
al., 2013 
NOD2 WD40 domain H.sapiens Binds to Atg16L1 interacting motif (AIM). Is directed to site of 
bacterial entry by NOD2 and drives anti-bacterial autophagy to 
engulf pathogen. 
Travassos et al., 
2010. 
*Refined by 
Boada-Romero et 
al., 2013 
LC3B/GABARAP Whole protein H.sapiens Interacts independently of LIR-LDS interface of LC3 (LC3-
interaction region docking site).  
Atg16L1 known to specify site of LC3 lipidation and incorporation 
into autophagosome membrane. 
Behrends et al., 
2010. 
Clathrin 2-77 (N-term) H.sapiens Atg16L1 interacts with clathrin heavy chain, and is involved in 
formation of early autophagosomes from plasma membrane 
precursors. 
Ravikumar et al., 
2010. 
SNX18 Whole protein Not cited Recruits Atg16L1 to perinuclear recycling endosomes. Positive 
regulator of autophagy. 
Knævelsrud et 
al., 2013. 
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Table 4.1 Continued 
Interacting protein Region of Atg16L1 
that binds to 
interacting protein 
Species of 
Atg16L1 used in 
study 
Function in Autophagy Reference 
Human 
transmembrane 
protein 59 
TMEM59 
WD40 domain H.sapiens Identified Atg16L1 interacting motif (AIM). 
Promotes LC3 labelling of endocytic compartments and mediates 
autophagy in response to Staphylococcus aureus infection. 
Boada-Romero 
et al., 2013. 
Toll-like receptor 2 
TLR2 
WD40 domain H.sapiens Interacts via AIM. Is known to promote labelling of endocytic/phagocytic 
compartments with LC3 
Boada-Romero 
et al., 2013. 
FIP200 E235 
D237 
D238 
D239 
E241 
M.musculus Charge mutations from acidic residues to arginine weakened FIP200 
binding. 
 
Was thought to regulate targeting of Atg16L1 to membrane, but this has 
been attributed to an interaction with WIPI2. However, other research 
has shown a role for FIP200 in targeting Atg16L1 to ubiquitinated 
endosomal membranes  
Gammoh et al., 
2013 
Nishimura et al., 
2013 
Fujita et al., 
2013 
Dooley et al, 
2014^ 
 
^most recent 
and accurate 
data 
Ubiquitin WD40 domain H.sapiens Targets Atg16L1 to ubiquitin decorated endosomes containing 
pathogens/phagocytosed beads coated with transfection reagents. 
Fujita et al., 
2013. 
WIPI2 E226 
E230 
M.musculus Recruits Atg16L1 to site of early autophagosome formation. Required for 
both starvation induced autophagy and clearance of Salmonella 
Typhimurium. 
Dooley et al., 
2014 
BTD 
AVIL 
GARS 
CALU 
NOC1 
Whole protein H.sapiens Identified in a quantitative proteomics screen. siRNA depletion shows 
reduced LC3–Salmonella colocalization and intracellular bacterial 
replication assays, suggesting roles for these genes in antibacterial 
autophagy. 
 
Other proteins have been identified in this screen but not included in this 
table as they were not analysed. 
Lassen et al., 
2014 
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To identify novel protein interactions with Atg16L1 which may be responsible for the 
regulation of Atg16L1 activity, a yeast-two-hybrid screen was carried out using mouse 
Atg16L1 γ as bait against a human colon cDNA library. An interaction with a good confidence 
level was found for the protein MEKK4. MEKK4 belongs to the sterile (Ste) serine/threonine 
protein kinase family and is a member of the MAPK kinase kinase subfamily. 
 
MEKK4 is a mitogen activated protein kinase kinase kinase (MAP3K), and is also referred to 
as MAP3K4, and MTK1. MEKK4 is involved in stress activated mitogen protein kinase 
pathways (SAPK), which enables cells to respond to life death decisions in the face of extra-
cellular stress, e.g. physical stress such as UV radiation or biological stress such as DNA 
damage or cytokines (Miyake et al., 2007, Bettinger and Amberg., 2007). It consists of an 
N terminal autoinhibitory domain and C-terminal kinase domain (Takekawa et al., 1997; 
Gerwins et al., 1997). The MAP3Ks facilitate downstream signalling by activating an 
intermediate MAP kinase kinase (MAP2K) by phosphorylation, which subsequently 
phosphorylate and activate their target MAP kinase (Fig. 4.1). Similar to other MAP3Ks, 
MEKK4 activation is regulated by the release of autoinhibition, allowing MEKK4 to go from 
a closed to an open conformation (Miyake et al., 2007). One of the most characterised 
activators of MEKK4 is the GADD45 (growth arrest and DNA damage inducible) family of 
proteins, which bind to the N-terminus of MEKK4 and trigger the release of autoinhibition. 
Full activation is achieved when MEKK4 homodimerises and transautophosphorylates, 
allowing it to phosphorylate downstream targets. MEKK4 has been shown to phosphorylate 
various MAP2Ks, including MKK4 and MKK6, which function in both the p38 and JNK 
pathways (Gerwins et al., 1997, Takekawa et al., 1997). Recently, MEKK4 has been linked 
to autophagy regulation. The GADD45β-MEKK4-p38 pathway was shown to direct 
phosphorylated p38 to autophagosomes, where a subsequent interaction between p38 and 
Atg5 lead to inhibition of autophagy (Keil et al., 2012). However a specific role for MEKK4 
in the regulation of autophagy has not been described. 
 
MEKK4 has also been shown to play a key role in the NOD2 pathway, by binding the effector 
kinase RIP2 and preventing NOD2 signalling (Clark et al., 2008; Fig. 4.2a-b). The interaction 
between ATG16L1 and NOD2 has been investigated in the context of selective autophagy 
and the CD associated mutations in these two genes (Travassos et al., 2010; Sorbara et 
al., 2013). Activation of NOD receptors by bacterial cell wall peptidoglycan results in the 
activation of autophagy (Travassos et al., 2010, Cooney et al., 2010; Homer et al, 2010). 
ATG16L1 can specifically regulate NOD-driven cytokine responses, with knockdown of 
ATG16L1 but not ATG5 leading to up regulation of cytokine production (Sorbara et al., 
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2013). Furthermore, ATG16L1 can inhibit polyubiquitination of RIP2, the mechanism by 
which activation of RIP2 is controlled. As yet, the precise molecular mechanism that governs 
the activation of NOD2 directed autophagy is unclear. The CD associated ATG16L1 mutant 
has been reported as defective in selective autophagy against intracellular pathogens 
(Kuballa et al., 2008; Travassos et al., 2010), though retains the ability to bind NOD2. 
Therefore a proximity model of activation cannot be solely responsible for ATG16L11 
activation following NOD2 stimulation. Further post-translational modification of ATG16L1 
might be required, with MEKK4 a likely candidate for crosstalk between the autophagy and 
NOD signalling pathways. 
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Figure 4.1 The MAPK signalling cascade. Activation of MAP3Ks by small GTPases in response to 
a variety of extracellular stresses. MAP3Ks phosphorylate and activate MAP2Ks that subsequently 
phosphorylate and activate MAPKs (only p38 shown). Modified from Ashwell (2006). 
 
 
 
 
Figure 4.2 Diagrammatic representation of the interactions and regulators of Nod2 
signalling 
A 
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Figure 4.2 Continued 
(A) Bacterial invasion of epithelial cells results in the stimulation of NOD2 proteins by peptidoglycan-
derived peptides such as MDP. Once activated, NOD2 undergoes homoligomerisation via the 
NACHT/NOD domain. RIP2 is recruited via homotypic CARD:CARD interactions, followed by 
binding of TRIP protein to RIP2 and XIAP and Pellino3-mediated polyubiquitination of RIP2. The 
results in recruitment of TAK1 and IKK complexes and downstream activation of NF-κB, MAPKs 
and AP-1, driving the expression of proinflammatory responses. ATG16L1 negatively regulates 
NOD2 signalling by interfering with the polyubiquitination of RIP2 and the recruitment of RIP2 
into NOD-signalling complexes. MEKK4 also negatively regulates NOD2 signalling by 
sequestering RIP2 and preventing the formation of the NOD2:RIP2 complex 
(B) Established interactions between MEKK4, NOD2, ATG16L1 and RIP2 in the context of bacterial 
invasion. In the absence of NOD2 activation, MEKK4 is bound to RIP2 and NOD2 is inactive. 
When NOD2 is active, it undergoes a conformational change allowing it to outcompete MEKK4 
for RIP2 binding (Clark et al., 2008). ATG16L1 is also bound to NOD2 and is recruited to the site 
of bacterial entry (Travassos et al., 2010). Modified from Humphries et al. (2014). 
 
 
B 
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4.3 Results 
 
4.3.1 Yeast two hybrid screen identifies MEKK4 as a novel binding 
partner of Atg16L1 
To identify novel protein interactions with ATG16L1, a yeast-two-hybrid screen was carried 
out with the aid of Hybrigenics Global PBS®. The bait protein, Mus musculus ATG16L1γ 
was screened against a human colon cDNA library, to identify interactions likely to occur in 
the gut epithelium. Positive interactions were identified, analysed and assigned a grade to 
indicate confidence in the interaction. An interaction with a good confidence level was found 
for the protein MEKK4. To verify MEKK4 as a binding partner of Atg16L1, cell lines that 
constitutively express Atg16L1 and or NOD2 had to be generated for use in 
immunoprecipitation experiments. 
 
4.3.2 Generation of Atg16L1-GFP and NOD2-HA episomal vector 
constructs 
The conditions under which MEKK4 binds Atg16L1 are unknown. Transient transfection is 
known to activate autophagy (Roberts et al., 2013), with transfection of NOD known to 
activate downstream NOD signalling (Inohara et al., 2000). To overcome these issues, and 
to ensure even expression of two plasmids in the same cells, an episomal expression system 
was utilised. 
 
The two episomal vectors used in this project were pCEP-Pu, which contains a puromycin 
resistance gene, and pCEP4 (Invitrogen) which contains a hygromycin resistance gene. The 
episomal expression vectors utilise the Epstein-Barr virus replication origin (oriP) and 
nuclear antigen (EBNA-1) to maintain extrachromasomal replication of the plasmid within 
cells (Craenenbroeck et al., 2000). This system allows a high transfection efficiency, with 
stable protein expression maintained by selective antibiotics, without chromosomal 
integration into the host cell genome (Belt et al., 1991; Craenenbroeck et al., 2000). 
 
The Atg16L1-GFP sequence was cloned into the pCEP-Pu vector as follows. The 3’-end of 
Atg16L1-GFP was digested with NotI, then blunted with a Klenow reaction. The 5’-end of 
Atg16L1-GFP was digested with NheI in a separate reaction, to generate the Atg16L1-GFP 
insert. To prepare the pCEP-Pu vector, the MCS was digested with XhoI, then blunted with 
a Klenow reaction. A second digest with NheI was carried out on pCEP-Pu, and the Atg16L1-
GFP fragment ligated into the plasmid. This resulted in the generation of full length 
Atg16L1-GFP in the episomal vector pCEP-Pu.  
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The NOD2-HA plasmid was a kind gift from Prof. Dana Philpott (UT, Canada). The NOD2-
HA sequence was cloned into the pCEP4 vector as follows. The NOD2-HA fragment was 
generated by restriction digestion with NheI and XhoI. This was ligated into the MCS of 
pCEP4, which was digested with NheI and XhoI to create compatible ends. This resulted in 
the generation of NOD2-HA in the episomal vector pCEP4. 
  
  4.3.3 Generation of stable HEK293 episomal cell lines 
To generate stable episomal cell lines, the pCEP-Pu-Atg16L1-GFP or pCEP4-NOD2-HA 
vectors were transfected into HEK293 cells. Two days post transfection, media containing 
a pre-determined concentration of antibiotics (10 μg/ml puromycin or 200 μg/ml 
hygromycin) was added to the cells and changed every 3-4 days until antibiotic resistant 
colonies were identified. These colonies were picked and expanded until enough cells were 
available for analysis. This process of transfection and selection was repeated with cells 
that were positive for pCEP4-NOD2-HA, to transfect and select for pCEP-Pu-Atg16L1-GFP. 
This resulted in the generation of the following cell lines; HEK293 Atg16L1-GFP, HEK293 
NOD2-HA and HEK293 Atg16L1-GFP & NOD2-HA. 
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4.3.4 Confirmation of Atg16L1-GFP and NOD2-HA expression in 
episomal cell lines by immunofluorescence 
The subcellular localisation of the proteins encoded in the episomal vectors and their ability 
to respond to key signalling pathways are indicators of how well they are expressed by the 
episomal vector. The episomal cell line HEK293 Atg16L1-GFP was cultured in nutrient rich 
medium or media with Torin1 to induce autophagy, and stained for the autophagosome 
markers WIPI2 and LC3. The HEK293 NOD2-HA cells were cultured in supplemented 
medium alone, or media with 10 μg/ml muramyl di-peptide (MDP), a NOD2 agonist, to 
induce NOD2-directed autophagy. The cells were stained for HA and the autophagosome 
marker LC3. The HEK293 Atg16L1-GFP cell line was able to respond to the induction of 
autophagy with the formation of GFP positive puncta which co-localised with WIPI2 and 
LC3 (Fig 4.3). The HEK293 NOD2-HA cells were able to respond to the presence of MDP 
with an increase in the number of LC3 puncta (Fig 4.4). The subcellular distribution of NOD2 
is consistent with that reported in the literature, which is mainly cytosolic, with a fraction 
located at the plasma membrane (Barnich et al., 2005).  
 
The ability of the HEK293 Atg16L1-GFP & NOD2-HA cell line to respond to both starvation 
induced autophagy and NOD2-directed autophagy was tested and quantified by Imaris, to 
determine how suitable these cells were for analysis during autophagy. Both 10 μg/ml and 
20 μg/ml MDP were used, based on earlier papers (Clarke et al., 2008; Travassos et al., 
2010; Homer et al., 2010). The formation of autophagosomes was followed over 6 hours 
at the indicated time points, and the autophagosomes stained with LC3. The HEK293 
Atg16L1-GFP & NOD2-HA cell line was able to respond to starvation induced autophagy and 
NOD2 activation by generating Atg16L1 puncta and LC3 puncta (Fig 4.5). The LC3 puncta 
were quantified by Imaris, which showed that for starvation induced autophagy, LC3 puncta 
after 60 min starvation increased over 4 h, but then reduced slightly after 6 h (Fig 4.6). For 
treatment with 10 μg/ml MDP, an increase in LC3 puncta was seen after 30 min, and a 
small increase was only seen after 4 hrs (Fig 4.6). When cells were treated with 20 μg/ml 
MDP, a higher number of LC3 puncta were observed after 30 min compared to the 10 μg/ml 
MDP treatment. However, this level decreased and never reached the level obtained with 
treatment of cells with 10 μg/ml MDP for the rest of the time course, with the exception of 
the 90 min time point (Fig 4.6). Based on these results, the 10 μg/ml concentration was 
chosen for future experiments focussing on NOD2 activation in the context of autophagy, 
and the time points of 2h and 4h for both starvation induced and NOD2-directed autophagy 
were chosen as points of interest for future experiments. 
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Figure 4.3 The HEK293 Atg16L1-GFP episomal cell line is able to respond to autophagy induced by Torin1. The episomal cells were stained for WIPI2 (false 
colour cyan, Alexa 647) and LC3 (red Alexa 594) to mark autophagosomes. The nuclei were stained with DAPI. Cells were fixed with methanol and viewed by widefield 
fluorescence microscopy.Regions of interest highlighted with dashed boxes, co-localised autophagosomes indicated with arrows. Scale bars, 10 μm. 
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Figure 4.4 The HEK293 NOD2-HA episomal cell line is able to respond to MDP stimulation and activate autophagy. NOD2-HA was visualised by staining with 
HA (red Alexa 594) and autophagosomes by LC3 (green Alexa 488). Cells were fixed with methanol and viewed by widefield fluorescence microscopy. Scale bars, 10 μm. 
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4.3.5 Expression and retention of Atg16L1-GFP and NOD2-HA in 
episomal cell lines by Western blotting 
Antibiotic selection is the primary method used to maintain the expression of proteins 
encoded in the Atg16L1-GFP and NOD2-HA episomal vectors. However, removal of the 
selective antibiotic is required when transfecting other plasmids e.g. Mekk4-HA.  
To show that the episomal cells could retain the plasmids in the absence of the antibiotic 
(which has been reported by Sclimenti et al., 1998 and Yates et al., 1985), the selective 
antibiotic media was replaced with supplemented media for 1 or 3 days. This was the 
maximum length of time prior to cell lysis and subsequent immunoprecipitation experiment, 
hence why this time point was chosen. Lysates were collected and analysed by Western 
blotting. After three days without antibiotic selection Atg16L1-GFP could be detected in both 
episomal cell lines, and NOD2-HA could be detected in HEK293 Atg16L1-GFP NOD2-HA cells 
(Fig 4.7). This confirms that the episomal vectors are retained and expressed following the 
removal of selective antibiotics. 
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Figure 4.5 HEK293 Atg16L1-GFP & NOD2-HA cells are able to form autophagosomes in 
response to autophagy induction. Cells were cultured in HBSS (a) or supplemented media with 
MDP (b) and (c) at the specified concentration. Cells were fixed at the specified time point and 
stained for NOD2-HA (not shown) and LC3 (red Alexa 568). Atg16L1-GFP is in green, and the nuclei 
were stained with DAPI (blue). Regions of interest are highlighted with boxes, and arrows indicate 
Atg16L1 puncta that colocalise with LC3. Part (c) is continued on the next page. Scale bars, 10 μm. 
 
 
 
A 
B 
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Figure 4.5 (c) HEK293 Atg16L1-GFP & NOD2-HA cells are able to form autophagosomes 
in response to autophagy induction. Cells were cultured in supplemented media with MDP (c) 
at the specified concentration. Cells were fixed at the specified time point and stained for NOD2-HA 
(not shown) and LC3 (red Alexa 568). Atg16L1-GFP is in green, and the nuclei were stained with 
DAPI (blue). Regions of interest are highlighted with boxes, and arrows indicate Atg16L1 puncta that 
colocalise with LC3. Scale bars, 10 μm. 
 
 
  
 
C 
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Figure 4.6 Analysis of the HEK293 Atg16L1-GFP & NOD2-HA episomal cell time course. 
The images from the experiments in figure 4.5 were analysed by Imaris to determine the number of 
LC3 puncta per cell.  
 
 
 
Figure 4.7 Atg16L1-GFP and NOD2-HA are retained in HEK293 episomal cells after 
removal of selective antibiotics. 
Lysates from HEK293 Atg16L1-GFP and HEK293 Atg16L1-GFP & NOD2-HA episomal cells were 
analysed by SDS-PAGE and immunoblotting after being cultured without selective antibiotic for 0, 1 
or 3 days.  
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4.3.6 Verification of interaction between Atg16L1-GFP and Mekk4-
HA 
To confirm the results of the yeast-two-hybrid screen, a co-immunoprecipitation was carried 
out. For this the HEK293 Atg16L1-GFP episomal cell line was transfected with HA-tagged 
Mekk4 from Mus musculus. Atg16L1-GFP was immunoprecipitated from cell lysates with 
antibodies against GFP. Western blotting with antibodies specific for HA then confirmed the 
findings of the yeast-two-hybrid screen that Mekk4-HA was bound to Atg16L1-GFP (Fig. 
4.8). 
 
4.3.7 Atg16L1 binds Mekk4 during starvation induced autophagy, 
but does not localise to the autophagosome 
To further determine the functional role of this interaction, the effect of autophagy 
activation on the interaction between Mekk4 and Atg16L1 was investigated. Mekk4-HA was 
transfected into HEK293 Atg16L1-GFP episomal cells, which were cultured in nutrient rich 
conditions, or deprived of amino acids to induce autophagy, and a co-immunoprecipitation 
was carried out. As before, in the absence of autophagy, Mekk4 was bound to Atg16L1. 
When autophagy was induced through amino acid starvation in HBSS, Mekk4 remained 
bound to Atg16L1 (Fig. 4.9). Next, the cellular localisation of Mekk4 and Atg16L1 was 
observed, to determine whether Mekk4 translocates to the early autophagosome with 
Atg16L1. To study autophagy activation following starvation or NOD2 activation, Vero cells 
were used as they are able to form LC3 puncta in response to MDP. Vero cells were 
cotransfected with Mekk4-HA and Atg16L1-GFP, and autophagy induced by amino acid 
starvation or 10 μg/ml MDP. When cultured in nutrient rich conditions, both Atg16L1 and 
Mekk4 appeared diffuse in the cytoplasm and showed some co-localisation (Figure 4.10), 
indicating they are either bound, or that they may localise to the same subcellular structure 
within the cytosol, which could be the endoplasmic reticulum or cytoskeleton. When 
autophagy was induced by amino acid starvation or NOD2 activation through MDP, 
Atg16L1-GFP formed puncta, which were negative for Mekk4-HA. Some of the Atg16L1 
puncta did co-localise with LC3, confirming the presence of autophagosomes. However, 
there was still co-localisation between Mekk4-HA and Atg16L1-GFP in the cytoplasm during 
autophagy (Fig. 4.10). This suggests that the Atg16L1:Mekk4 complex does not localise to 
autophagosomes and may not directly contribute towards the autophagosome 
development, though Mekk4 may bind the cytosolic fraction of Atg16L1 that does not take 
part in autophagy.   
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Figure 4.8 Atg16L1-GFP binds Mekk4-HA in HEK293 cells 
Mekk4-HA was transiently expressed in HEK293 Atg16L1-GFP episomal cells, the lysate collected and 
the complex immunoprecipitated with anti GFP antibody. The proteins were separated by SDS-PAGE. 
Mekk4-HA binding was analysed by immunoblotting with antibodies against GFP and HA. Mekk4-HA 
was shown to bind Atg16L1-GFP (highlighted with blue boxes). 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot. 
Figure 4.9 Atg16L1-GFP binds Mekk4-HA during starvation induced autophagy in 
HEK293 cells 
Mekk4-HA was transiently expressed in HEK293 Atg16L1-GFP episomal cells, which were cultured in 
nutrient rich media or HBSS for 2h to induce autophagy. The lysate was collected and the complex 
immunoprecipitated with anti GFP antibody. The proteins were separated by SDS-PAGE. Mekk4-HA 
binding was analysed by immunoblotting with antibodies against GFP and HA. Mekk4-HA was shown 
to bind Atg16L1-GFP after activation of autophagy by starvation (highlighted with blue boxes). 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot. 
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Figure 4.10 Subcellular distribution of Atg16L1-GFP and HA-MEKK4 in Vero cells 
Atg16L1-GFP and Mekk4-HA (far red Alexa 647, false coloured cyan) were co-expressed in HeLa cells to observe their subcellular localisation. Both Atg16L1 and MEKK4 show 
an even cytosolic distribution and are absent from the nucleus. In nutrient rich conditions, there is colocalisation between Atg16L1-GFP and Mekk4-HA in the cytosol. 
Activation of autophagy by HBSS or MDP results in Atg16L1-GFP and LC3 positive puncta (red Alexa 594) which are negative for Mekk4-HA. Scale bars 10 μm 
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  4.3.8 Mekk4 binds the linker region of Atg16L1 
The results of the yeast-two-hybrid screen do not detail where Mekk4 binds to Atg16L1. 
Understanding the regions of Atg16L1 required for Mekk4 binding could help elucidate the 
function of the Atg16L1-Mekk4 interaction. To investigate this, the Atg16L1 deletion 
mutants CCD-GFP, CCD+L-GFP, L+WD40-GFP or WD40-GFP (chapter 3; figure 3.2 and 3.4 
for details) were co-transfected with Mekk4-HA in HEK293 cells. Reciprocal 
immunoprecipitations were carried out with either Mekk4-HA or GFP tagged Atg16L1 
deletion constructs precipitated from the lysates, and binding assayed by Western blotting. 
The CCD+L-GFP but not the CCD-GFP domain was able to bind to Mekk4-HA (Fig. 4.11 and 
4.12). Similarly, the WD40-GFP alone was unable to bind Mekk4-HA, but addition of the 
linker region to the WD40 domain enabled L+WD40-GFP to bind Mekk4-HA (Fig. 4.11 and 
4.12). Though the interactions were weak, as suggested by the intensity of the bands in 
Fig 4.11 and 4.12, they were consistent. This suggests that the linker region of Atg16L1 is 
responsible for the binding of Atg16L1 to Mekk4. To see whether the Atg16L1 binding motif 
identified by Boada-Romero et al (2013) was present in Mekk4, the motif ([YW]-X(2,6)-[ED]-
X(2,6)-[YWF]-X2-L) was run against multiple Mekk4 sequences across different species using 
the Prosite algorithm. The results of this search confirmed the presence of the motif in the 
N-terminus of Mekk4, and the conservation of this motif among higher eukaryotes (Fig 
4.13). 
 
4.3.9 The Atg16L1 mutants T316A and S305A are able to bind 
Mekk4 
The CD risk associated mutation T316A and the putative phosphorylation defective S305A 
mutations lie within the linker region of Atg16L1. To determine whether these mutations 
affected the interaction between Atg16L1 and Mekk4, Atg16L1-GFP, Atg16L1-T316A-GFP 
or Atg16L1-S305A-GFP (chapter 3; figure 3.2 and 3.6 for details) were co-expressed with 
Mekk4-HA in HEK293 cells. Mekk4-HA was immunoprecipitated from the lysate and binding 
of Atg16L1 mutants assayed by Western blotting. Both the CD associated T316A mutant 
and the S305A mutant retained the ability to bind Mekk4-HA (Fig. 4.14), indicating that 
these residues are not essential for the interaction between Atg16L1 and Mekk4. However, 
further reciprocal immunoprecipitations are required to confirm that these residues are not 
required for the interaction with Mekk4, as the quality of the interaction in Fig 4.14 was not 
to a high standard. 
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Figure 4.11 The CCD+L of Atg16L1 binds Mekk4 
The CCD+L-GFP or WD40-GFP domains of Atg16L1 were transiently co-expressed with Mekk4-HA in 
HEK293 cells. The lysate was collected and the complex immunoprecipitated with anti HA antibody. 
The proteins were separated by SDS-PAGE. Domain binding was analysed by immunoblotting with 
antibodies against GFP and HA. The CCD+L was shown to bind Mekk4-HA (highlighted with blue 
boxes), and the WD40 domain was unable to bind Mekk4. 
 IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot. 
 
 
Figure 4.12 The L+WD40 of Atg16L1 binds Mekk4 
The CCD-GFP or L+WD40-GFP domains of Atg16L1 were transiently co-expressed with Mekk4-HA in 
HEK293 cells. The lysate was collected and the complex immunoprecipitated with anti GFP antibody. 
The proteins were separated by SDS-PAGE. Domain binding was analysed by immunoblotting with 
antibodies against GFP and HA. The L+WD40 was shown to bind Mekk4-HA (highlighted with blue 
boxes), and the CCD domain was unable to bind Mekk4. A crosslinker was used to stabilise this 
interaction. 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot. 
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Figure 4.13 Conservation of the Atg16L1 binding motif in Mekk4 
The amino acid sequences of Mekk4 from various higher eukaryotes were analysed using the Prosite 
Scan algorithm, to identify Atg16L1 binding motifs. In bold and red typeface are the residues 
consistent with the Atg16L1 binding motif published by Boada-Romero et al (2013). This shows 
evolutionary conservation of the Atg16L1 binding motif in this region of Mekk4. 
 
 
Figure 4.14 The Atg16L1 mutants retain the ability to bind Mekk4. 
The Atg16L1-GFP, Atg16L1-T316A-GFP or Atg16L1-S305A-GFP constructs were transiently co-
expressed with Mekk4-HA in HEK293 cells. The lysate was collected and the complex 
immunoprecipitated with anti HA antibody. The proteins were separated by SDS-PAGE. Atg16L1 
binding was analysed by immunoblotting with antibodies against GFP and HA. The wild type and 
mutant Atg16L1 constructs were shown to bind Mekk4-HA (highlighted with blue boxes). 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot.  
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4.3.10 The kinase dead mutant of Mekk4-HA cannot bind Atg16L1-
GFP 
The kinase activity of MEKK4 is vital for phosphorylation and activation of substrates 
involved in the MAPK signalling pathways i.e. MAP2Ks. However, not all proteins that bind 
MEKK4 require kinase activity, including RIP2 (Clark et al, 2008). To determine whether the 
interaction between Mekk4-HA and Atg16L1-GFP required the kinase activity of Mekk4, a 
kinase dead mutant of Mekk4-HA, in which lysine 1361 is mutated to methionine (Gerwins 
et al., 1997) was obtained from Addgene. The kinase dead Mekk4-HA was co-expressed 
with Atg16L1-GFP in HEK293 cells. Atg16L1-GFP was immunoprecipitated from the lysate 
and kinase dead Mekk4-HA binding assayed by SDS-PAGE and Western blotting. The kinase 
dead Mekk4-HA did not bind Atg16L1-GFP (Fig 4.15), indicating that the kinase activity of 
MEKK4 is required to allow binding of Atg16L1. 
 
4.3.11 NOD2-HA binds Atg16L1-GFP in the absence of autophagy 
activation and after NOD2 activation with MDP 
Previous immunoprecipitation results in this chapter have investigated the interaction 
between Atg16L1 and Mekk4 in the absence of NOD2. As Mekk4 is a potential candidate 
for crosstalk between the autophagy and NOD signalling pathways, and previous research 
has demonstrated an interaction between Atg16L1 and NOD2 (Travassos et al., 2010), 
NOD2 expression and activation could play an essential role. Therefore, a possible 
interaction between Atg16L1 and NOD2 in the episomal HEK293 cell line had to be 
established.  The dual episomal HEK293 Atg16L1-GFP & NOD2-HA cells were cultured in 
supplemented medium or medium with 10 μg/ml MDP for 4 h. Atg16L1-GFP was 
immunoprecipitated from the lysates and NOD2-HA binding assayed by Western blotting. 
In both conditions, NOD2-HA bound Atg16L1-GFP (Fig 4.16). This confirmed the interaction 
published by Travassos et al., (2010) and demonstrated that the interaction between NOD2 
and Atg16L1 occurs without MDP activation of NOD2 in the episomal cells. 
 
  
  Chapter 4 
 
 
120 
 
Figure 4.15 The kinase dead Mekk4 does not bind Atg16L1-GFP 
Kinase dead Mekk4-HA was transiently expressed in HEK293 Atg16L1-GFP episomal cells. The cells 
were cultured in nutrient rich media or HBSS to induced autophagy, the lysate collected and 
immunoprecipitation carried out with an anti-GFP antibody. The proteins were separated by SDS-
PAGE., followed by immunoblotting with antibodies against GFP and HA. The kinase dead Mekk4 did 
not co-precipitate with Atg16L1 (highlighted with blue boxes and asterisks). 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot. 
 
 
Figure 4.16 NOD2 binds Atg16L1 in HEK293 cells  
HEK293 Atg16L1-GFP & NOD2-HA episomal cells were cultured in nutrient rich media or media with 
the NOD2 agonist MDP, to activate NOD2 signalling and NOD2-directed autophagy. The lysates were 
collected and immunoprecipitation carried out with an anti-GFP antibody. The proteins were 
separated by SDS-PAGE. NOD2 binding was analysed by immunoblotting with antibodies against GFP 
and HA. NOD2 was bound to Atg16L1 in the absence of MDP stimulation and following MDP 
stimulation (highlighted with blue boxes). 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot.  
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4.3.12 Mekk4 dissociates from Atg16L1 following NOD2 activation 
in HEK293 episomal cells 
So far, the immunoprecipitation results have shown that canonical autophagy does not 
affect the interaction between Atg16L1 and Mekk4 in episomal cells. To determine whether 
the activation of NOD-directed autophagy through MDP would alter the interaction between 
Atg16L1 and Mekk4, HEK293 Atg16L1-GFP & NOD2-HA episomal cells were transfected with 
Mekk4-HA. The cells were cultured in supplemented media, or in media with 10 μg/ml MDP 
for 4 h to activate NOD2 directed autophagy. Atg16L1-GFP was immunoprecipitated from 
the lysates with antibodies against GFP and Mekk4-HA and NOD2-HA binding assayed by 
Western blotting with antibodies specific for HA. In the absence of NOD2 activation, 
Atg16L1-GFP precipitated Mekk4-HA and NOD2-HA (Fig 4.17). This is probably not within 
the same complex, but likely a result of pulling down separate Atg16L1-GFP hetero-dimeric 
complexes. Following activation of NOD2, Atg16L1-GFP remained bound to NOD2-HA, but 
Mekk4-HA dissociated from Atg16L1-GFP (Fig. 4.17). This result indicates that the activation 
of NOD2 signalling leads to the dissociation of Atg16L1 and MEKK4 in the episomal cell 
model.  
 
4.3.13 Confirmation of the interaction of endogenous Atg16L1 and 
Mekk4  
The characterisation of the interaction between Mekk4 and Atg16L1 has so far been carried 
out using epitope tagged proteins in episomal and overexpression models. To ensure that 
the interaction was not an artefact caused by overexpression, the interaction between 
endogenous Atg16L1 and Mekk4 was validated using two different cell lines. HEK293 cells 
were used to characterise the human endogenous proteins, and Raw 264.7 cells were 
chosen to investigate the murine endogenous proteins. Additionally, the Raw 264.7 cell line 
are a mouse macrophage cell line which respond to MDP by activating NOD2 signalling 
(Clark et al., 2008). To validate the interaction in a human cell line, HEK293 cells were 
cultured in nutrient rich medium or HBSS for 2 h to induce autophagy. ATG16L1 was 
immunoprecipitated from the lysate and MEKK4 binding assayed by Western blotting. In 
nutrient rich conditions and following the activation of autophagy, ATG16L1 bound MEKK4, 
confirming the earlier results (Fig. 4.18). This was not a strong interaction, and the results 
were not as convincing as those in cells overexpressing epitope-tagged proteins. A 
crosslinker was used to stabilise the interaction between ATG16L1 and MEKK4 prior to cell 
lysis, which indicates that the interaction may be low affinity or transient. The DSP 
(Dithiobis[succinimidyl propionate]) crosslinker was used for intracellular conjugation of 
proteins prior to cell lysis, to preserve weak interactions. This crosslinker has been used 
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with similar effect to study interactions between Atg16L1 and FIP200 (Nishimura et al., 
2013) and Atg16L1 and WIPI2 (Dooley et al., 2014).  
 
To validate the interaction in the mouse macrophage cell line in the context of Nod2 
expression, Raw 264.7 cells were cultured in supplemented medium, HBSS for 2 h or MDP 
10 μg/ml for 4h. Mekk4 was immunoprecipitated from the lysate and Atg16L1 binding 
assayed by SDS-PAGE and Western blotting. In the absence of autophagy activation, Mekk4 
was bound to Atg16L1 (Fig 4.19). Following activation of canonical autophagy by amino 
acid starvation there was a small decrease in the binding between Mekk4 and Atg16L1. A 
similar decrease in binding was also seen in cells where Nod2 was activated by MDP (Fig 
4.20). This decrease in binding was difficult to quantify and could be due to background 
noise in the assay. However, if accurate this result indicates that the expression and 
activation of endogenous Nod2 in a specialised immune cell affects the interaction between 
Atg16L1 and Mekk4 during both canonical and selective autophagy, leading to a reduction 
in binding. 
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 Figure 4.17 Mekk4-HA dissociates from Atg16L1-GFP following activation of NOD2 in 
HEK293 cells 
Mekk4-HA was transiently expressed in HEK293 Atg16L1-GFP & NOD2-HA episomal cells, which were 
cultured in nutrient rich media or media with the NOD2 agonist MDP. Lysates were collected and 
immunoprecipitation carried out with an anti-GFP antibody. Mekk4 and NOD2 binding were analysed 
by immunoblotting with antibodies against HA and GFP. Mekk4 was bound to Atg16L1 in the absence 
of NOD2 activation (highlighted with blue boxes). When NOD2 was stimulated with MDP, Mekk4 
dissociated from Atg16L1 (highlighted with asterisk and blue boxes). 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot. 
 
Figure 4.18 Endogenous Atg16L1 and Mekk4 proteins interact in HEK293 cells 
HEK293 cells were cultured in nutrient rich media or HBSS to induce autophagy. The lysates were 
collected and an immunoprecipitation carried out with an anti ATG16L1 antibody. The proteins were 
separated by SDS-PAGE. MEKK4 binding was analysed by immunoblotting with anti MEKK4 and anti 
ATG16L1 antibodies. In nutrient rich conditions and following activation of autophagy, the 
endogenous MEKK4 bound ATG16L1 (highlighted with blue boxes). 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot. 
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Figure 4.19 Endogenous Atg16L1 and Mekk4 interact in Raw 264.7 cells 
Raw 264.7 cells were cultured in nutrient rich media, HBSS to induce autophagy, media with the 
Nod2 agonist MDP to induce Nod2-directed autophagy. The lysates were collected and 
immunoprecipitated carried out with an anti Mekk4 antibody. The proteins were separated by SDS-
PAGE. Atg16L1 binding was analysed by immunoblotting with anti Atg16L1 and anti Mekk4 
antibodies. In nutrient rich conditions, the endogenous Atg16L1 bound Mekk4. Following starvation 
induced autophagy and Nod2-directed autophagy, there was a decrease in Atg16L1 binding to Mekk4 
(highlighted with blue boxes). 
IP = immunoprecipitation. TL = total lysate. NB = non bound protein. IB = immunoblot. 
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4.4 Chapter Discussion 
The results of a yeast-two-hybrid screen identified a novel interaction between Atg16L1 and 
Mekk4. Co-immunoprecipitation studies carried out in this project confirmed the interaction 
between Atg16L1 and Mekk4, validating the results of the yeast-two-hybrid screen. The 
Atg16L1 deletion constructs, CCD-GFP and WD40-GFP failed to co-precipitate with Mekk4, 
whereas the constructs CCD+L-GFP and L+WD40-GFP were able to co-precipitate with 
Mekk4, suggesting that the linker region of Atg16L1 is responsible for binding Mekk4. 
Furthermore, the CD-associated Atg16L1 mutant T316A and the serine phosphorylation 
deficient Atg16L1 mutant S305A retained the ability to bind Mekk4. Both of these mutations 
reside in the linker region of Atg16L1 (Fig 4.20). 
 
The presence of a putative Atg16L1 binding motif within the N-terminus of Mekk4 raises 
the possibility that Mekk4 and Atg16L1 interact through the same mechanism as other 
proteins that contain this motif, including NOD1, NOD2, TLR2 and TMEM59 (Boada-Romero 
et al., 2013). These proteins play a role in the promotion or activation of autophagy in 
response to pathogen invasion. The Atg16L1 binding motif was originally identified by 
Boada-Romero et al (2013) in TMEM59, where deletion constructs of Atg16L1 showed that 
the region of interaction was in the WD40 domain. This appears to contradict the findings 
in this chapter, that Mekk4 binds the linker region but not the WD40 domain, despite 
containing a conserved Atg16L1 binding motif. However, this discrepancy could be caused 
by two reasons; firstly the different species of Atg16L1 used (human β isoform by Boada-
Romero et al., and mouse γ isoform in this thesis), and secondly the precise regions that 
were deleted in each construct. When each species isoform was aligned, and the regions 
for the respective deletion constructs mapped, a 10 amino acid discrepancy was revealed 
between the Boada-Romero et al. ΔWD40 construct and the equivalent CCD+L construct 
used in this thesis (Appendix 2). It would be appealing to suggest that this 10 amino acid 
region in Atg16L1 could be responsible for binding proteins containing the Atg16L1 binding 
motif, but without mutational analysis of the Atg16L1 binding motif in Mekk4, there is little 
evidence for this argument (Fig. 4.20). However, future work could focus on mutating the 
Atg16L1 binding motif in Mekk4, to determine if this region is responsible for Mekk4 binding 
to Atg16L1. Additionally, the 10 amino acid region within the linker of Atg16L1 could be 
mutated and Atg16L1 binding motif containing proteins could be assayed for binding to this 
region. As the Atg16L1 binding motif is a novel motif, further characterisation is needed to 
determine its precise mechanism within autophagy. 
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The results also demonstrated that a kinase dead Mekk4 lost the ability to bind Atg16L1. If 
the site of Atg16L1 binding resides within the N-terminus of Mekk4, then this may explain 
why Atg16L1 cannot bind kinase dead Mekk4. Fully activated Mekk4 requires alleviation of 
autoinhibition, allowing Mekk4 to change from a closed to an open conformation (Fig 4.21). 
Overexpression of a kinase dead Mekk4 results in it remaining in a closed conformation, 
due to its lack of catalytic activity (Miyake et al., 2007). Therefore, the region where 
Atg16L1 binds on Mekk4 could be masked when it is in a closed conformation, and Mekk4 
may need to be activated and in an open conformation to bind Atg16L1. Indeed, the 
Atg16L1 binding motif lies within the autoinhibitory domain of human and mouse Mekk4 
(Fig. 4.22). As kinase-dead Mekk4 lacks any catalytic activity, alleviation autoinhibition 
would not occur and the protein would remain in closed conformation and never dimerise 
and become fully activated (Miyake et al., 2007), with the Atg16L1 binding motif revealed 
only when MEKK4 is in an open confirmation (Fig 4.23). The best characterised activators 
of Mekk4 are the stress inducible GADD45 family of proteins. These proteins interact with 
Mekk4 by binding the N-terminus and alleviating auto-inhibition, allowing the catalytic 
kinase domain to become fully activated and phosphorylate substrate proteins (Figure 4.21) 
(Mita et al., 2002, Miyake et al., 2007). Interestingly, GADD45β expression is up regulated 
by cellular stress-induced inflammatory cytokines and LPS (Liebermann et al., 2002; Zhang 
et al., 2005). A point of future research would be whether Mekk4 activators are required 
for the interaction between Atg16L1 and Mekk4, and whether their expression can lead to 
an up regulation of autophagy. 
 
This raises the issue of whether Atg16L1 is a substrate of Mekk4. A mass spec analysis of 
phosphorylated proteins extracted from mouse liver identified a serine phosphorylation in 
Atg16L1 (Villén et al., 2007). This serine residue lies 11 amino acids upstream of the 
equivalent site of the T316A mutation in murine Atg16L1. Mekk4 is described as a ser/thr 
kinase; its substrate proteins Mkk3/6 in the MAPK pathways are phosphorylated on 
serine/threonine residues within their activation loop, and autophosphorylation of the 
human MEKK4 occurs on Thr1493 (Miyake et al., 2007). The conditions that cause Atg16L1 
to become phosphorylated, and the consequences of this modification are unknown. 
However, the evidence in this report that Atg16L1 only binds activated Mekk4 suggests that 
Mekk4 could be responsible for serine phosphorylation of Atg16L1. Additionally, it would be 
equally attractive to suggest that the threonine residue at the T316A site is also 
phosphorylated by Mekk4, and that this somehow promotes or regulates Atg16L1 activity. 
Whilst both Atg16L1 mutants were able to bind Mekk4, the  
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Figure 4.20 Schematic showing regions of Atg16L1 required for Mekk4 binding 
The linker region of Atg16L1 is required for Mekk4 binding (red line). Mutation of the S305 and CD 
associated T316 residue had no effect on Mekk4 binding. Alignment between Atg16L1 WD40 
construct used in this thesis and ATG16L1 WD40 construct used by Boada-Romero et al (2013) 
reveals a 10 amino acid region that may hold residues key for binding of proteins that contain 
Atg16L1 binding motif. Conserved residues within this region are shown in bold blue underlined 
typeface. 
Figure 4.21 Activation of MEKK4 by GADD45 binding 
GADD45 is an activator of MEKK4 signalling. When inactive, MEKK4 is in a closed conformation, 
with the auto-inhibitory domain (AID) blocking the kinase domain. When expressed, GADD45 binds 
to its N-terminal binding domain, inducing a conformational change in MEKK4 to an open 
conformation. This allows MEKK4 to dimerise, transphosphorylate on Thr -1493 and become fully 
activated, allowing it to phosphorylate its substrate protein MKK6 (taken from Miyake et al., 2007). 
AID = Autoinhibitory domain. KD = kinase domain. 
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Figure 4.22 Schematic showing regions of Mekk4 required for Atg16L1 binding 
The kinase activity of Mekk4 was necessary for Atg16L1 binding. The Atg16L1 binding motif lies in 
the autoinhibitory domain of Mekk4. Numbering refers to amino acid sequence of Mus musculus 
Mekk4. 
AID = autoinhibitory domain. KD = kinase domain 
 
 
 
Figure 4.23 Schematic representation of the site of the Atg16L1 binding motif in Mekk4 
in closed and open conformations 
When Mekk4 is in closed conformation the autoinhibitory domain blocks the kinase domain. This 
could mask the site of the Atg16L1 binding motif and prevent binding of Atg16L1. When Mekk4 is 
in open conformation the autoinhibitory domain releases the kinase domain, which would reveal 
the Atg16L1 binding motif. 
AID = Autoinhibitory domain. KD = kinase domain. ABM = Atg16L1 binding motif.  
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phosphorylation status of these residues in response to autophagy activation was not 
investigated, as phospho-specific threonine and serine antibodies did not produce 
consistent results in preliminary tests. Therefore, the phosphorylation of Atg16L1 by Mekk4 
on these residues cannot be ruled out. 
The nature of the interaction between Mekk4 and Atg16L1 was also determined during the 
activation of canonical and NOD2 directed autophagy. In cells that do not express NOD2, 
Atg16L1 co-precipitated with Mekk4 during starvation induced autophagy. In cells where 
NOD2 was expressed, Mekk4 co-precipitated with Atg16L1 in the absence of autophagy, 
but when autophagy was induced by MDP, or starvation (macrophage cells with 
endogenous Nod2 expression only), there was a weakened affinity between Atg16L1 and 
Mekk4. This suggests that expression of NOD2 alters the dynamic of the interaction 
between Atg16L1 and Mekk4. This could be related to the interactions between Atg16L1 
and NOD2 (Travassos et al., 2010), and Mekk4 and RIP2 (Clark et al., 2008). In the absence 
of NOD2 stimulation, MEKK4 binds and sequesters RIP2 from the NOD signalling pathway. 
By outcompeting NOD2 for RIP2 binding, MEKK4 prevents the NOD2-RIP2 complex forming, 
which has been shown to have a specific inhibitory effect on NF-κB activity (Clark et al., 
2008). When NOD2 is activated the ability of MEKK4 to bind RIP2 is abolished. The role of 
this interaction in autophagy is unclear.  
 
Recently, the assembly of the NOD2-RIP2 complex was shown to be negatively regulated 
by ATG16L1 (Sorbara et al., 2013). This intricate crosstalk between components of the 
autophagy pathway and NOD signalling pathways converges around ATG16L1. It would be 
attractive to suggest that MEKK4 is also able to regulate Atg16L1 activity in selective 
autophagy as well, in addition to its involvement in regulating NOD2 signalling. Both 
ATG16L1 and NOD2 mutations have been associated with Crohn’s disease (Hampe et al., 
2007; Ogura et al., 2001), with defects in bacterial handling and inefficient targeted 
activation of autophagy against pathogens thought to contribute towards the 
pathophysiology of the disease. Interestingly, a study has shown that Crohn’s disease 
patients had a reduction in MEKK4 expression, which led to defective IL-1A expression (van 
der Pouw Kraan et al., 2012). The reduction in MEKK4 expression could be explained by 
the enhanced degradation of the CD associated ATG16L1 mutation by caspase 3 (Murthy 
et al., 2014). Degradation of ATG16L1 may lead to a feedback mechanism in the cell 
resulting in reduced transcription and expression of MEKK4. Additionally, MEKK4 has been 
linked to the caspase 8/caspase 3 apoptotic signalling. The TNF-related apoptosis-inducing 
ligand, TRAIL activates apoptosis through activation of caspase 8, which leads to cleavage 
and activation of caspase 3 (Falschlehner et al., 2007). Treatment of a human prostate 
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adenocarcinoma cell line with TRAIL induced caspase 8 activation, downstream p38 and 
JNK activation through MEKK4 (Sun et al., 2011). This further strengthens the argument 
for the regulation of Atg16L1 in the NOD2: autophagy signalling axis by MEKK4, and 
highlights an area of future research focus. 
The subcellular localisation of Mekk4 and Atg16L1 during both canonical and NOD2-directed 
autophagy indicates that Mekk4 remains cytosolic during the activation of autophagy, whilst 
Atg16L1 localises to the autophagosome. Therefore, the interaction does not appear at the 
autophagosomal membrane, and may not be required for proper localisation of Atg16L1 
during autophagy. When combined with the immunoprecipitation results, this suggests that 
Mekk4 is bound to a subcellular pool of Atg16L1 with a portion released to the 
autophagosome. It could be that the interaction between Atg16L1 and Mekk4 is a transient 
interaction, similar to that of ATG16L1 and FIP200, or ATG16L1 and WIPI2, as indicated by 
the need to use a cross-linker to stabilise the interaction between endogenous proteins 
(Dooley et al., 2014; Nishimura et al., 2013). On the other hand, the interaction between 
Atg16L1 and Mekk4 may be a sequestration model, analogous to the MEKK4-RIP2 
interaction (Clark et al., 2008). As this is the early stages of dissecting out the interaction, 
there is not enough evidence to conclude which of these models it is. 
 
The evidence presented in this chapter establishes a novel interaction between Atg16L1 
and Mekk4, which is dynamically affected by the expression of NOD2 and activation of 
autophagy. As the catalytic activity of Mekk4 is required for the interaction, there is the 
prospect of this interaction playing a key role in the regulation of autophagy. The function 
of Mekk4 in autophagy is explored in the next chapter.
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Chapter 5: Function of MEKK4 in the autophagy pathway 
 
 5.1 Chapter Aims 
The aims of this chapter are to investigate the role of MEKK4 in the autophagy pathway 
through gene silencing. The effects on autophagy are determined by measuring processing 
of LC3, degradation of p62, and observing the cellular distribution of autophagosome 
markers. MEKK4 knockdown is achieved first through the use of short interfering RNAs 
(siRNAs), and then a number of cell lines are developed and characterised using 
CRISPR/Cas9 mediated genome editing to knockout MEKK4 gene expression. The proteins 
of interest are MEKK4, LC3 and p62. 
 
 5.2 Introduction 
In the previous chapter, Mekk4 was identified and characterised as a novel binding partner 
of Atg16L1. Though the results have defined the domains and conditions required for the 
interaction, they do not identify the functional consequence of this interaction in the 
autophagy pathway.  
 
Mekk4 was originally identified from the yeast-two-hybrid screen due to its role in the 
negative regulation of NOD2 signalling (Clark et al., 2008). Existing research has established 
an interaction between NOD2 and Atg16L1, with activation of NOD2 shown to drive 
autophagy (Travassos et al., 2010; Homer et al., 2010; Cooney et al., 2010). The NOD2-
Atg16L1 axis represents an important arm of the innate immune system, and mutation of 
either of these genes leads to defective microbial handling and failure to target bacteria to 
autophagosomes in tissue culture (Kuballa et al., 2008; Travassos et al., 2010). Therefore, 
the interaction between Atg16L1 and Mekk4 may function in regulating the crosstalk 
between the autophagy and NOD signalling pathways. Silencing of MEKK4 has been shown 
to inhibit NOD2 mediated autophagy, leading to an increase in the survival of Salmonella in 
infected cells (Homer et al., 2012).  
The family of GADD45 proteins that activate MEKK4 are intricately linked to immunity. The 
expression of GADD45 can be induced by inflammatory cytokines and the bacterial outer-
membrane component lipopolysaccharide (LPS) (Liebermann et al., 2002; Zhang et al., 
2005). Additionally, GADD45 proteins are important for the function of granulocytes and 
macrophages (Gupta et al., 2006). In relation to autophagy, GADD45 and MEKK4 have been 
linked to the regulation of autophagy through p38 mediated phosphorylation of Atg5 (Keil 
et al., 2013). This modification of Atg5 results in the inhibition of autophagy, linking MEKK4 
to the regulation of autophagy once more. 
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However, the effect of silencing MEKK4 on the autophagy pathway has not been well 
characterised. Any autophagy specific phenotype arising from gene knockdown could be 
explained by the interaction between Atg16L1 and MEKK4. Two methods which are used to 
mediate gene silencing are RNA interference with siRNAs, and genome editing using the 
CRISPR/Cas9 system. 
RNA interference as a tool for gene silencing was first described in C.elegans in 1998 (Fire 
and Mello, 1998). It has since been developed and widely accepted as valuable technology 
in mammalian systems. Short interfering RNA duplexes of 21bp length are designed to 
complement the mRNA of the target gene. Upon entering the cell, siRNAs will be 
incorporated into the RNAi induced silencing complex (RISC), which guides siRNAs to the 
target RNA sequence (Nykänen et al., 2001). The siRNA duplex will then unwind, and RISC 
directs the antisense siRNA to the complimentary mRNA sequence, where it is subsequently 
degraded by endo and exonucleases (Martinez et al., 2002). Gene silencing using this 
technique relies on careful design of the siRNA target sequence, to ensure there are no off 
target effects. The reliability of siRNA mediated gene knockdown relies on both transfection 
efficiency of the siRNAs and the specificity of the siRNA target sequence. The target gene 
may not achieve 100% knockdown, and it is possible that off-target effects could cause 
false-positive results. Problems with transfection efficiency can also lead to reliability issues 
with the experiments. Therefore, this technique lends itself well to an initial screening of 
whether knockdown of MEKK4 has an effect on autophagy, but is not a long term solution 
for studying the effects of gene knockout. For a reliable and permanent knockout of gene 
expression, the genome editing tool CRISPR/Cas9 can be used. 
CRISPR/Cas9 is a microbial adaptive immune system that uses an RNA guided nuclease 
(Cas9) to cleave DNA at a specified locus (Barrangou et al., 2007; Garneau et al., 2010; 
Ran et al., 2013; Hsu et al., 2014). For two decades, the function of what is now known as 
the CRISPR locus (clustered regularly interspaced short palindromic repeats) was studied. 
The first report of CRISPR clustered repeats was in E.coli (Ishino et al., 1987). These 
clustered repeat elements were present in >40% of sequenced bacteria and 90% of archae 
(Mojica et al., 2000). Subsequently, several clusters of conserved genes adjacent to the 
CRISPR repeats were identified as CRISPR associated (Cas) genes (Jansen et al., 2002). 
The key discovery came when analysis identified that regions of the CRISPR repeats were 
phage or extrachromosomal sequences (Mokica et al., 2005; Pourcel et al., 2005). Following 
invasion by a phage, Cas genes are rapidly transcribed and translated into proteins, and 
CRISPR arrays transcribed as single RNA, before processing into shorter CRISPR RNAs 
(crRNAs). These crRNAs direct the processing and degradation of the phage by the Cas 
enzymes (Brouns et al., 2008). Soon, this system was engineered for successful genome 
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editing in mammalian cells. Coexpression of Cas9 from Streptococcus thermophilus (Cong 
et al., 2013) or S.pyogenes (Cong et al., 2013; Mali et al., 2013) with single guide RNAs 
targeted against a genomic locus was able to direct a double stranded break (DSB) within 
the genome. To design a guide RNA against a genomic target, a 20 nt sequence must be 
identified which must immediately precede a 5’ – NGG sequence, known as a protospacer 
adjacent motif (PAM) (Fig 5.1). Cas9 from S.pyogenes will make a blunt cut between the 
17th and 18th bases in the target sequence. This subsequently stimulates the host DNA 
repair mechanisms; the error prone non-homologous end joining (NHEJ) where in the 
absence of a repair template DNA is religated with insertion/deletion (indel) mutations, or 
the more precise homology directed repair (HDR), where a repair template is introduced 
(Fig 5.2). Should an indel occur within a coding exon, this can lead to frameshift mutations 
and premature stop codons, making this a useful technique for generating gene knockouts 
(Ran et al., 2013). This system has been made widely available and is now used by 
thousands of laboratories in a variety of cell types and organisms (Sander and Joung., 
2014), including humans, mice and C.elegans (Ran et al., 2013; Cong et al., 2013; Malie et 
al., 2013; Wang et al., 2013; Friedland et al., 2013). 
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Figure 5.1 Schematic of the RNA guided Cas9 nuclease. The 20 nt guide sequence 
(blue) plus scaffold (red) acts as the single guide RNA (sgRNA) The guide sequence pairs  
with the target DNA (blue bar) via Watson-Crick base pairing, upstream of the required 
NGG protospacer adjacent motif (PAM; pink). Cas9 is directed to the genomic DNA by the 
sgRNA and generates a double stranded break 3bp upstream of the PAM (red triangle). 
Modified from Ran et al., 2013. 
 
Figure 5.2 DNA damage repair in the CRISPR Cas9 system; NHEJ and HDR. 
Double stranded breaks induced by Cas9 can be repaired via the NHEJ pathway or by HDR. 
When the ends of a DSB are repaired by the error prone NHEJ, random insertions/deletions 
(indels) can result at the site of repair. This leads to frameshift mutations and premature 
stop codons. The HDR pathway can be utilised for precise gene editing, when a repair 
template is present e.g. in the form of a plasmid. Modified from Ran et al., 2013. 
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 5.3 Results 
 
  5.3.1 siRNA mediated silencing of MEKK4 
 
5.3.1.1 Screening of siRNA oligoprobes identifies s8675 as 
sufficient to silence MEKK4 expression in HEK293 GFP-LC3 
cells 
To ascertain whether MEKK4 played a role in autophagy, siRNA probes were used to 
knockdown expression in HEK293 GFP-LC3 cells. This cell line was chosen for ease of 
imaging GFP tagged LC3. Two siRNAs (s8673 and s8675) were transfected into cells at 
different concentrations to determine which probe would effectively knock down MEKK4 
expression. A scrambled siRNA was used as a negative control. The lysates were collected 
and analysed by Western blot. At a concentration of 50 nM, both s8673 and s8675 could 
efficiently silence MEKK4 expression in HEK293 GFP-LC3 cells (Fig 5.3a, b). Both of these 
siRNAs were used in tandems in latter experiments to silence MEKK4 expression. 
 
5.3.1.2 Silencing MEKK4 reduces LC3 conversion during 
starvation induced autophagy in HEK293 GFP-LC3 cells 
Having identified suitable siRNA probes, the role of MEKK4 could be examined during 
starvation induced autophagy. MEKK4 was silenced in HEK293 LC3-GFP cells, and HBSS 
starved over 6 hours. The lysates were collected and the conversion of LC3 I to LC3 II 
analysed by Western blot. Compared to the scrambled control, MEKK4 silenced cells showed 
a loss of LC3 II conversion, as indicated by decreased turnover of LC3 throughout the 6 
hour time course (Fig. 5.4 a, b). To determine whether autophagic flux had been disrupted 
by MEKK4 silencing, the degradation of the adaptor protein p62 was also assessed. As p62 
can bind LC3, it is selectively degraded during autophagy (Bjørkøy et al., 2005), and the 
accumulation of p62 can be an indicator of autophagy deficiency (Mizushima and Yoshimori, 
2007). In MEKK4 silenced cells, there were higher levels of p62 present compared to the 
scrambled control. After 1 h of HBSS starvation, there was an increase of p62 in MEKK4 
silenced cells, which was then degraded at a comparable rate compared to the controls 
(Fig. 5.5 a, b). Taken together, these results indicate that MEKK4 promotes the conversion 
of LC3 I to LC3 II during starvation induced autophagy, and silencing MEKK4 leads to an 
accumulation of p62 which is partially degraded during starvation. Therefore, MEKK4 
silenced cells are autophagy deficient. 
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Figure 5.3 MEKK4 expression is knocked down by siRNAs s8673 and s8675 
(A) HEK 293 GFP-LC3 cells were transiently transfected with MEKK4 siRNAs at indicated 
concentrations and analysed by Western blot. 
(B) Densitometry analysis of data from experiment in (A). A concentration of 50 nM of both 
siRNAs is sufficient to knockdown MEKK4 expression. 
Figure 5.4 Silencing MEKK4 in HEK293 GFP-LC3 cells decreases LC3 turnover 
(A) HEK293 GFP-LC3 cells transfected with siRNAs against MEKK4 show reduced levels of 
LC3 II throughout HBSS starvation. Image representative of two experiments. 
(B) Densitometry analysis of experiment in (A). Mean and SEM graphed. A student’s t-test 
was performed, and none of the results were statistically significant. 
p values as follows; 0 h = 0.3059, 1 h = 0.2986, 2h = 0.1152, 4 h = 0.1402, 6h = 
0.0892. 
A B 
B 
A 
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Figure 5.5 Silencing MEKK4 in HEK293 GFP-LC3 cells results in accumulation of 
p62 
(A) HEK293 GFP-LC3 cells were transfected with MEKK4 siRNAs, lysates collected at 
indicated timepoints during HBSS starvation timecourse and analysed by Western blot.  
(B) Densitometry analysis of data from experiment (A). MEKK4 silenced cells have increased 
levels of p62 compared to the scrambled controls. 
 
  
B 
A 
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5.3.1.3 Silencing MEKK4 redistributes GFP-LC3 to large peri-
nuclear puncta that co-localise with p62 
With the previous results demonstrating a requirement for MEKK4 for the conversion of LC3 
I to LC3 II, the precise effect of MEKK4 silencing on autophagosome formation and 
dynamics was not known. To see how GFP-LC3 distribution was influenced by MEKK4 
silencing, HEK293 LC3-GFP cells were transfected with scrambled siRNA or the two MEKK4 
siRNA probes and HBSS starved over a course of 4 hours. The formation of GFP-LC3 puncta 
and their co-localisation with the early autophagosome marker WIPI2, or the 
autophagosome cargo marker p62 observed. In the scrambled control, the expected 
localisation of GFP-LC3 was observed in response to starvation induced autophagy, with an 
increase of puncta which was sustained over the 4 hour time course (Fig. 5.6, 5.7, 5.10and 
5.11). These puncta also co-localised as expected with WIPI2 and p62. Silencing MEKK4 
resulted in a dramatic redistribution of GFP-LC3 to large perinuclear puncta (Fig. 5.6, 5.7, 
5.10 and 5.11). These large puncta were present even in the absence of autophagy 
activation (Fig 5.6, 5.10). Additionally, GFP-LC3 was harder to detect in the cytosol of the 
MEKK4 silenced cells than in the scrambled control cells. WIPI2 was recruited and only 
partly localised to the large GFP-LC3 puncta when MEKK4 silenced cells were starved (Fig 
5.7 a-c), suggesting that upstream of Atg16L1, the autophagy machinery was localised to 
these large puncta when autophagy was activated. The greatest degree of co-localisation 
was seen between the large GFP-LC3 puncta and p62 (Fig. 5.10, 5.11), with a number of 
LC3 puncta surrounded by p62. Due to this level of colocalisation, the nature of the GFP-
LC3 puncta and p62 puncta were further quantified. 
 
5.3.1.4 Quantification of autophagosome markers in MEKK4 
silenced cells reveals increase in large aggregates 
To further characterise the dramatic GFP-LC3 phenotype seen in MEKK4 silenced cells, 
images from the previous experiment were analysed using Imaris software to determine 
the number, size and degree of colocalisation of GFP-LC3 and p62 puncta. This was 
compared to the scrambled control. In MEKK4 silenced cells, the number of GFP-LC3 puncta 
per cell was decreased compared to the scrambled control throughout the timecourse, and 
was statistically significant at 1 hour, 2 hours and 4 hours HBSS starvation (Fig 5.8). The 
diameter of LC3 puncta were then measured and classified into 5 subgroups; 0 – 0.5 μm 
and 0.51 – 1 μm diameter indicative of the expected sizes of autophagosomes (Mizushima 
2004), 1 – 1.5 μm of intermediate autophagosome size, and 1.51 – 2 μm and > 2 μm 
diameter which would signify a potential aggregate. Throughout the timecourse, there was 
a higher number of GFP-LC3 puncta in the autophagosome subgroups (0 – 0.5 μm and 0.51 
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– 1 μm diameter) in scrambled siRNA treated cells, compared to MEKK4 silenced cells. 
Importantly there was an increase in the number of GFP-LC3 puncta classified as 
aggregates and intermediate autophagosomes. The number of puncta in these categories 
remained fairly static during the timecourse. Few cells from the scrambled controls 
generated puncta in the 1 – 1.5 μm category, and no puncta were measured above 1.51 
μm (Fig 5.9 a – d). Overall, this indicates that MEKK4 silenced cells generate fewer GFP-
LC3 puncta than the scrambled controls, that these puncta are prone to form aggregates 
above 1.51 μm diameter, and that following activation of autophagy, there is no dynamic 
change in the number of aggregates. 
 
The quantification was repeated for p62 puncta, and revealed that the number of p62 
puncta per cell were comparable between scrambled controls and MEKK4 silenced cells at 
0 hours, 2 hours and 4 hours HBSS. There was a statistically significant decrease at 1 hour 
HBSS in MEKK4 silenced cells compared to the scrambled control, though it is unclear how 
this fits with the trend seen throughout the timecourse (Fig 5.12). The p62 puncta were 
categorised by diameter, as previously with GFP-LC3, and the results demonstrated that 
there was a small increase in the number p62 puncta in the aggregate and intermediate 
autophagosome categories at all timepoints. (Fig 5.13 a-d). When the degree of co-
localisation between GFP-LC3 and p62 was measured, the scrambled controls showed an 
increase in the number of colocalised GFP-LC3/p62 puncta following autophagy induction. 
However, in MEKK4 silenced cells, the number of colocalised GFP-LC3/p62 puncta was 
significantly lower during starvation induced autophagy than the scrambled controls. The 
number of co-localised puncta did not differ significantly throughout the timecourse 
between the MEKK4 silenced cells, indicating that these aggregates are stagnant. The 
aggregates shared similar characteristics to aggresome-like induced structures (ALIS), 
which form in response to cellular stress and cleared by autophagy, and are also observed 
in autophagy deficient cells (Szeto et al., 2006).  
 
5.3.1.5 Confirmation of effects of MEKK4 silencing on 
autophagy in cells that express NOD2  
The effect of MEKK4 silencing on autophagy had been established in HEK293 cells, which 
do not express NOD2 (Travassos et al., 2010). However, results in chapter 4 indicate that 
the expression and activation of NOD2 is involved in the interaction between Mekk4 and 
Atg16L1. To determine whether Mekk4 plays a role in autophagy in cells where Nod2 is 
expressed, a lentiviral vector containing shRNA against Mekk4 was used to transduce Raw 
264.7 cells. This shRNA had been previously validated in this cell line and was shown to 
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efficiently knockdown Mekk4 expression (Clark et al., 2008). Increasing volumes of 
prepared shRNA lentiviral particles were added to cells, the lysates collected 5 days post 
transduction and assayed for Mekk4 expression by Western blot. A 50 μl volume of Mekk4 
shRNA lentivirus was sufficient to knockdown Mekk4 expression to 31% of its original levels 
(Fig 5.14 a, b). Therefore, this volume of lentiviral particles was used to generate a stable 
knockdown in Raw 264.7 cells. 
 
Cells that had stably incorporated the lentiviral vector were selected using puromycin, as 
the vector contained a puromycin resistance gene (Fig 5.14 c). The stable Raw 264.7 cells 
were pooled and subjected to HBSS starvation or MDP treatment to induce autophagy, the 
lysates collected and LC3 processing analysed by Western blot. The control cell line (Raw 
264.7 only) was able to process LC3 following induction of autophagy by HBSS starvation 
and MDP stimulation. However, the Mekk4 knockdown cell lines showed reduced levels of 
LC3 I and LC3 II in nutrient rich conditions, and following activation of autophagy by HBSS 
starvation and MDP stimulation (Fig. 5.14 e-g). Interestingly, when LC3 turnover was 
calculated, the difference between Raw 264.7 cells and cells where Mekk4 was silenced was 
less pronounced (Fig. 5.13 h. However, this could be due to a reduction in LC3 I in the 
silenced cells. These results confirm a role for Mekk4 in the autophagy pathway in both 
cells that lack or express Nod2.   
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Figure 5.6 MEKK4 silencing induces large perinuclear GFP-LC3 puncta that are negative for WIPI2 in the absence of autophagy 
HEK293 GFP-LC3 cells were transfected with scrambled or MEKK4 siRNAs and the localisation of GFP-LC3 and WIPI2 observed in the absence of starvation 
induced autophagy. WIPI2 was immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes. Scale bars 10 μm 
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Figure 5.7 WIPI2 is recruited to sites close to the large GFP-LC3 puncta induced by autophagy following MEKK4 silencing 
(A) HEK293 GFP-LC3 cells were transfected with scrambled or MEKK4 siRNAs and the localisation of GFP-LC3 and WIPI2 observed after 1 h HBSS to induce 
autophagy. WIPI2 was immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes. Scale bars 10 μm 
A 
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Figure 5.7 cont. WIPI2 is recruited to sites close to the large GFP-LC3 puncta induced by autophagy following MEKK4 silencing 
(B) HEK293 GFP-LC3 cells were transfected with scrambled or MEKK4 siRNAs and the localisation of GFP-LC3 and WIPI2 observed after 2 h HBSS to induce 
autophagy. WIPI2 was immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes. Scale bars 10 μm 
B 
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Figure 5.7 cont. WIPI2 is recruited to sites close to the large GFP-LC3 puncta induced by autophagy following MEKK4 silencing 
(C) HEK293 GFP-LC3 cells were transfected with scrambled or MEKK4 siRNAs and the localisation of GFP-LC3 and WIPI2 observed after 4 h HBSS to induce 
autophagy. WIPI2 was immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes. Scale bars 10 μm
C 
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Figure 5.8 MEKK4 silencing decreases GFP-LC3 puncta per cell generated during 
autophagy 
Images from experiments in Fig 5.6 – 5.9 were analysed using Imaris software to quantify 
GFP-LC3 puncta/cell. 
Mean and SEM graphed. A students t-test was performed. * p = < 0.001 
Figure 5.9 MEKK4 silencing leads to an increase in the diameter of GFP-LC3 
puncta 
(A) Images from experiments performed in Fig 5.6 and 5.10 were analysed using Imaris 
software. Mean and SEM are graphed. * p = < 0.001 
(B) Images from experiments performed in Fig 5.7a and 5.10a were analysed using Imaris 
software. Mean and SEM are graphed. * p = < 0.0005 for 0 – 0.5 and 0.51 – 1 μm. * p = 
<0.01 for 1.51 - 2 μm. 
A B 
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Figure 5.9 cont. 
(C) Images from experiments performed in Fig 5.7b and 5.10b were analysed using Imaris 
software. Mean and SEM are graphed. * p = < 0.01 
(D) Images from experiments performed in Fig 5.7c and 5.10c were analysed using Imaris 
software. Mean and SEM are graphed. * p = < 0.001 
 
C D 
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Figure 5.10 p62 colocalised with large GFP-LC3 puncta induced by MEKK4 silencing 
HEK293 GFP-LC3 cells were transfected with scrambled or MEKK4 siRNAs and the localisation of GFP-LC3 and p62 observed in the absence of starvation 
induced autophagy. p62 was immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes. Scale bars 10 μm 
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Figure 5.11 p62 continues to co-localise with GFP-LC3 puncta induced by MEKK4 silencing following induction of autophagy 
(A) HEK293 GFP-LC3 cells were transfected with scrambled or MEKK4 siRNAs and the localisation of GFP-LC3 and p62 observed after 1 h HBSS to induce 
autophagy. P62 was immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes. Scale bars 10 μm 
A 
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Figure 5.11 cont. p62 continues to co-localise with GFP-LC3 puncta induced by MEKK4 silencing following induction of autophagy 
 (B) HEK293 GFP-LC3 cells were transfected with scrambled or MEKK4 siRNAs and the localisation of GFP-LC3 and p62 observed after 2 h HBSS to induce 
autophagy. P62 was immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes. Scale bars 10 μm 
 
B 
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Figure 5.11 cont. p62 continues to co-localise with GFP-LC3 puncta induced by MEKK4 silencing following induction of autophagy 
(C) HEK293 GFP-LC3 cells were transfected with scrambled or MEKK4 siRNAs and the localisation of GFP-LC3 and p62 observed after 4 h HBSS to induce 
autophagy. P62 was immunostained and the nuclei stained with DAPI. Regions of interest are highlighted in boxes. Scale bars 10 μm 
C 
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Figure 5.12 MEKK4 silencing does not consistently affect the number of p62 
puncta per cell during autophagy 
Images from experiments in Fig 5.10 – 5.11 were analysed using Imaris software to quantify 
p62 puncta/cell. Mean and SEM graphed. A student’s t-test was performed. * p = <0.01 
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Figure 5.13 MEKK4 silencing leads to an increase in the diameter of p62 puncta 
(A-D) Images from experiments 5.10- 5.11 were analysed with Imaris software and the 
diameter of p62 puncta quantified. A student’s t-test was performed. 
(A) * p = 0.005 
(B) * p = < 0.005 
(C) * p = <0005 
(D) * p = < 0.001 
A 
C 
B 
D 
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Figure 5.14 Overall co-localisation between p62 and GFP-LC3 is impaired in 
MEKK4-silenced cells 
Images from experiments in 5.10-5.11 were analysed using Imaris and the co-localisation 
between p62 and GFP-LC3 quantified. Mean and SEM graphed. A student’s t-test was 
performed. * p = < 0.005 
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Figure 5.15 Mekk4 shRNA silencing in Raw 264.7 cells leads to decreased LC3 II 
(A) Increasing volumes of concentrated shRNA lentiviral particles were added to Raw 264.7 
cells, the lysates collected and MEKK4 expression analysed by Western blot. 
(B) Densitometry analysis of (A) 
(C) Raw 264.7 cells stably expressing MEKK4 shRNA were generated and the lysates 
analysed by Western blot. 
(D) Densitometry analysis of (C) 
A 
B 
D 
C 
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Figure 5.15 cont.  
(E) Raw 264.7 MEKK4 shRNA cells were subjected to an HBSS timecourse, the lysates 
collected and analysed with the indicated antibodies by Western blot. 
(F) Densitometry analysis of LC3 I levels in control cells (white) vs MEKK4 shRNA (black) 
(G) Densitometry analysis of LC3 II levels in control cells (white) vs MEKK4 shRNA (black) 
(H) Densitometry analysis of LC3 turnover in control cells (white) vs MEKK4 shRNA (black) 
  
H 
E 
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5.3.2 Generation of MEKK4 knockout cell lines using CRISPR-Cas9 
mediated genome editing 
 
Having characterised an autophagy specific defect in MEKK4 silenced cells using siRNA 
mediated gene silencing, the next step was to repeat the gene silencing using CRISPR-Cas9 
genome editing. This would allow comparison to the siRNA experiments, to determine 
whether the results were due to off-target effects of the siRNAs. In addition to generating 
MEKK4 knockout cells against a wild type background, Atg5 knockout and p62 knockout 
cells were also chosen as candidate cell lines for Mekk4 knockout. This was to study the 
nature of the cellular aggregates, the formation of which is dependent on p62 and are 
cleared by autophagy (Lelouard et al., 2004; Lamark et al., 2012; Rubinsztein., 2006; 
Thoreen and Sabatini., 2004). 
 
5.3.2.1 Designing guide oligo targets for sgRNA expression 
construct 
A bicistronic expression vector pSpCas9(BB)-2A-GFP was obtained from www.addgene.org 
and has been described previously (Ran et al., 2013). Briefly, this vector contains a U6 
promoter driven sgRNA expression cassette, with two BbsI cloning sites for the insertion of 
guide oligo targets. This is followed by a CBh promoter driven Cas9 2A GFP cassette, which 
allows screening of transfected cells. Both human and murine cell lines were chosen for the 
generation of MEKK4 knockout cell lines; HEK293, MEFs, MEF Atg5 knockout and MEF p62 
knockout. To identify target sites within the MEKK4 gene suitable for use as sgRNA designs, 
the software tool E-CRISP was used (Heigwer et al., 2014). The algorithms identified target 
sequences in the human and mouse genes, and sequences were chosen that had low 
predicted off-target effects. The sgRNA oligos were synthesised and cloned into the vector 
as described (Ran et al., 2013). The orientation was verified by sequencing, resulting in the 
generation of pSpCas9(BB)-2A-GFP constructs targeting human MEKK4 or mouse Mekk4. 
 
   5.3.2.2 FACS sorting and expansion of transfected cells 
The sgRNA Cas9-2A-GFP constructs were transiently transfected into HEK293, MEF, MEF 
Atg5 knockout and MEF p62 knockout cells. The cells were then analysed and sorted by 
FACS, with untransfected cells as a negative control (Fig 5.15-5.16). The HEK293 cells 
showed the greatest enrichment of GFP positive cells, which was confirmed by a post-sort 
analysis (Fig. 5.15). The assorted MEF cell lines did have some GFP positive cells, though 
this was reduced in comparison to the HEK293 transfected cells (Fig 5.16). Following 
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sorting, the GFP positive cells were cultured until enough viable cells were available for 
analysis. 
 
5.3.2.3 Confirmation of MEKK4 knockdown and ALIS 
phenotype in CRISPR-Cas9 genome edited cell lines 
The expression of an sgRNA and Cas9 protein in the same cell may not guarantee gene 
knockout in the cell; a double stranded break must be induced in both alleles and the repair 
pathway must induce indels that lead to frameshift mutations and premature stop codons. 
Therefore, it is desirable to isolate clonal cells to ensure a homogenous population of cells 
that likely have the same mutation. However, prior to this, it was necessary to ascertain 
whether MEKK4 had been knocked down adequately in a non-clonal population. The lysates 
were collected from the various cell lines and analysed for MEKK4 expression by Western 
blot. All cell lines demonstrated a subtle reduction in MEKK4 expression compared to the 
untransfected controls which was confirmed by densitometry (Fig 5. 18 a-d). At the time of 
writing, analysis of p62 cell lines by Western blot had been unsuccessful due to problems 
with protein extraction.  
In conjunction with this analysis, MEF and p62 knockout cells were immunostained to 
establish whether the ALIS-like phenotype was replicated in these cells. The autophagy 
markers LC3 and WIPI were used as autophagosome markers. In a separate 
immunostaining, GFP-tagged ubiquitin, mCherry-tagged LC3 and p62 were used to 
determine if any aggregates contained ubiquitin. Advantage was also made of a construct 
expressing a mutant GFP-LC3-G120A, which cannot be cleaved and processed to LC3 II. 
This was used to verify whether the p62/LC3 positive aggregates were LC3 I positive. 
 
In MEF MEKK4 Crispr-Cas9 treated cells, there were a small number of cells that contained 
large LC3 aggregates, which were negative for WIPI2 in the absence of autophagy (Fig 
5.18). These aggregates were p62 and ubiquitin positive (Fig 5.19). These aggregates were 
able to recruit the cleavage defective LC3 mutant, indicating that the aggregates are LC3 I 
positive, and are likely an ALIS response (Fig 5. 20). Interestingly, there appeared by eye 
to be fewer ALIS structures in these cells than those seen in the MEKK4 siRNA experiments. 
This could reflect the short term response to an siRNA experiment versus the long term 
effects of gene knockout via CRISPR Cas9. 
 
As p62 is required for ALIS formation, it was not expected that ALIS structures would be 
detected in the MEKK4 CRISPR p62 knockout cells (Fujita et al., 2011). This hypothesis was 
confirmed as no LC3 aggregates were seen in the immunostained cells, no large ubiquitin 
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puncta seen, nor were there any LC3 I positive structures (Fig. 5.21-23). These results 
indicate that any LC3/p62/ubiquitin positive aggregates seen in MEFs are likely an ALIS 
response to MEKK4 knockdown. 
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Figure 5.16 FACS sorting of HEK293 cells transfected with Cas9-2A-GFP vector 
The population of cells to be sorted was identified in gate P2. GFP cells were sorted using 
B/530/30-A channel (P3) and subjected to a post-sort enrichment analysis to confirm the 
isolation of a GFP positive population 
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Figure 5.17 FACS sorting of MEF cell lines transfected with Cas9-2A-GFP vector 
All cell lines were transfected with the Cas9 plasmid containing sgRNA against the genomic target. The population of cells to be sorted was identified in gate 
P2. GFP cells were sorted using B/530/30-A channel (P3). 
(A) MEF cell line 
A 
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Figure 5.17 cont. 
(B) ATG5KO MEF cells sorted for GFP after transfection with the Cas9-2A-GFP vector. 
(C) p62 KO MEF cells sorted for GFP after transfection with the Cas9-2A-GFP vector. 
 
 
 
 
C B 
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Figure 5.18 CRISPR/Cas9 genome editing results in a small decrease in MEKK4 
expression in a non-clonal population of cells 
(A) Lysates from non-clonal populations of cells post FACS sorting were analysed for MEKK4 
expression by Western blot. 
(B) Densitometry analysis of MEKK4 expression in HEK293 cells subjected to CRISPR/Cas9 
genome editing 
(C) Densitometry analysis of Mekk4 expression in MEF cells subjected to CRISPR/Cas9 
genome editing 
(D) Densitometry analysis of Mekk4 expression in MEF Atg5 KO cells subjected to 
CRISPR/Cas9 genome editing 
 
  
D 
A 
B 
C 
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Figure 5.19 A population of Mekk4 CRISPR MEFs generate large perinuclear LC3 
aggregates 
Non clonal Mekk4 CRISPR MEFs and WT MEFs were immunostained for LC3 and WIPI post 
FACS sorting and the nuclei stained with DAPI. Scale bars 10 μm 
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Figure 5.20 LC3 positive aggregates which associate with p62 and ubiquitin are formed in MEKK4 CRISPR knockout cells 
Wild type MEFS and MEF Mekk4 CRISPR cells post FACS sorting were transfected with cherry-LC3 and GFP-ubiquitin (CRISPR cells only). The cells were 
immunostained for p62 (cyan) and the nuclei stained with DAPI. Regions of interest highlighted with boxes. Scale bars 10 μm 
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Figure 5.21 LC3 I associates with p62 and ubiquitin positive aggregates following silencing of MEKK4 
MEFS were silenced for MEKK4 using CRISPR/CAS. Cells expressing CAS-GFP were sorted by FACS and transfected using plasmids expressing GFP-LC3-
G120A and RFP-ubiquitin. The silenced MEFs were compared with control MEFs following immunostaining for p62 (Far red Alexa 647, cyan). The nuclei 
were stained with DAPI. Regions of interest highlighted with boxes. Scale bars 10 μm
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Figure 5.22 LC3 positive aggregates are not formed following silencing of Mekk4 
in cells lacking p62 
p62 KO MEFS were silenced for MEKK4 using CRISPR/CAS. Cells expressing CAS-GFP were 
sorted by FACS, and immunostained for LC3 (green Alexa 488) and WIPI (red Alexa 594) 
and post FACS sorting. The nuclei were stained with DAPI. Scale bars 10 μm 
Figure 5.23 Ubiquitin -positive aggregates are not formed following silencing of 
MEKK4 in cells lacking p62. 
MEFS lacking expression of p62 (p62-KO) were silenced for MEKK4 using CRISPR/CAS. Cells 
expressing CAS-GFP were sorted by FACS and transfected with a plasmid expressing cherry-
LC3 and GFP-ubiquitin. 
The nuclei were stained with DAPI. Scale bars 10 μm 
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Figure 5.24 LC3 I-positive aggregates are not formed following silencing of 
MEKK4 in cells lacking p62 
MEFS lacking expression of p62 (p62-KO) were silenced for MEKK4 using CRISPR/CAS.  
Cells expressing CAS-GFP were sorted by FACS and transfected with plasmids expressing 
GFP-LC3-G120A and RFP-ubiquitin. 
The nuclei were stained with DAPI. Scale bars 10 μm  
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 5.4 Chapter Discussion 
 
The main aims of this chapter were to investigate the effect of silencing MEKK4 on the 
autophagy pathway. A primary screen of siRNAs to transiently knockdown MEKK4 
expression was carried out, and the effects on LC3 processing and LC3 distribution were 
observed. The co-localisation of LC3 with autophagosome and autophagic cargo markers 
were observed and quantified by Imaris. Cell lines were generated where MEKK4 had been 
knocked out by CRISPR/Cas9 mediated genome editing, to replicate the earlier siRNA 
results. This resulted in the generation of a heterogeneous population of cells, some of 
which may have had Mekk4 knocked out via CRISPR. However, clonal selection to isolate 
these cells was unsuccessful. The experiments do serve as good preliminary data for 
analysing the effect of Mekk4 knockdown on the autophagy pathway. 
 
When MEKK4 was transiently knocked down by siRNA, there was a defect in the processing 
of LC3 I to LC3 II which was indicated by the Western blot results. In this situation, the LC3 
was expected to localise in the cytosol, with a reduction in the number of LC3 positive 
puncta. However, the localisation of LC3 in these cells was to large perinuclear aggregates. 
These aggregates were p62 positive, and had a larger than expected size of 
autophagosomes. When the cells were starved, there was no change in the number and 
size of LC3 puncta in the silenced cells. Interestingly, a small amount of WIPI2 was recruited 
to the aggregates, but did not fully co-localise with LC3. In cells that had Mekk4 gene 
expression knocked out by CRISPR/Cas9 mediated genome editing, LC3 positive aggregates 
were detected that contained p62 and ubiquitin. Interestingly, an LC3 mutant (G120A), 
which cannot be processed from LC3 I to LC3 II) was also able to form aggregates in the 
Mekk4 knockout cells, which indicates that the LC3 aggregates are likely LC3 I positive, 
rather than LC3 II. 
 
The persistent presence of the LC3 positive aggregates in MEKK4 silenced cells during 
autophagy activation indicates two things. Firstly, that these cells are autophagy deficient 
and secondly that this defect probably lies downstream of WIPI2 in the autophagy pathway. 
If the inhibition of autophagy following MEKK4 silencing is a result of disruption of the 
ATG16L1: MEKK4 interaction, then there would be no expected effects on upstream 
components of the autophagy pathway e.g. WIPI2. The localisation of ATG16L1 in MEKK4 
silenced cells does require further investigation, to determine how this is affected when 
MEKK4 is depleted. Based on the previous immunoprecipitation and localisation results 
(chapter 4), it is unlikely that the recruitment of ATG16L1 to the autophagosome will be 
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attenuated, as MEKK4 doesn’t localise to the autophagosome. As the kinase activity of 
MEKK4 is involved in the interaction, it is possible that MEKK4 is involved in the activation 
of ATG16L1 by phosphorylation, which acts as a “molecular switch” for autophagic activity. 
However, the lack of large LC3 positive aggregates in Atg16L1 knockout cells (Saitoh et al., 
2008) would imply that the formation of these structures in MEKK4 silenced cells is not 
solely due to the interaction between Atg16L1 and Mekk4. 
 
The results of this study agree with previous research, which identified a putative role for 
MEKK4 in NOD2 mediated autophagy, whereby silencing MEKK4 led to an increase in the 
survival of Salmonella typhimurium in cell culture, due to a decrease in autophagy-directed 
destruction of bacteria (Homer et al., 2012). However, MEKK4 appears to have a role in 
canonical autophagy rather than just selective autophagy in the work carried out in this 
thesis. MEKK4 has also been linked to autophagy through its involvement in the GADD45-
MEKK4-p38 pathway, which has been shown to regulate autophagy (Keil et al., 2012). 
When p38 is activated through GADD45 mediated MAPK signalling, ATG5 is phosphorylated, 
which leads to the inhibition of autophagosome maturation and fusion with the lysosome. 
As MEKK4 appears to be the main MAP3K involved in this signalling cascade, based on the 
results of Keil et al., 2012 the expectation would be that a knockdown in MEKK4 expression 
would lead to an increase in autophagy. Indeed, Gadd45 -/- primary macrophages and p38 
-/- MEFs both displayed an increase in basal and autophagy responses to LPS and 
starvation, respectively (Keil et al., 2012). As this is not the case, this raises issues with the 
true role of MEKK4 in the GADD45-MEKK4-p38 regulation of autophagy, and demands 
further investigation into the specific role of MEKK4 in regulating autophagic flux.  
 
The nature of the large perinuclear LC3/p62/ubiquitin aggregates also warrants additional 
characterisation. The structures share characteristics with ALIS and aggresomes. Both 
contain p62 and both rely on autophagy for clearance (Lelouard et al., 2004; Lamark et al., 
2012; Rubinsztein., 2006; Thoreen and Sabatini., 2004). What was intriguing about the 
MEKK4 silencing-induced structures was that they had a tendency to localise to the 
perinuclear region, which is similar to the site of the aggresome. The aggresome is also 
metabolically stable (Lamark et al., 2012), unlike ALIS which are transient structures (Fujita 
et al., 2011; Szeto et al., 2006). The microtubule organising centre (MTOC) is the main site 
of aggresome formation, where protein aggregates are deposited and can accumulate to 
inclusions of between 1 and 3 μm diameter, when degradation pathways in the cell are 
overwhelmed (Wileman., 2007). The size of these aggresomes are comparable to those 
induced by MEKK4 silencing. The transport of ubiquitinated substrates to the aggresome is 
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mediated by the motor-protein dynein, and facilitated by histone deacetylase 6 (HDAC6), 
which enables the clearance of aggresomes by autophagy (Kawaguchi et al., 2003; Iwata 
et al., 2005; Yao et al., 2010). HDAC6 also regulates microtubule deacetylation, and plays 
an important role in microtubule dynamics, with inhibition altering the rate of growth and 
shrinkage of microtubules (Zilberman et al., 2009). If the aggregates observed in MEKK4 
silenced cells are aggresomes, then their formation would be dependent on HDAC6, 
therefore inhibition of HDAC6 would be a useful experiment to determine if the aggregates 
could still form in these conditions. Alternatively, nocodazole treatment would depolymerise 
the microtubules, which would inditcate if the aggregates relied on the microtubule network 
for transport. However, the finding that the mutant LC3 G120A, which cannot be processed 
to LC3 I, is recruited to MEKK4 silencing-induced aggregates would indicate that these 
structures are a form of ALIS. During aggresome formation the intermediate filament 
vimentin has been known to collapse and form a cage around the aggresome, sequestering 
the aggregates and protecting the cell from further damage (Garcia-Mata et al., 1999). The 
localisation of the MEKK4 silencing aggregates with the MTOC and vimentin, and time-lapse 
microscopy would help determine whether these structures were ALIS or aggresomes.  
The use of CRISPR/Cas9 mediated genome editing in this chapter has facilitated rapid 
generation of hetergenous knockout cell lines, which is an advantageous technique when 
studying effects of long term gene knockout versus the effects of transient gene 
knockdown. The design of the sgRNA target sequence was determined computationally, 
which allows for a relatively straightforward custom design and construction of the sgRNA. 
Considerations must be given for off-target cleavage activities of Cas9 (Hsu et al., 2013; Fu 
et al., 2013; Jiang et al., 2013), which can be determined computationally (Ran et al., 
2013). Tolerance for mismatches between the sgRNA target sequence and off-target 
genomic DNA is position dependent; the first 6 bp of the 5’ end of the guide sequence will 
tolerate mismatches. More than three mismatches will in most instances not be tolerated, 
and increasing the amount of transfected sgRNA/Cas9 can also increase the number of off-
target cleavages (Ran et al., 2013). After the cell lines used in this study were generated, 
new algorithms and software became available to design sgRNA and calculate off-target 
effects (http://tools.genome-engineering.org). The suitability of the sgRNA target 
sequences were assessed and whilst the human sgRNA was deemed as a high quality guide; 
the number of off-target effects were low with mismatches of 3bp or more and the majority 
occurring outside of exons (appendix 3). However, the mouse sgRNA used in this thesis 
was classified as a mid-quality guide, with an increased number of exon off-target effects, 
with fewer mismatches between the sgRNA and the off-target sequence, increasing the 
likelihood of off-target cleavage (appendix 4). Therefore, additional mouse sgRNA 
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Figure 5.25 Diagrammatic representation of the potential role of ATG16L1 and MEKK4 in the ALIS response 
In the response to cellular stress, p62 and ubiquitin accumulate into large aggregates that recruit LC3 I. This promotes the formation of the autophagosomal 
membrane around the aggregate, where ATG16L1 which may be activated by MEKK4, drives the conversion of LC3 I to LC3 II, facilitating the clearance of 
the aggregates via autophagy. 
Figure assembled using data from Szeto et al., 2006 and Fujita et al., 2011. 
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sequences could be used to generate MEKK4 knockout cell lines in the MEFs, to ensure that 
the phenotype observed is not due to off-target effects. These cells were progressed to 
clonal selection, though this was unsuccessful (data not shown). Primers were also designed  
for sequencing the genomic target from clonal cells which can be sent for sequencing to 
detect indels (Appendix 5), which is a technique favoured by Ran et al., 2013.  
 
Overall, the results demonstrate a strong autophagy defective phenotype when MEKK4 is 
silenced, with LC3 I positive aggregates that share similarities with both aggresomes and 
ALIS. This could be as a result of the interaction between Atg16L1 and Mekk4, but is likely 
not the single contributing factor to the defect in autophagy. The further characterisation 
of these structures in CRISPR/Cas9 mediated MEKK4 knockout cells will help understand 
how these structures form and how they link MEKK4 to autophagy.
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Chapter 6 
 
General Discussion and Future Work 
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Chapter 6: Discussion 
 
 6.1 General Summary 
 
This thesis has studied the Atg16L1 protein in respect of domain function in autophagy, 
and in the identification and characterisation of a novel interaction with MEKK4. Tools were 
generated for the study of the domains Atg16L1 and to characterise various point mutants 
of Atg16l1. This work confirmed the requirement of the coiled-coil domain for autophagy, 
and identified a defect in the CD associated mutant to form larger autophagosomes, a 
finding which was later confirmed in other publications. 
 
Tools were generated to verify and study a novel interaction between Atg16L1 and MEKK4, 
a serine threonine kinase that has shown to be important for regulating NOD2 signalling. 
Existing research has established an interaction between NOD2 and Atg16L1, with this 
signalling axis representing an important arm of the innate immune system. Co-
immunoprecipitation experiments confirmed the interaction between Atg16L1 and MEKK4, 
narrowing down the region required for MEKK4 binding to the linker region of Atg16L1. The 
kinase activity of MEKK4 was also required for the interaction. Whilst MEKK4 did not localise 
to the autophagosome with Atg16L1, the proteins remained bound during starvation 
induced autophagy in cells where NOD2 was not expressed. When autophagy was induced 
by starvation or by MDP in cells that expressed NOD2, there was a reduction in MEKK4 
Atg16L1 binding.  
 
The functional role of MEKK4 in autophagy was also studied by various means of gene 
silencing. Experiments showed that MEKK4 expression is required for LC3 conversion, which 
phenocopies Atg16L1 knockout in this respect. Furthermore, the lack of MEKK4 expression 
results in a redistribution of LC3 to perinuclear aggresomes or ALIS structures independently 
of starvation, which are positive for p62 and ubiquitin. These MEKK4 silencing-induced LC3 
structures were distinct from autophagosomes in their number and size, as there were 
fewer puncta, which had a larger diameter than a normal autophagosome. The formation 
of these aggregates was dependent on p62 expression, and the aggregates were also able 
to recruit LC3-I. 
 
 6.2 Model of the Atg16L1:MEKK4 interaction in autophagy 
The results of chapter 4 have established that in the absence of autophagy, MEKK4 and 
Atg16L1 form a complex. In cells which have not been silenced for MEKK4, autophagy is 
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able to proceed normally (Fig 6.1). Starvation induced autophagy inhibits the activity of 
mTOR, which allows the initiation of the autophagy signalling cascade. Through an 
unknown mechanism, MEKK4 may be activated by an upstream activator e.g. GADD45, 
which is known to be upregulated during cellular stress (Liebermann et al., 2002), or by an 
undiscovered MEKK4 activator. As the kinase activity of MEKK4 is required for the interaction 
between Atg16L1 and MEKK4, it can be postulated that MEKK4 is in an open conformation, 
and Atg16L1 could be a substrate for MEKK4. The active MEKK4 then phosphorylates and 
activates Atg16L1, which could act as a molecular switch for Atg16L1 activity. Several serine 
phosphorylation sites of unknown function have been documented within Atg16L1, though 
the mechanism and function of this modification is unclear (Villén et al., 2007; Olsen et al., 
2010). What is evident, however, is that the phosphorylation of Atg16L1 does occur and 
could serve as a potential regulatory mechanism, as has been shown in other autophagy 
proteins (Keil et al., 2012). The cellular distribution studies of Atg16L1 and MEKK4 show 
that Atg16L1 localises to the autophagosome, whilst MEKK4 remains in the cytosol. The 
immunoprecipitation results are less clear however, with Atg16L1 and MEKK4 remaining 
bound during autophagy activation in cells that lack NOD2 expression. This could represent 
a pool of Atg16L1 that remains bound to MEKK4, with a portion released to the 
autophagosome during autophagy. The mechanism behind Atg16L1 recruitment to the 
autophagosome is predominantly the interaction between WIPI2 and Atg16L1, which is 
recruited to the early autophagosome upstream of Atg16L1 (Dooley et al., 2014). It is 
therefore unlikely that phosphorylation of Atg16L1 by MEKK4 is required for recruitment of 
Atg16L1 to the autophagosome. The experiments showed that MEKK4 was required for LC3 
conversion, a process that involves the two ubiquitin-like conjugation pathways; Atg16L1-
Atg5-Atg12 and Atg3-LC3. The phosphorylation could result in a conformational change 
that leads to increased affinity for Atg5 binding, with autophagy being driven through 
increased recruitment of  the Atg5-12 complex which binds and activates Atg3, leading to 
subsequent lipidation of LC3 (Ichimura et al., 2000; Sakoh-Nakatogawa et al., 2013).This 
could be a reason as to why MEKK4 is required for LC3 conversion. When MEKK4 has been 
knocked out or silenced, the phosphorylation of Atg16L1 would no longer occur. Whilst 
recruitment of Atg16L1 to the autophagosome would still take place, the lack of Atg16L1 
activation would result in a failure to recruit members of the Ub-like conjugation pathways, 
or efficiently carry out the E3-like activity of Atg16L1 required for LC3 conversion. As seen 
in chapter 5, this results in a failure to activate autophagy in response to starvation, and 
an abnormal accumulation of aggregates, which cannot be degraded. 
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Figure 6.1 Schematic representation of proposed model of Atg16L1 activation by MEKK4 
During autophagy initiation, MEKK4 is activated by as yet unknown mechanism, phosphorylates Atg16L1 which activates its autophagic activity. This allows 
Atg16L1, once recruited to the autophagosome, to efficiently drive LC3 lipidation and autophagy through the ubiquitin-like conjugation pathways. 
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There are however, gaps in this model which remain unexplained. As autophagy is an 
essential process, then an important regulator such as MEKK4 would be expected to be 
broadly expressed in development and in all tissues. Gene expression data in a number of 
databases indicate that MEKK4 is widely expressed throughout development through to 
adulthood, with high expression found in skeletal muscle, kidney, testis followed by heart 
brain and lung (Gerwins et al., 1997; ArrayExpress; Bgee; CleanEx; Genevestigator). This 
is reassuring, as if MEKK4 is vital for autophagy then expression would not be heavily 
restricted. MEKK4 knockout and MEKK4 kinase inactive mice display perinatal lethality, with 
very few mice surviving to adulthood (Chi et al., 2004; Abell et al., 2005), which also 
demonstrates that MEKK4 expression is vital for development and survival. 
 
It is possible that MEKK4 may be one of many kinases able to activate ATG16L1 activity in 
response to specific cellular stressors. In the MAPK cascade, the individualised functions of 
the MAP3Ks (MEKKs) provide for specificity and complexity in the ability to respond to a 
variety of extra-cellular stresses. As with this system, other kinases could provide alternative 
means of activating ATG16L1 in response to different autophagic stimuli e.g. mitophagy. 
What is unclear, is how these kinases would coordinate basal autophagy. 
 
6.3 Future Work 
To further dissect the MEKK4:Atg16L1 interaction and its role in regulating the autophagy 
pathway, further experiments have been proposed. 
 
  6.3.1 Short term work 
The requirement for MEKK4 in autophagy was based on the results seen in the siRNA screen 
in chapter 5. To confirm the phenotype and further explore this, knockout Mekk4 MEFs will 
be generated from Mekk4 flox/flox embryos and immortalised using the Adeno-Cre virus. 
These mice were a kind gift from Dr Andy Greenfield (MRC Harwell) and are described in 
Chi et al., 2004. These cells will have their knockout status confirmed by genotyping and 
Western blot, before autophagy assays are carried out. The cells will be subjected to HBSS 
starvation with and without the lysosomal inhibitor bafilomycin A1 (BafA1), which inhibits 
degradation of LC3 II. If the decrease in LC3 II throughout the timecourse is due to an 
overall decrease/inhibition of autophagosome formation, this will confirm that MEKK4 is 
required for autophagy. If there is an increase in LC3 II following BafA1 treatment, then 
this could indicate an increase in autophagic flux, with accelerated degradation of LC3 II.  
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The nature of the aggregates seen in the siRNA screen and CRISPR/Cas MEKK4 knockout 
cells also require further investigation. To see whether the recruitment of LC3 to the 
aggregates is dependent on the interaction with p62, an LC3 mutant defective in p62 
binding (where lysine 51 has been mutated to alanine) has been obtained (Ichimura et al., 
2008; Fujita et al., 2010). The recruitment of this LC3-K51A mutant to p62/ubiquitin positive 
aggregates will be compared with wt-LC3 and the cleavage defective LC3-G120A mutant. 
The LC3-K51A mutant has been shown to colocalise with p62 ALIS structures, so could 
indicate if the aggregates are ALIS (Fujita et al., 2010). To further characterise the 
aggregates, their co-localisation with the intermediate filament vimentin should also be 
considered. Aggresomes are sometimes caged by collapsed vimentin, which acts as a 
sequestering mechanism (Garcia-Mata et al., 1999). A lack of co-localisation or vimentin 
cage would indicate that the aggregates were ALIS not aggresomes. The perinuclear 
location of the aggregates raises the question of how they were transported there in the 
first place. As aggresome transport to the MTOC is facilitated by HDAC6, inhibitors of HDAC6 
or nocodazole will be used to see if the formation or localisation of perinuclear aggregates 
in the MEKK4 knockout cells. These experiments will aim to determine whether the 
aggregates in MEKK4 knockout cells are a transient ALIS response or a metabolically stable 
aggresome. 
 
The identification of an Atg16L1 binding motif in the N-terminus MEKK4 will be confirmed, 
by mutating the motif using site directed mutagenesis. Co-immunoprecipitations will then 
be carried out. This will enable a greater understanding of how MEKK4 may interact with 
Atg16L1, and reveal the importance of the C-terminal kinase activity of MEKK4 in the 
interaction. Should the motif in MEKK4 be required for Atg16L1 binding, then the previous 
results demonstrating that kinase activity is required for Atg16L1 binding would indicate 
that this is due to the conformational state of MEKK4 when active. 
 
  6.3.2 Long term work 
Two aims have been identified that will address the question; does MEKK4 play a functional 
role in autophagy by regulating the activation of autophagy through Atg16L1? 
 
The first aim will be to determine if Atg16L1 is a substrate for MEKK4 and if phosphorylation 
is required for activation of Atg16L1 and lipidation of LC3. Phosphorylation of Atg16L1 could 
be investigated by Q-MALDI-TOF mass spectrometry to scan Atg16L1 for novel 
phosphopeptides. Atg16L1 would be isolated from HEK293 Atg16L1-GFP. Atg16L1 will be 
immmunopurified from control cells cultured in nutrient rich conditions and cells starved to 
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induce autophagy. Any novel sites could be mutated in the Atg16L1-GFP construct by site-
directed mutagenesis. The putative phospho-defective mutants would then be used to 
reconstitute Atg16L1 KO MEFs to see if there are any changes in autophagosome number 
and localisation as a result of the mutation. Autophagic flux could also be monitored by 
analysing the degradation of p62 and conversion of LC3 I to LC3 II by Western blot.  
Parallel pull down experiments would determine whether the Atg16L1 phosphorylation 
mutants retain the ability to bind MEKK4. This aim could be completed using in vitro kinase 
assays to determine whether recombinant active MEKK4 directly phosphorylates 
recombinant wild type and mutant Atg16L1.  
 
The second aim could be to determine if the MEKK4:Atg16L1 interaction is required for 
activation of autophagy by NOD2 and if this is regulated by phosphorylation. Whilst MEKK4 
was shown to be required for starvation induced autophagy in chapter 5, this work was not 
extended to investigating NOD2 directed autophagy due to time constraints. Using the 
HEK293 Atg16L1-GFP NOD2-HA episomal cells, the mass spectrometry analysis could be 
repeated following MDP incubation and NOD2 activated autophagy. This would indicate 
whether different phosphorylation sites are involved, if at all, in Atg16L1 activation. To 
confirm that the interaction between Atg16L1 and MEKK4 controls MDP-activation of 
autophagy by MEKK4, Atg16L1 -/- MEFs could be reconstituted with NOD2-HA and 
phosphorylation deficient mutants of Atg16L1 generated in Aim 1. The CRISPR/Cas MEKK4 
knockout cell lines would then be used to see if MEKK4 is required for MDP induced 
autophagy.  
 
 6.4 Concluding Remarks 
The discovery and characterisation of a novel interaction between Atg16L1 and MEKK4 has 
demonstrated a functional role for MEKK4 in the regulation of the autophagy pathway. 
Whilst previous literature had shown an indirect involvement for MEKK4 in autophagy 
through undefined mechanisms, this body of work presents a feasible molecular basis for 
the involvement of MEKK4 in autophagy. Should future work be able to elucidate how this 
interaction contributes towards regulating the ATG16L1:NOD2 signalling axis, then there is 
great potential for understanding how autophagy is activated in response to infection. This 
would represent a specific druggable target for the control of autophagy, which would be 
worth developing. However, it is clear that further investigation into the activation of 
Atg16L1 is required to determine whether the vital role of MEKK4 in autophagy is directly 
as a consequence of its interaction with Atg16L1
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Appendix 1 
 
Schematic representation of the splice variants of Atg16L1 
 
Three isoforms of murine Atg16L1 have been described, Atg16L1 α, β and γ. Atg16L1 γ contains 
exons 1-19, and is the longest splice variant. Atg16L1 β is referred to as the canonical sequence 
(Mizushima et al., 2003) and lacks exon 9, whereas Atg16L1 α is missing exon 8 and 9. 
 
Modified from an original figure created by Dr Ernst Poschl 
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Appendix 2 
 
Alignment between Human ATG16L1 β and Mouse Atg16L1 γ protein sequences to highlight 
potential region for binding of proteins containing Atg16L1 binding motif 
 
CLUSTAL 2.1 multiple sequence alignment 
 
 
humanatg16l1beta       MSSGLRAADFPRWKRHISEQLRRRDRLQRQAFEEIILQYNKLLEKSDLHSVLAQKLQAEK 60 
mouseatg16L1gamma      MSSGLRAADFPRWKRHIAEELRRRDRLQRQAFEEIILQYTKLLEKSDLHSVLTQKLQAEK 60 
                       *****************:*:*******************.************:******* 
 
humanatg16l1beta       HDVPNRHEISPGHDGTWNDNQLQEMAQLRIKHQEELTELHKKRGELAQLVIDLNNQMQRK 120 
mouseatg16L1gamma      HDMPNRHEISPGHDGAWNDSQLQEMAQLRIKHQEELTELHKKRGELAQLVIDLNNQMQQK 120 
                       **:************:***.**************************************:* 
 
humanatg16l1beta       DREMQMNEAKIAECLQTISDLETECLDLRTKLCDLERANQTLKDEYDALQITFTALEGKL 180 
mouseatg16L1gamma      DKEIQMNEAKISEYLQTISDLETNCLDLRTKLQDLEVANQTLKDEYDALQITFTALEEKL 180 
                       *:*:*******:* *********:******** *** ******************** ** 
 
humanatg16l1beta       RKTTEENQELVTRWMAEKAQEANRLNAENEKDSRRRQARLQKELAEAAKEPLPVEQDDDI 240 
mouseatg16L1gamma      RKTTEENQELVTRWMAEKAQEANRLNAENEKDSRRRQARLQKELAEAAKEPLPVEQDDDI 240 
                       ************************************************************ 
 
humanatg16l1beta       EVIVDETSDHTEETSPVRAISRAATKRLSQPAGGLLDSITNIFG---------------- 284 
mouseatg16L1gamma      EVIVDETSDHTEETSPVRAVSRAATKRLSQPAGGLLDSITNIFGLSESPLLGHHSSDAAR 300 
                       *******************:************************                 
 
humanatg16l1beta       RRSVSSFPVPQDNVDTHPGSGKEVRVPATALCVFDAHDGEVNAVQFSPGSRLLATGGMDR 344 
mouseatg16L1gamma      RRSVSSIPVPQDIMDTHPASGKDVRVPTTASYVFDAHDGEVNAVQFSPGSRLLATGGMDR 360 
                       ******:***** :****.***:****:**  **************************** 
 
humanatg16l1beta       RVKLWEVFGEKCEFKGSLSGSNAGITSIEFDSAGSYLLAASNDFASRIWTVDDYRLRHTL 404 
mouseatg16L1gamma      RVKLWEAFGDKCEFKGSLSGSNAGITSIEFDSAGAYLLAASNDFASRIWTVDDYRLRHTL 420 
                       ******.**:************************:************************* 
 
humanatg16l1beta       TGHSGKVLSAKFLLDNARIVSGSHDRTLKLWDLRSKVCIKTVFAGSSCNDIVCTEQCVMS 464 
mouseatg16L1gamma      TGHSGKVLSAKFLLDNARIVSGSHDRTLKLWDLRSKVCIKTVFAGSSCNDIVCTEQCVMS 480 
                       ************************************************************ 
 
humanatg16l1beta       GHFDKKIRFWDIRSESIVREMELLGKITALDLNPERTELLSCSRDDLLKVIDLRTNAIKQ 524 
mouseatg16L1gamma      GHFDKKIRFWDIRSESVVREMELLGKITALDLNPERTELLSCSRDDLLKVIDLRTNAVKQ 540 
                       ****************:****************************************:** 
 
humanatg16l1beta       TFSAPGFKCGSDWTRVVFSPDGSYVAAGSAEGSLYIWSVLTGKVEKVLSKQHSSSINAVA 584 
mouseatg16L1gamma      TFSAPGFKCGSDWTRVVFSPDGSYVAAGSAEGSLYVWSVLTGKVEKVLSKQHSSSINAVA 600 
                       ***********************************:************************ 
 
humanatg16l1beta       WSPSGSHVVSVDKGCKAVLWAQY 607 
mouseatg16L1gamma      WAPSGLHVVSVDKGSRAVLWAQP 623 
                       *:*** ********.:******  
 
 
 
Boada-Romero WD40 construct 
Atg16L1 WD40 construct used in this thesis 
     = 10 aa region of difference between constructs 
 
Alignments were carried out using the Clustal 2.1 algorithm, to align the sequences of 
human ATG16L1 β and mouse Atg16L1 γ. This allowed determination of the regions of 
discrepancy between the WD40 construct used for interaction studies by Boada-Romero et 
al., (320-607aa) and the WD40 construct used in this thesis (327-623aa). The alignments 
reveal a 10 amino acid region which is present in the WD40 construct used in this thesis, 
which is missing from the Boada-Romero WD40 construct. This region may explain why 
Mekk4, which contains an Atg16L1 interacting motif, cannot bind the WD40 construct used 
in this thesis. 
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Appendix 3 
 
 
Updated sgRNA design for human MEKK4 using http://tools.genome-engineering.org 
software from Dr Fen Zhang. 
 
 
 
        = sgRNA used in thesis to generate HEK293 MEKK4 
Crispr genome edited cells. 
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Appendix 4 
 
 
Updated sgRNA design for mouse using http://tools.genome-engineering.org software from 
Dr Fen Zhang. 
 
 
 
 
 
    = sgRNA used in thesis to generate MEF Mekk4 Crispr 
genome edited cell lines.
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Appendix 5 
 
Designing primers to amplify Mouse Mekk4 Cas9 target for Surveyor/sequencing assays 
 
 
MAP3K4-201 ENSMUSG00000014426 
 
 
 
Mekk4 on the chromosome 
 
>chromosome:GRCm38:17:12227021:12319260:-1 
 
 
Primer-BLAST in order to avoid nonspecific amplification. SURVEYOR primers should be 
designed to amplify 200–400 bp on either side of the Cas9 target (for a total amplicon 400–
800 bp long) to allow clear visualization of cleavage bands by gel electrophoresis. To 
prevent excessive primer dimer formation, SURVEYOR primers should be designed to be 
typically 18 to 25 nt long with melting temperatures of ~60 °C. For SURVEYOR assay or 
sequencing analysis, we recommend testing that each pair of candidate primers produces 
a single PCR product, as well as testing for the absence of nonspecific cleavage during the 
SURVEYOR nuclease digestion process 
 
 
Design primers to amplify this region 
 
 
GCAGAATCCAGTGGCGCAGAGACCTTGAGCTCCAGTTTATGAAGCATTCCTGCTCGCCCAGACAACC
CTACCTCTCCAAATGTCTCCTGTGCCCTTAGCCTCAGGACCTCCCGAGGCCACCCGCGGTCACCCAGC
GACACCTGATTTACCACTGGCCAGTGCGCTCCTCCCTCCCGCCTCGCCCCGCCCAGGCGGACTCAGCC
GCCCGCCGAGGCGTGTCCCTCGCTGCCCGCCGTAGCCCAGCGTTCGGCCGGCCGCCGTTCCCAAGAT
GGCCGCTGCGCGCACGGCTCCTGCGGCGGGCTAGAGGCGGAGGCGGAGTCGAGTCACTCCCTCACCC
CGCGGCTCCTGGTCTTCCCGCACCAGGCTGCAGCTGACGACCCGCCGCGGTCATGCGAAGCTTGGT
GCACGGATGAGAGACGCCATCGCCGAGCCGGTGCCCCCTCCTGCCCTCGCCGACACCCCTGCA
GCCGCCATGGAGGAGCTGCGGCCAGCACCGCCGCCACAGCCCGAGCCGGATCCGGAGTGCTG
CCCAGCGGCGAGGTGAGTGCACGGCTGCAGCTGCAGCTCGGAGGGAGCAGGGTGGCGCGTGAAGG
GGGCGTGGGGTCCTCGGCTGCGCGCCAGGTGGGCGCGGAGCATCCGGACCTCCGGTGGCGGGAGGG
GCGCGGTGCAGCGCGGAGCCCGGTGCTCCGCTTCCGCGCGACCCCTGCCCGGGCTCGGAGGCCAAGC
TCCCGAGCGACCCTGGCCTTTGCAGTAGTGCTCCCCGGGGCCCTGCTGCAGACAGCCCCAGCTTGCCC
CGGACTGCCGCTCGGGCTCGGATCAGTGATCGGATGGAAGGAAGGTGGTCCATCTTTCTCCTTTTTCC
AGGAAAAGAGAGGCGACGTGCCTCTCGGCAGTTC 
 
660 896 
 
 
Primers designed using Primer blast 
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Primer pair 1 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
TCCAAATGTCTCCTGTGCC
C 
Plus 20 75 94 
59.9
6 
55.00 2.00 2.00 
Reverse 
primer 
ACGTCGCCTCTCTTTTCCT
G 
Minus 20 881 862 
60.0
4 
55.00 4.00 1.00 
Internal 
oligo 
 Plus        
Product 
length 
807 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 807 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
 
Forward primer  1         TCCAAATGTCTCCTGTGCCC  20 
Template        12318963  ....................  12318944 
 
Reverse primer  1         ACGTCGCCTCTCTTTTCCTG  20 
Template        12318157  ....................  12318176 
 
Products on allowed transcript variants 
 
Products on potentially unintended templates 
 
 
Primer pair 2 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
CCAAATGTCTCCTGTGCCC
T 
Plus 20 76 95 
59.9
6 
55.00 2.00 0.00 
Reverse 
primer 
CACGTCGCCTCTCTTTTCC
T 
Minus 20 882 863 
60.0
4 
55.00 4.00 0.00 
Internal 
oligo 
 Plus        
Product 
length 
807 
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Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 807 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
 
Forward primer  1         CCAAATGTCTCCTGTGCCCT  20 
Template        12318962  ....................  12318943 
 
Reverse primer  1         CACGTCGCCTCTCTTTTCCT  20 
Template        12318156  ....................  12318175 
 
Products on allowed transcript variants 
 
 
Products on target templates 
 
Primer pair 3 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
ATGTCTCCTGTGCCCTTAG
C 
Plus 20 80 99 
59.4
6 
55.00 3.00 2.00 
Reverse 
primer 
GACCACCTTCCTTCCATCC
G 
Minus 20 844 825 
60.1
1 
60.00 2.00 2.00 
Internal 
oligo 
 Plus        
Product 
length 
765 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 765 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
 
Forward primer  1         ATGTCTCCTGTGCCCTTAGC  20 
Template        12318958  ....................  12318939 
 
Reverse primer  1         GACCACCTTCCTTCCATCCG  20 
Template        12318194  ....................  12318213 
 
Products on allowed transcript variants 
 
 
Products on target templates 
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Primer pair 4 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
CACCCAGCGACACCTGATT
T 
Plus 20 128 147 
60.6
1 
55.00 3.00 1.00 
Reverse 
primer 
GGACCACCTTCCTTCCATC
C 
Minus 20 845 826 
59.7
4 
60.00 3.00 0.00 
Internal 
oligo 
 Plus        
Product 
length 
718 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 718 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
 
Forward primer  1         CACCCAGCGACACCTGATTT  20 
Template        12318910  ....................  12318891 
 
Reverse primer  1         GGACCACCTTCCTTCCATCC  20 
Template        12318193  ....................  12318212 
 
Products on allowed transcript variants 
 
 
Primer pair 5 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
GCCCAGACAACCCTACCTC
T 
Plus 20 56 75 
60.9
1 
60.00 3.00 0.00 
Reverse 
primer 
ACCACCTTCCTTCCATCCG
A 
Minus 20 843 824 
60.5
5 
55.00 3.00 3.00 
Internal 
oligo 
 Plus        
Product 
length 
788 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 788 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
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Forward primer  1         GCCCAGACAACCCTACCTCT  20 
Template        12318982  ....................  12318963 
 
Reverse primer  1         ACCACCTTCCTTCCATCCGA  20 
Template        12318195  ....................  12318214 
 
Products on allowed transcript variants 
 
 
Products on target templates 
 
Primer pair 6 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
TCTCCTGTGCCCTTAGCCTC Plus 20 83 102 
60.9
8 
60.00 3.00 1.00 
Reverse 
primer 
GAGCACTACTGCAAAGGCC
A 
Minus 20 759 740 
60.6
1 
55.00 6.00 2.00 
Internal 
oligo 
 Plus        
Product 
length 
677 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 677 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
 
Forward primer  1         TCTCCTGTGCCCTTAGCCTC  20 
Template        12318955  ....................  12318936 
 
Reverse primer  1         GAGCACTACTGCAAAGGCCA  20 
Template        12318279  ....................  12318298 
 
Products on allowed transcript variants 
 
Products on target templates 
 
Primer pair 7 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
ACCCAGCGACACCTGATTT
A 
Plus 20 129 148 
59.0
2 
50.00 3.00 2.00 
Reverse 
primer 
AGCACTACTGCAAAGGCCA
G 
Minus 20 758 739 
60.6
1 
55.00 6.00 1.00 
Internal 
oligo 
 Plus        
Product 
length 
630 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
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Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 630 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
 
Forward primer  1         ACCCAGCGACACCTGATTTA  20 
Template        12318909  ....................  12318890 
 
Reverse primer  1         AGCACTACTGCAAAGGCCAG  20 
Template        12318280  ....................  12318299 
 
Products on allowed transcript variants 
 
Products on potentially unintended templates 
 
Products on target templates 
 
 
 
 
 
Primer pair 8 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
CACCCAGCGACACCTGATT Plus 19 128 146 
60.0
0 
57.89 3.00 1.00 
Reverse 
primer 
CTACTGCAAAGGCCAGGGT
C 
Minus 20 754 735 
60.6
8 
60.00 4.00 2.00 
Internal 
oligo 
 Plus        
Product 
length 
627 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 627 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
 
Forward primer  1         CACCCAGCGACACCTGATT  19 
Template        12318910  ...................  12318892 
 
Reverse primer  1         CTACTGCAAAGGCCAGGGTC  20 
Template        12318284  ....................  12318303 
 
Products on allowed transcript variants 
 
Products on target templates 
 
Primer pair 9 
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 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
TCTCCAAATGTCTCCTGTGC
C 
Plus 21 73 93 
60.0
0 
52.38 2.00 1.00 
Reverse 
primer 
CGTCGCCTCTCTTTTCCTGG Minus 20 880 861 
60.7
4 
60.00 3.00 3.00 
Internal 
oligo 
 Plus        
Product 
length 
808 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 808 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
 
Forward primer  1         TCTCCAAATGTCTCCTGTGCC  21 
Template        12318965  .....................  12318945 
 
Reverse primer  1         CGTCGCCTCTCTTTTCCTGG  20 
Template        12318158  ....................  12318177 
 
Products on allowed transcript variants 
 
 
Primer pair 10 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
AATCCAGTGGCGCAGAGAC Plus 19 5 23 
60.0
8 
57.89 5.00 1.00 
Reverse 
primer 
GGGGAGCACTACTGCAAAG
G 
Minus 20 762 743 
60.6
8 
60.00 6.00 0.00 
Internal 
oligo 
 Plus        
Product 
length 
758 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000083.6 Mus musculus strain C57BL/6J chromosome 17, GRCm38.p2 C57BL/6J 
 
product length = 758 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform X1 
 
   mitogen-activated protein kinase kinase kinase 4 
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Forward primer  1         AATCCAGTGGCGCAGAGAC  19 
Template        12319033  ...................  12319015 
 
Reverse primer  1         GGGGAGCACTACTGCAAAGG  20 
Template        12318276  ....................  12318295 
 
Products on allowed transcript variants 
 
Products on potentially unintended templates 
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Designing primers to amplify human MEKK4 Cas9 target for Surveyor/sequencing assays 
 
 
Human MEKK4 
 
Ensembl summary 
Name Transcript ID Length (bp) Protein ID Length (aa) Biotype CCDS 
MAP3K4-001 ENST00000392142  5490 ENSP00000375986  1608 Protein coding  
 
 
Primer-BLAST in order to avoid nonspecific amplification. SURVEYOR primers should be 
designed to amplify 200–400 bp on either side of the Cas9 target (for a total amplicon 400–
800 bp long) to allow clear visualization of cleavage bands by gel electrophoresis. To 
prevent excessive primer dimer formation, SURVEYOR primers should be designed to be 
typically 18 to 25 nt long with melting temperatures of ~60 °C. For SURVEYOR assay or 
sequencing analysis, we recommend testing that each pair of candidate primers produces 
a single PCR product, as well as testing for the absence of nonspecific cleavage during the 
SURVEYOR nuclease digestion process 
 
Design primes to amplify this region with Primer blast 
 
GAGCTCCCAGCCCGCTGCACAGCCCGGCTCCGCTCCACAGTCCCCCACTGCCACCGGCCGGGGCGACACCGGGCGAG
CTGGCGAGACCCGGCTCCAGGACCGAATCGCGCCGACACTTGACGGCGCTCCCCGCCCCTCCCTGCCGCCGTCTCCG
CCCCCGTCCGGTCGCATTCCGGCGCCCGCCGCCGCCGCCGCCACCGCCGCCGATCTGGGAGGCTTGTCCCTCGCCGC
CCACCGTAGCCCCGGCGCTCGGCCGGTCGCCGTTTCCAAGATGGCCGCGGCGCGCACGGCTCCTGCGGCGGGGTAGA
GGCGGAGGCGGAGTCGAGTCACTCCCGCACTTCGGGGCTCCGGTGCCCCGCGCCAGGCTGCAGCTTACTGCCCGCCG
CGGCCATGCGGGGCTCCGTGCACGGATGAGAGAAGCCGCTGCCGCGCTGGTCCCTCCTCCCGCCTTTGCCGTCACGC
CTGCCGCCGCCATGGAGGAGCCGCCGCCACCGCCGCCGCCGCCACCACCGCCACCGGAACCCGAGACCGAGTCAGAA
CCCGAGTGCTGCTTGGCGGCGAGGTGAGTGTGGCGGCCGCAGTCGGTCGCTCGCAGAAAGCGGGGCGGGTCCTGGCC
CGAACTCGGTCGGGCCCGAGGGCCTCTGCTTCCCGCCAGGTGGGGAGGGAAGCATCCAGTCTCTGCAGGCTGGGGCG
GGAGGGGCGCGGTGCATCCCTGGGTCCCAGGGGACCGCGTCTGAGTCTGTCCGGCGACTCCTCCCGGGGTTGCAGCT
CCGCAGGGTTCCGCTCGAGCGTGTTGCCGGCTCCCCTTCCCTTGTAGACTCCCCCAGCTCACCCTCAACGTTGCGGG
GGCTGGGAGCAGAGTGC 
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Primer pair 1 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
CGGCTCCAGGACCGAATC Plus 18 89 106 
59.8
9 
66.67 7.00 3.00 
Reverse 
primer 
CTGGGGGAGTCTACAAGGG
A 
Minus 20 827 808 
59.9
6 
60.00 3.00 0.00 
Internal 
oligo 
 Plus        
Product 
length 
739 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 739 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          CGGCTCCAGGACCGAATC  18 
Template        160991610  ..................  160991627 
 
Reverse primer  1          CTGGGGGAGTCTACAAGGGA  20 
Template        160992348  ....................  160992329 
 
Products on allowed transcript variants 
 
Products on potentially unintended templates 
 
 
Primer pair 2 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
GCTCCACAGTCCCCCACT Plus 18 32 49 
60.9
3 
66.67 3.00 1.00 
Reverse 
primer 
CCTGCAGAGACTGGATGCT
T 
Minus 20 685 666 
59.7
5 
55.00 6.00 2.00 
Internal 
oligo 
 Plus        
Product 
length 
654 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
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product length = 654 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          GCTCCACAGTCCCCCACT  18 
Template        160991553  ..................  160991570 
 
Reverse primer  1          CCTGCAGAGACTGGATGCTT  20 
Template        160992206  ....................  160992187 
 
Products on allowed transcript variants 
 
Products on potentially unintended templates 
 
 
Primer pair 3 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
GCTCCGCTCCACAGTCC Plus 17 27 43 
59.7
7 
70.59 3.00 0.00 
Reverse 
primer 
TGAGCTGGGGGAGTCTACA
A 
Minus 20 831 812 
59.8
8 
55.00 4.00 1.00 
Internal 
oligo 
 Plus        
Product 
length 
805 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 805 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          GCTCCGCTCCACAGTCC  17 
Template        160991548  .................  160991564 
 
Reverse primer  1          TGAGCTGGGGGAGTCTACAA  20 
Template        160992352  ....................  160992333 
 
Products on allowed transcript variants 
 
 
Primer pair 4 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
CTCCACAGTCCCCCACTG Plus 18 33 50 
58.9
3 
66.67 4.00 3.00 
Reverse 
primer 
CAGCCTGCAGAGACTGGAT
G 
Minus 20 688 669 
60.4
6 
60.00 6.00 3.00 
Internal 
oligo 
 Plus        
Product 
length 
656 
Product 
Tm 
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Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 656 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          CTCCACAGTCCCCCACTG  18 
Template        160991554  ..................  160991571 
 
Reverse primer  1          CAGCCTGCAGAGACTGGATG  20 
Template        160992209  ....................  160992190 
 
Products on allowed transcript variants 
 
 
Primer pair 5 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
ACAGTCCCCCACTGCCA Plus 17 37 53 
60.0
9 
64.71 4.00 3.00 
Reverse 
primer 
GAGACTGGATGCTTCCCTC
C 
Minus 20 679 660 
59.5
3 
60.00 6.00 2.00 
Internal 
oligo 
 Plus        
Product 
length 
643 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 643 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          ACAGTCCCCCACTGCCA  17 
Template        160991558  .................  160991574 
 
Reverse primer  1          GAGACTGGATGCTTCCCTCC  20 
Template        160992200  ....................  160992181 
 
Products on allowed transcript variants 
 
 
Primer pair 6 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
GGCTCCGCTCCACAGTC Plus 17 26 42 
59.7
7 
70.59 3.00 1.00 
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Reverse 
primer 
TGGGGGAGTCTACAAGGGA
A 
Minus 20 826 807 
59.5
1 
55.00 3.00 0.00 
Internal 
oligo 
 Plus        
Product 
length 
801 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 801 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          GGCTCCGCTCCACAGTC  17 
Template        160991547  .................  160991563 
 
Reverse primer  1          TGGGGGAGTCTACAAGGGAA  20 
Template        160992347  ....................  160992328 
 
Products on allowed transcript variants 
 
 
Primer pair 7 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
TCCACAGTCCCCCACTGC Plus 18 34 51 
61.2
5 
66.67 4.00 2.00 
Reverse 
primer 
GTCTACAAGGGAAGGGGAG
C 
Minus 20 819 800 
59.4
6 
60.00 2.00 2.00 
Internal 
oligo 
 Plus        
Product 
length 
786 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 786 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          TCCACAGTCCCCCACTGC  18 
Template        160991555  ..................  160991572 
 
Reverse primer  1          GTCTACAAGGGAAGGGGAGC  20 
Template        160992340  ....................  160992321 
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Products on allowed transcript variants 
 
Products on potentially unintended templates 
 
 
 
 
 
 
 
 
 
Primer pair 8 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
CTCCACAGTCCCCCACTGC Plus 19 33 51 
62.2
6 
68.42 4.00 2.00 
Reverse 
primer 
AGCTGGGGGAGTCTACAAG
G 
Minus 20 829 810 
60.6
2 
60.00 4.00 1.00 
Internal 
oligo 
 Plus        
Product 
length 
797 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 797 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          CTCCACAGTCCCCCACTGC  19 
Template        160991554  ...................  160991572 
 
Reverse primer  1          AGCTGGGGGAGTCTACAAGG  20 
Template        160992350  ....................  160992331 
 
Products on allowed transcript variants 
 
 
Primer pair 9 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
GCTCCACAGTCCCCCACTG Plus 19 32 50 
62.2
6 
68.42 4.00 3.00 
Reverse 
primer 
TCTACAAGGGAAGGGGAGC
C 
Minus 20 818 799 
60.6
2 
60.00 2.00 2.00 
Internal 
oligo 
 Plus        
Product 
length 
787 
Product 
Tm 
 
Product 
Tm - 
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min(OLIG
O Tm) 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 787 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          GCTCCACAGTCCCCCACTG  19 
Template        160991553  ...................  160991571 
 
Reverse primer  1          TCTACAAGGGAAGGGGAGCC  20 
Template        160992339  ....................  160992320 
 
Products on allowed transcript variants 
 
 
Primer pair 10 
 Sequence (5'->3') 
Templat
e strand 
Lengt
h 
Star
t 
Sto
p 
Tm 
GC
% 
Self 
complementarit
y 
Self 3' 
complementarit
y 
Forward 
primer 
CCGGCTCCAGGACCGAATC Plus 19 88 106 
62.4
5 
68.42 7.00 3.00 
Reverse 
primer 
GTGAGCTGGGGGAGTCTAC
A 
Minus 20 832 813 
60.6
1 
60.00 4.00 2.00 
Internal 
oligo 
 Plus        
Product 
length 
745 
Product 
Tm 
 
Product 
Tm - 
min(OLIG
O Tm) 
 
Exon 
junction 
 
Total 
intron size 
 
Products on intended target 
 
>NC_000006.12 Homo sapiens chromosome 6, GRCh38 Primary Assembly 
 
product length = 745 
Features associated with this product: 
   mitogen-activated protein kinase kinase kinase 4 isoform a 
 
   mitogen-activated protein kinase kinase kinase 4 isoform b 
 
Forward primer  1          CCGGCTCCAGGACCGAATC  19 
Template        160991609  ...................  160991627 
 
Reverse primer  1          GTGAGCTGGGGGAGTCTACA  20 
Template        160992353  ....................  160992334 
 
Products on allowed transcript variants 
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